data_1i1s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i1s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.634 ' H ' ' HG1' ' A' ' 19' ' ' THR . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 52' ' ' ASN . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.687 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.489 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.489 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.578 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.506 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.506 HD22 ' C ' ' A' ' 48' ' ' VAL . 82.4 m-20 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' HZ2' ' A' ' 59' ' ' LYS . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HZ2' HG21 ' A' ' 55' ' ' VAL . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.501 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.687 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.601 ' H ' ' HG1' ' A' ' 19' ' ' THR . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.601 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.692 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.544 0.741 0 CA-C-O 121.614 0.721 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.471 ' C ' HD21 ' A' ' 52' ' ' ASN . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 48' ' ' VAL . 76.2 m-20 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG23 ' HZ3' ' A' ' 58' ' ' LYS . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HZ3' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.63 ' H ' ' HG1' ' A' ' 19' ' ' THR . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.666 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.435 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.555 0.693 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' C ' HD22 ' A' ' 52' ' ' ASN . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.5 m-20 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.666 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.852 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.852 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.648 ' H ' ' HG1' ' A' ' 19' ' ' THR . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HZ1' HG13 ' A' ' 48' ' ' VAL . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.648 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.686 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.435 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' H ' ' HG1' ' A' ' 33' ' ' THR . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.624 HG13 ' HZ1' ' A' ' 18' ' ' LYS . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.409 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.5 m-20 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.523 ' CG2' ' HZ3' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.523 ' HZ3' ' CG2' ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.686 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.401 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' H ' ' HG1' ' A' ' 19' ' ' THR . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.576 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.678 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.603 HH21 ' HB2' ' A' ' 46' ' ' ASN . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.603 ' HB2' HH21 ' A' ' 38' ' ' ARG . 5.2 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.175 0.512 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' C ' HD22 ' A' ' 52' ' ' ASN . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.9 m-20 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HZ1' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HZ1' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.678 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.811 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.811 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.657 ' CG1' ' HZ3' ' A' ' 59' ' ' LYS . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.587 ' H ' ' HG1' ' A' ' 19' ' ' THR . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.587 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.691 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' C ' HD22 ' A' ' 52' ' ' ASN . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.9 m-20 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HZ3' ' CG1' ' A' ' 14' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' H ' ' HG1' ' A' ' 19' ' ' THR . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.684 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.493 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.9 m-20 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 HD11 ' CB ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.684 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.775 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.775 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.716 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.6 ' H ' ' HG1' ' A' ' 19' ' ' THR . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.6 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 52' ' ' ASN . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' H ' ' HG1' ' A' ' 33' ' ' THR . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.482 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 48' ' ' VAL . 82.0 m-20 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.524 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.637 ' H ' ' HG1' ' A' ' 19' ' ' THR . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.637 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.415 HH21 ' ND2' ' A' ' 50' ' ' ASN . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' C ' HD22 ' A' ' 52' ' ' ASN . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' ND2' HH21 ' A' ' 38' ' ' ARG . 1.2 t-20 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.431 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.5 m-20 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.657 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 15' ' ' LEU . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.485 ' H ' ' HG1' ' A' ' 19' ' ' THR . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.485 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.692 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.516 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.516 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' C ' HD22 ' A' ' 52' ' ' ASN . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 48' ' ' VAL . 84.5 m-20 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.517 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.643 ' H ' ' HG1' ' A' ' 19' ' ' THR . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HZ1' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.643 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.662 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HH22 ' A' ' 38' ' ' ARG . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.575 HH22 ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.596 HG11 ' HZ1' ' A' ' 18' ' ' LYS . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.462 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.0 m-20 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.522 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HZ2' ' HA3' ' A' ' 66' ' ' GLY . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.522 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.662 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.651 ' H ' ' HG1' ' A' ' 19' ' ' THR . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.664 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB1' HH22 ' A' ' 38' ' ' ARG . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HE ' HD22 ' A' ' 46' ' ' ASN . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.639 HD22 ' HE ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.223 -0.341 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' C ' HD22 ' A' ' 52' ' ' ASN . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.447 HD21 ' NH2' ' A' ' 38' ' ' ARG . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.0 m-20 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.52 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.52 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.633 ' H ' ' HG1' ' A' ' 19' ' ' THR . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 . . . . . 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' C ' HD22 ' A' ' 52' ' ' ASN . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.0 m-20 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' H ' ' HG1' ' A' ' 19' ' ' THR . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.531 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.679 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' H ' ' HG1' ' A' ' 33' ' ' THR . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.445 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.5 m-20 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.679 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' CD ' ' HG1' ' A' ' 72' ' ' THR . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.414 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 15' ' ' LEU . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' H ' ' HG1' ' A' ' 19' ' ' THR . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.454 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.669 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.499 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.499 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' C ' HD22 ' A' ' 52' ' ' ASN . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' C ' ' A' ' 48' ' ' VAL . 83.9 m-20 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' H ' ' HG1' ' A' ' 19' ' ' THR . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.674 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.514 0.673 . . . . 0.0 112.143 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' C ' HD22 ' A' ' 52' ' ' ASN . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.8 m-20 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.674 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.747 ' CG1' ' HZ2' ' A' ' 59' ' ' LYS . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.488 ' H ' ' HG1' ' A' ' 19' ' ' THR . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASN . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HZ3' HG11 ' A' ' 48' ' ' VAL . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.488 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HZ2' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.721 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.223 0.535 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.564 HG11 ' HZ3' ' A' ' 18' ' ' LYS . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HZ2' ' CG1' ' A' ' 14' ' ' VAL . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.404 HD13 ' CB ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.721 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.803 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.803 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.529 HG13 ' HZ2' ' A' ' 59' ' ' LYS . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' H ' ' HG1' ' A' ' 19' ' ' THR . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.627 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 69' ' ' LEU . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.489 0.661 . . . . 0.0 112.569 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' C ' HD22 ' A' ' 52' ' ' ASN . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.445 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.5 m-20 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HZ2' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.849 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.448 ' HA2' HE21 ' A' ' 76' ' ' GLN . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.849 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.448 HE21 ' HA2' ' A' ' 73' ' ' GLY . 34.9 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.612 ' H ' ' HG1' ' A' ' 19' ' ' THR . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 16' ' ' ASN . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.612 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.685 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 . . . . . 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.482 0.658 . . . . 0.0 112.208 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' C ' HD22 ' A' ' 52' ' ' ASN . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.0 m-20 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.685 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' HZ2' ' A' ' 59' ' ' LYS . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.585 ' H ' ' HG1' ' A' ' 19' ' ' THR . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.585 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.666 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 52' ' ' ASN . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.454 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.1 m-20 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HZ2' ' CG1' ' A' ' 14' ' ' VAL . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.666 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mmm . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.761 0.791 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.638 ' HG ' ' H ' ' A' ' 3' ' ' LYS . 13.8 t 71.19 158.93 0.2 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.999 -1.91 . . . . 0.0 110.119 116.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.638 ' H ' ' HG ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -64.05 -25.9 68.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.439 -119.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.66 -38.93 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.302 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.634 ' H ' ' HG1' ' A' ' 19' ' ' THR . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.687 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.489 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.489 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.578 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 -71.21 -41.07 70.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.61 -55.36 17.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.074 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -56.94 123.66 60.52 Favored Pre-proline 0 N--CA 1.439 -0.979 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.128 -145.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -62.67 -62.51 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.508 1.472 . . . . 0.0 111.998 144.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.25 49.14 2.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 112.713 -2.039 . . . . 0.0 110.355 -160.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 6.4 mp -95.14 -66.04 0.94 Allowed 'General case' 0 C--N 1.35 0.607 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.733 154.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.94 114.47 2.66 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 113.954 -1.475 . . . . 0.0 111.043 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -51.92 -45.23 64.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 118.584 -1.246 . . . . 0.0 113.177 -161.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.506 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.506 HD22 ' C ' ' A' ' 48' ' ' VAL . 82.4 m-20 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' HZ2' ' A' ' 59' ' ' LYS . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HZ2' HG21 ' A' ' 55' ' ' VAL . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.501 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.687 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -47.48 73.23 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.46 67.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.039 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -61.45 -36.73 81.22 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.582 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.4 mt -68.33 -37.2 80.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.662 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -45.22 64.03 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.365 160.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.76 92.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.155 -1.418 . . . . 0.0 112.413 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.94 -43.11 95.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.159 -1.816 . . . . 0.0 112.28 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -48.69 6.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.362 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -66.29 -64.72 0.8 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 116.668 -2.013 . . . . 0.0 110.18 165.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB1' ' H ' ' A' ' 95' ' ' LEU . . . 59.91 81.87 0.24 Allowed Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.577 -170.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.91 134.15 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.348 2.032 . . . . 0.0 111.075 157.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.71 119.87 11.38 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 118.087 -1.445 . . . . 0.0 109.752 -95.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.13 -55.89 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.821 -140.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' H ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 tm? -127.89 -62.61 1.06 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.631 -172.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.347 0.489 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.728 159.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 121.943 0.878 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -167.72 -69.39 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.858 -142.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -74.05 -52.29 13.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.106 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.788 -160.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' H ' ' HG1' ' A' ' 19' ' ' THR . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.601 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.692 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.93 -41.18 71.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.91 -13.74 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.497 -172.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 123.52 85.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.872 163.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 -63.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.213 1.942 . . . . 0.0 111.386 126.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.41 -9.68 32.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.777 -144.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 mp -76.27 -69.1 0.52 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.049 -166.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 130.05 133.18 3.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.52 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.15 -50.25 67.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 117.758 -1.577 . . . . 0.0 111.893 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.471 ' C ' HD21 ' A' ' 52' ' ' ASN . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 48' ' ' VAL . 76.2 m-20 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG23 ' HZ3' ' A' ' 58' ' ' LYS . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HZ3' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.44 73.8 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.89 -38.71 67.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.48 -1.237 . . . . 0.0 112.465 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 m -61.75 -42.63 99.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.13 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 69.7 mt -60.06 -38.28 82.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.25 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -50.23 74.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.667 162.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.85 70.2 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.681 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -57.07 -43.12 81.76 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.544 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.0 -57.38 2.17 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.987 -150.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.13 -62.3 1.71 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.559 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.58 82.94 0.23 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 113.547 -1.661 . . . . 0.0 110.904 153.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -75.85 144.71 27.84 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.288 1.992 . . . . 0.0 111.327 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.85 111.87 3.48 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.639 -91.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.19 -52.01 0.83 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.898 -153.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.37 -59.02 5.59 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.96 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 C--N 1.348 0.525 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.769 -114.032 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 122.003 0.906 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t -77.88 -63.54 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 112.783 -2.008 . . . . 0.0 110.171 -155.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -52.26 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.294 -155.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.8 m -58.88 -38.78 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.695 -160.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.63 ' H ' ' HG1' ' A' ' 19' ' ' THR . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.05 -41.17 71.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.64 -12.85 12.21 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.588 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 124.23 88.79 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 117.369 -1.732 . . . . 0.0 109.842 163.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 -63.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.964 1.776 . . . . 0.0 111.644 129.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.72 43.6 3.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.993 -151.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.96 -68.5 0.8 Allowed 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.63 159.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 131.96 134.0 3.52 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.655 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -56.44 -50.23 72.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.774 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' C ' HD22 ' A' ' 52' ' ' ASN . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.5 m-20 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.666 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.852 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.852 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.75 85.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.213 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.7 m -61.81 -38.01 86.53 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.48 168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 75.7 mt -63.85 -35.95 82.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.597 177.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -50.18 70.42 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.435 158.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.05 -40.34 76.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.585 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -55.93 -40.2 72.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.634 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 3.1 mm-40 -103.58 -41.41 5.97 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.831 -153.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -63.67 -64.99 0.75 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 117.201 -1.8 . . . . 0.0 110.109 153.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.34 82.92 0.23 Allowed Pre-proline 0 C--N 1.347 0.497 0 CA-C-N 112.866 -1.97 . . . . 0.0 111.29 -168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -82.73 130.33 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.241 1.96 . . . . 0.0 111.656 160.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.79 133.79 48.82 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 117.085 -1.846 . . . . 0.0 109.515 -84.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.74 -57.9 0.15 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 112.581 -2.099 . . . . 0.0 109.656 -149.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' A' ' 96' ' ' LYS . 1.3 tp -163.0 -63.94 0.04 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.726 -2.034 . . . . 0.0 109.994 -156.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HB3' ' H ' ' A' ' 95' ' ' LEU . 5.2 pttt . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.556 129.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.829 0.823 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 64.34 173.34 0.19 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.172 -1.831 . . . . 0.0 110.04 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -25.62 68.18 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.958 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 m -58.44 -38.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -140.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.648 ' H ' ' HG1' ' A' ' 19' ' ' THR . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HZ1' HG13 ' A' ' 48' ' ' VAL . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.648 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.686 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' H ' ' HG1' ' A' ' 33' ' ' THR . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.02 -41.2 71.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.04 -11.23 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.552 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.402 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -66.78 124.06 87.57 Favored Pre-proline 0 N--CA 1.442 -0.875 0 C-N-CA 117.572 -1.651 . . . . 0.0 109.86 161.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -65.33 -63.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.022 1.815 . . . . 0.0 111.667 129.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.78 41.43 3.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.168 -150.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.15 -69.05 0.77 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.576 160.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 130.27 135.12 3.79 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.355 175.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -58.19 -50.07 74.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 116.707 -1.997 . . . . 0.0 112.534 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.624 HG13 ' HZ1' ' A' ' 18' ' ' LYS . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.409 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.5 m-20 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.523 ' CG2' ' HZ3' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.523 ' HZ3' ' CG2' ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.686 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.401 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.24 74.81 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.68 67.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 118.251 -1.38 . . . . 0.0 112.248 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -61.59 -37.0 82.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.746 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.55 -39.77 94.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.531 -1.267 . . . . 0.0 113.181 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -41.4 61.4 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.64 160.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.59 99.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.809 -1.557 . . . . 0.0 112.201 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -59.36 -43.12 92.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 117.005 -1.878 . . . . 0.0 112.435 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.44 -61.32 1.38 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.971 -166.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.8 -52.61 62.49 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 113.395 -1.73 . . . . 0.0 110.636 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.01 84.26 0.18 Allowed Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.191 145.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -74.15 147.59 38.16 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.723 2.282 . . . . 0.0 111.456 153.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.04 77.82 0.02 OUTLIER 'General case' 0 C--N 1.348 0.523 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.919 -91.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -43.05 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 112.016 -2.356 . . . . 0.0 111.389 -150.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -59.94 0.76 Allowed 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.015 -154.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mttm . . . . . 0 C--N 1.349 0.572 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.899 -135.409 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.821 0.82 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -55.78 26.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.122 151.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.86 -52.29 60.71 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.884 -164.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 m -59.03 -41.21 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.288 -1.323 . . . . 0.0 112.524 -163.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' H ' ' HG1' ' A' ' 19' ' ' THR . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.576 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.603 HH21 ' HB2' ' A' ' 46' ' ' ASN . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.03 -41.3 71.03 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' O ' ' CD ' ' A' ' 42' ' ' PRO . 9.0 p -91.58 -7.5 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.055 -173.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.508 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -61.87 109.46 2.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 109.071 134.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.508 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 1.6 Cg_endo -67.66 -57.22 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.995 2.464 . . . . 0.0 112.168 127.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.03 -43.5 57.67 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.478 -2.146 . . . . 0.0 112.119 -156.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . 6.9 mp -66.26 -65.49 0.67 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.273 -142.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.46 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 140.02 136.5 3.36 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.237 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.603 ' HB2' HH21 ' A' ' 38' ' ' ARG . 5.2 p30 -62.99 -50.1 72.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.613 -2.035 . . . . 0.0 112.081 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' C ' HD22 ' A' ' 52' ' ' ASN . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.9 m-20 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG22 ' HZ1' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HZ1' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.678 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.811 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.811 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.29 -48.14 71.34 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.66 68.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.374 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 m -61.55 -42.71 99.23 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.279 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 54.0 mt -58.92 -40.0 83.27 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 118.399 -1.321 . . . . 0.0 113.012 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -50.16 74.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.734 163.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -36.21 62.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.632 -168.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 6.3 pt20 -57.64 -43.2 84.71 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.485 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.51 -56.58 2.28 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.053 -156.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.22 -50.88 71.28 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB2' ' H ' ' A' ' 95' ' ' LEU . . . 64.56 83.6 0.19 Allowed Pre-proline 0 C--N 1.348 0.504 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.475 145.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -75.44 141.99 26.06 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.684 2.256 . . . . 0.0 111.808 156.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.5 77.18 0.04 OUTLIER 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.678 -87.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.83 -44.49 7.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 111.812 -2.449 . . . . 0.0 111.201 -156.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' H ' ' HB2' ' A' ' 91' ' ' ALA . 16.5 mt -64.87 -59.64 3.97 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.119 161.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.349 0.558 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.642 -98.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.25 0.547 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.459 ' HG ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 62.85 -176.17 0.15 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.877 102.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' N ' ' HG ' ' A' ' 2' ' ' SER . 2.6 ttmm -63.74 -48.1 78.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.278 -42.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -58.6 -38.37 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.391 -163.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.657 ' CG1' ' HZ3' ' A' ' 59' ' ' LYS . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.587 ' H ' ' HG1' ' A' ' 19' ' ' THR . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.587 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.691 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 -71.04 -41.14 71.18 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.81 -55.6 14.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.054 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -55.2 123.38 48.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 O-C-N 124.84 1.338 . . . . 0.0 111.224 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.48 -62.91 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 O-C-N 123.84 1.442 . . . . 0.0 111.921 141.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -135.59 47.63 2.27 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.711 -2.041 . . . . 0.0 110.384 -158.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 5.8 mp -89.93 -68.84 0.76 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.22 152.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.15 110.55 2.09 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.016 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -51.88 -46.76 64.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.988 -160.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' C ' HD22 ' A' ' 52' ' ' ASN . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.9 m-20 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HZ3' ' CG1' ' A' ' 14' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -47.98 72.17 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.47 67.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.157 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -61.73 -38.41 87.8 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.966 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.59 -40.96 98.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.01 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -43.15 62.71 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.221 160.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.14 -41.66 90.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.689 -172.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 6.4 pt20 -55.86 -42.46 75.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.251 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.45 -57.09 2.33 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.398 -156.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -58.66 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.895 174.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 62.3 56.56 2.62 Favored Pre-proline 0 C--N 1.345 0.384 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.389 143.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 94' ' ' LEU . 5.2 Cg_exo -57.84 -52.02 6.86 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 113.824 -146.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -142.28 105.26 4.57 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.483 144.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.415 ' CD1' ' HD2' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -171.98 -52.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 112.557 -2.111 . . . . 0.0 110.16 -142.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -112.64 -61.97 1.65 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.831 168.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HZ2' ' HB2' ' A' ' 96' ' ' LYS . 6.8 mtmp? . . . . . 0 C--N 1.347 0.46 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.714 -115.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 121.994 0.902 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.4 p -81.42 -168.05 1.71 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.645 -160.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -63.91 -52.31 60.46 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.085 -166.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 m -58.87 -38.68 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.666 -162.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' H ' ' HG1' ' A' ' 19' ' ' THR . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.684 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.493 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.13 -41.12 70.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.17 -9.47 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.75 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 123.96 87.76 Favored Pre-proline 0 N--CA 1.442 -0.838 0 C-N-CA 117.458 -1.697 . . . . 0.0 109.879 162.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.05 -63.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.025 1.817 . . . . 0.0 111.779 131.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.68 45.39 2.79 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.902 -152.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.96 -64.52 1.12 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.956 157.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.79 114.37 2.37 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.869 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -51.95 -46.02 64.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.599 -1.24 . . . . 0.0 113.055 -162.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.9 m-20 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 HD11 ' CB ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.684 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.775 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.775 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.56 73.14 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.49 67.51 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.09 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.8 m -61.61 -37.62 84.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.726 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.32 -39.3 93.63 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 118.594 -1.243 . . . . 0.0 113.331 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -44.95 63.69 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.259 159.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.89 94.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.915 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.98 -43.17 86.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 117.543 -1.663 . . . . 0.0 112.493 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -91.46 -61.94 1.54 Allowed 'General case' 0 C--N 1.35 0.624 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.161 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -53.28 58.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.756 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 62.51 99.65 0.04 OUTLIER Pre-proline 0 C--N 1.348 0.517 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.574 162.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -57.7 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.993 1.795 . . . . 0.0 113.159 155.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -134.8 59.32 1.74 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.709 -155.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.98 -65.06 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.312 -134.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -131.2 -65.13 0.78 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.415 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.347 0.487 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.097 -176.127 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 121.886 0.85 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -174.13 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.749 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -71.48 -52.31 19.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.114 137.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.76 -39.47 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 118.2 -1.4 . . . . 0.0 112.563 -159.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.716 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.6 ' H ' ' HG1' ' A' ' 19' ' ' THR . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.6 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 52' ' ' ASN . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' H ' ' HG1' ' A' ' 33' ' ' THR . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.9 -41.14 71.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.38 -10.26 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.66 -171.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 124.12 87.4 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.904 160.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.69 -65.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.038 1.825 . . . . 0.0 111.637 130.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -126.68 41.27 3.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.252 -150.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.95 -67.6 0.85 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.605 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 128.09 122.65 2.52 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.492 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -52.51 -49.73 64.2 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.958 -1.497 . . . . 0.0 112.942 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.482 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 48' ' ' VAL . 82.0 m-20 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.524 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.02 75.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.58 68.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.37 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 m -61.67 -36.86 82.06 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 117.434 -1.707 . . . . 0.0 112.219 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.75 -42.61 95.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.116 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.9 -41.49 61.99 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.551 163.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.11 87.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.178 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.08 -43.14 99.34 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.035 -1.866 . . . . 0.0 112.272 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.6 mt-10 -92.68 -52.89 4.41 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.087 -171.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -56.41 22.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.817 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . 61.31 84.2 0.2 Allowed Pre-proline 0 C--N 1.347 0.479 0 CA-C-N 113.363 -1.744 . . . . 0.0 110.692 152.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -73.75 140.05 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.718 2.279 . . . . 0.0 111.359 152.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.1 76.86 0.01 OUTLIER 'General case' 0 C--N 1.35 0.602 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.457 -100.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 ' HB2' ' CB ' ' A' ' 91' ' ' ALA . 2.1 mt -88.25 -56.67 3.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 111.825 -2.443 . . . . 0.0 110.716 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.9 tp -144.47 59.65 1.33 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.777 -2.01 . . . . 0.0 109.82 -153.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm . . . . . 0 C--N 1.347 0.477 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.68 147.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' C ' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 122.016 0.913 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 1' ' ' MET . 1.8 m -159.13 105.41 1.73 Allowed 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.363 -142.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -63.93 -52.51 59.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.983 171.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.9 m -61.02 -38.78 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.781 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.637 ' H ' ' HG1' ' A' ' 19' ' ' THR . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.637 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.415 HH21 ' ND2' ' A' ' 50' ' ' ASN . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.01 -41.13 71.32 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.21 -10.52 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.549 -170.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.413 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -66.6 123.79 86.66 Favored Pre-proline 0 N--CA 1.442 -0.855 0 C-N-CA 117.626 -1.63 . . . . 0.0 109.824 160.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -65.51 -64.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.88 1.72 . . . . 0.0 111.574 131.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -127.2 42.27 3.36 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.119 -151.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.38 -66.35 0.92 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.521 160.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 126.52 128.46 3.17 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.155 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -53.62 -50.03 66.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 117.501 -1.679 . . . . 0.0 112.862 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' C ' HD22 ' A' ' 52' ' ' ASN . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' ND2' HH21 ' A' ' 38' ' ' ARG . 1.2 t-20 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.431 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.5 m-20 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.657 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.29 -48.47 70.29 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.37 67.33 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.045 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -61.73 -37.06 82.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 117.678 -1.609 . . . . 0.0 112.5 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.74 -43.98 94.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.671 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -39.91 59.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.813 164.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.21 90.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 118.211 -1.396 . . . . 0.0 112.207 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.98 -43.23 99.28 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.001 -1.88 . . . . 0.0 112.353 -168.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.3 -64.34 1.17 Allowed 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.607 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.434 HD21 ' N ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -69.43 -50.91 41.3 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.62 -168.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' N ' HD21 ' A' ' 90' ' ' ASN . . . 66.2 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.322 161.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD3' HD21 ' A' ' 90' ' ' ASN . 6.7 Cg_endo -78.61 156.81 28.26 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.695 2.263 . . . . 0.0 111.462 154.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -48.84 79.46 0.0 OUTLIER 'General case' 0 C--N 1.351 0.66 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.211 -114.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -110.68 -38.0 5.28 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.436 -2.62 . . . . 0.0 111.235 -160.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -149.74 -43.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.637 -139.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm . . . . . 0 C--N 1.351 0.633 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.851 -153.293 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.925 0.869 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -162.22 74.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.598 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -63.96 -52.18 60.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.093 165.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -58.85 -38.7 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.39 -164.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 15' ' ' LEU . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' H ' ' HG1' ' A' ' 19' ' ' THR . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.692 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.516 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.516 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.14 -37.86 72.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -52.91 -56.72 6.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.195 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.46 126.11 81.38 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.733 -144.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.62 -62.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 O-C-N 123.923 1.486 . . . . 0.0 111.788 140.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.59 48.24 2.44 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.279 -158.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.9 -75.83 0.56 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.96 152.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 129.22 136.41 4.1 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.76 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -56.98 -50.12 73.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.627 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' C ' HD22 ' A' ' 52' ' ' ASN . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 48' ' ' VAL . 84.5 m-20 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.517 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.63 73.35 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.45 67.39 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.892 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -61.62 -36.94 82.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 118.254 -1.378 . . . . 0.0 112.59 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.45 -39.58 92.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 118.553 -1.259 . . . . 0.0 113.27 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.78 -41.56 61.74 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 159.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' O ' ' CA ' ' A' ' 91' ' ' ALA . . . -60.68 -45.54 93.77 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 117.945 -1.502 . . . . 0.0 111.84 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -55.85 -43.14 76.78 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 117.099 -1.84 . . . . 0.0 112.392 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.69 -61.39 1.68 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.874 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -49.97 74.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 117.051 -1.859 . . . . 0.0 110.887 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' CA ' ' O ' ' A' ' 87' ' ' ALA . . . 56.23 93.69 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.609 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.286 159.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -78.98 110.8 2.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.604 1.536 . . . . 0.0 113.929 166.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.42 52.23 2.18 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.815 -96.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 29.07 -73.5 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.435 -1.712 . . . . 0.0 113.317 103.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.7 mt -108.96 -61.86 1.56 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.698 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.4 mttm . . . . . 0 C--N 1.352 0.677 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.482 -103.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.801 0.81 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 3' ' ' LYS . 82.7 p -168.95 -65.0 0.02 OUTLIER 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.919 -166.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.721 ' H ' ' HG ' ' A' ' 2' ' ' SER . 26.4 ttmt -64.09 -52.35 59.67 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.99 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.8 -39.35 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.757 -162.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.643 ' H ' ' HG1' ' A' ' 19' ' ' THR . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HZ1' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.643 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.662 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HH22 ' A' ' 38' ' ' ARG . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.575 HH22 ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.01 -41.24 71.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.07 -9.61 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.524 -170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -66.3 122.62 82.39 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.812 157.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 1.6 Cg_endo -64.22 -63.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.013 1.809 . . . . 0.0 111.729 132.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.14 47.28 2.43 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 112.674 -2.057 . . . . 0.0 110.715 -153.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.35 -73.19 0.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.858 155.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.92 -127.8 3.31 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.498 -159.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -66.63 -34.04 77.0 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 127.01 2.124 . . . . 0.0 115.397 7.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.596 HG11 ' HZ1' ' A' ' 18' ' ' LYS . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.462 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.0 m-20 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.522 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HZ2' ' HA3' ' A' ' 66' ' ' GLY . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.522 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.662 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.47 74.15 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.55 67.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.144 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 m -61.82 -40.34 94.95 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.523 172.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.87 -41.36 95.8 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.916 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.51 61.81 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.919 -1.492 . . . . 0.0 111.622 162.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.27 94.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.139 -1.425 . . . . 0.0 111.979 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -57.75 -43.05 85.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 117.459 -1.696 . . . . 0.0 112.479 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.09 -60.55 1.52 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.037 -166.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.428 HD21 ' N ' ' A' ' 91' ' ' ALA . 1.6 t30 -65.25 -56.73 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' N ' HD21 ' A' ' 90' ' ' ASN . . . 67.15 76.59 0.27 Allowed Pre-proline 0 C--N 1.346 0.447 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.663 150.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.11 119.06 6.06 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.471 1.448 . . . . 0.0 112.106 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 26.95 45.42 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.631 -1.622 . . . . 0.0 114.241 -160.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.4 mt -103.2 -43.01 5.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.473 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 mt -52.79 -50.82 62.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.703 -1.589 . . . . 0.0 111.665 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 tttm . . . . . 0 C--N 1.349 0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.936 -110.344 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 121.769 0.795 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -76.21 65.69 2.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.018 170.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -67.38 -52.25 42.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.081 -1.872 . . . . 0.0 111.214 143.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.93 -38.94 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.685 -152.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.651 ' H ' ' HG1' ' A' ' 19' ' ' THR . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.664 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB1' HH22 ' A' ' 38' ' ' ARG . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HE ' HD22 ' A' ' 46' ' ' ASN . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.06 -41.15 71.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.62 -15.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.378 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -67.41 124.06 88.17 Favored Pre-proline 0 N--CA 1.441 -0.883 0 C-N-CA 117.521 -1.672 . . . . 0.0 109.754 163.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 1.8 Cg_endo -63.38 -64.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.882 1.721 . . . . 0.0 111.808 131.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.26 48.38 2.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.604 -154.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.39 -73.16 0.61 Allowed 'General case' 0 C--N 1.35 0.606 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.025 157.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.37 -147.98 6.97 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -162.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.639 HD22 ' HE ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -66.73 -50.17 63.65 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.816 2.446 . . . . 0.0 113.713 28.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' C ' HD22 ' A' ' 52' ' ' ASN . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.447 HD21 ' NH2' ' A' ' 38' ' ' ARG . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.0 m-20 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.52 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.52 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.48 73.83 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.38 67.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.245 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.8 m -61.73 -39.18 90.63 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.881 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.38 -39.86 94.58 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 118.444 -1.302 . . . . 0.0 113.221 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -46.69 64.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.968 159.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.85 98.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.805 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -55.91 -43.01 76.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.384 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.8 mm-40 -97.96 -50.36 4.44 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.047 -162.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -63.71 -64.33 0.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 117.464 -1.694 . . . . 0.0 110.242 165.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.38 68.89 2.01 Favored Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.144 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.07 -53.34 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 O-C-N 123.778 1.409 . . . . 0.0 113.874 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -151.85 86.81 1.32 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.45 -58.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 111.857 -2.429 . . . . 0.0 109.473 -133.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.8 mt -130.49 -58.5 1.04 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.151 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 C--N 1.348 0.512 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.731 -105.306 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.916 0.865 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' A' ' 5' ' ' THR . 13.9 t 63.52 60.23 1.13 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.659 160.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -68.66 -52.23 33.46 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.301 98.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -58.83 -38.73 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.756 -162.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HA ' ' A' ' 2' ' ' SER . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.633 ' H ' ' HG1' ' A' ' 19' ' ' THR . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 -71.21 -41.16 70.58 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.52 -55.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.97 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -56.22 122.71 50.51 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.204 -147.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.8 -62.57 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 O-C-N 123.802 1.422 . . . . 0.0 111.877 144.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.03 48.17 2.3 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.549 -159.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -96.56 -66.26 0.92 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.449 153.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 121.72 124.46 3.04 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.328 175.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -53.02 -49.04 67.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 117.858 -1.537 . . . . 0.0 112.982 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' C ' HD22 ' A' ' 52' ' ' ASN . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.0 m-20 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.13 -47.08 75.27 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.6 67.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.071 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -61.7 -39.76 92.6 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.537 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.85 -40.83 96.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 119.289 -0.964 . . . . 0.0 113.038 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -39.89 59.51 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.411 161.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.92 -46.49 84.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.03 -2.268 . . . . 0.0 112.004 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -58.7 -43.06 89.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 117.056 -1.858 . . . . 0.0 112.505 -164.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -70.82 -67.09 0.53 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.029 164.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -78.59 -79.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.63 -1.623 . . . . 0.0 109.878 -164.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 22.93 47.9 0.09 OUTLIER Pre-proline 0 C--N 1.349 0.557 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.401 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.76 173.12 2.38 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 O-C-N 124.036 1.546 . . . . 0.0 110.93 -138.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 102.57 0.08 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.858 -56.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.22 -52.02 3.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.03 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -146.49 -56.17 0.27 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.043 -153.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.35 0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.354 158.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.557 ' H ' ' H ' ' A' ' 4' ' ' VAL . 3.0 t 176.29 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.348 0.535 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.569 48.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.858 ' HZ1' ' HZ3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -66.11 -25.55 67.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.263 -1.789 . . . . 0.0 113.805 154.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.557 ' H ' ' H ' ' A' ' 2' ' ' SER . 23.2 m -58.69 -38.61 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -151.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' H ' ' HG1' ' A' ' 19' ' ' THR . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.531 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.858 ' HZ3' ' HZ1' ' A' ' 3' ' ' LYS . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' H ' ' HG1' ' A' ' 33' ' ' THR . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 -71.15 -41.16 70.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -55.04 -55.63 15.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.106 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -56.35 122.04 46.76 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.235 -147.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.07 -61.3 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 O-C-N 123.657 1.346 . . . . 0.0 112.406 146.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -143.47 52.13 1.35 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.327 -164.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 5.7 mp -88.34 -64.32 1.16 Allowed 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.637 149.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 118.95 120.89 2.96 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.619 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -52.19 -47.48 65.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.204 -166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' C ' HD22 ' A' ' 52' ' ' ASN . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.445 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.5 m-20 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.679 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' CD ' ' HG1' ' A' ' 72' ' ' THR . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.32 71.01 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.48 67.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.295 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.5 m -61.74 -38.84 89.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 118.444 -1.302 . . . . 0.0 112.828 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 61.6 mt -64.2 -38.84 92.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 118.998 -1.081 . . . . 0.0 113.397 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -46.81 64.41 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.88 158.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.59 83.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.669 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.1 pt20 -55.91 -40.12 72.6 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.433 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -120.43 -44.56 2.46 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.651 -146.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -62.42 -66.14 0.58 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 117.741 -1.584 . . . . 0.0 109.767 151.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.97 65.72 4.13 Favored Pre-proline 0 C--N 1.346 0.452 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.481 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.1 -55.35 3.96 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 O-C-N 123.86 1.452 . . . . 0.0 113.52 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.62 64.49 1.24 Allowed 'General case' 0 C--N 1.345 0.384 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.178 -172.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.02 -64.47 0.06 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.213 -134.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -171.81 51.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.806 -2.452 . . . . 0.0 110.823 -155.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--N 1.35 0.593 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.588 -173.086 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.949 0.88 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -177.1 152.77 0.92 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.682 -140.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' HZ2' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.91 -25.78 68.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.889 -162.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 m -58.62 -38.97 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.305 -157.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.414 ' CG1' ' HZ1' ' A' ' 59' ' ' LYS . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 15' ' ' LEU . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' H ' ' HG1' ' A' ' 19' ' ' THR . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.454 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.574 HG23 ' HZ2' ' A' ' 3' ' ' LYS . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.669 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.499 ' HG1' ' H ' ' A' ' 36' ' ' GLU . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.499 ' H ' ' HG1' ' A' ' 33' ' ' THR . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.12 -41.13 70.95 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.49 -9.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.449 -169.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 124.4 88.53 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 117.423 -1.711 . . . . 0.0 109.904 160.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.81 -63.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.947 1.765 . . . . 0.0 111.536 129.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.19 43.06 3.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.079 -151.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.66 -68.63 0.79 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.707 159.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 129.08 133.34 3.62 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.348 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -57.6 -50.07 74.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 116.487 -2.085 . . . . 0.0 112.6 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' C ' HD22 ' A' ' 52' ' ' ASN . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' C ' ' A' ' 48' ' ' VAL . 83.9 m-20 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.39 -47.61 72.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.58 67.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.599 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 m -61.54 -41.12 96.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.323 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.17 -43.01 96.16 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.727 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -50.13 69.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.872 165.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -30.24 45.39 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.934 -166.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -65.95 -43.16 88.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.534 -1.666 . . . . 0.0 112.548 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.1 -57.08 2.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.174 -156.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.02 -60.43 3.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.916 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB1' ' H ' ' A' ' 96' ' ' LYS . . . 56.02 82.39 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.211 152.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -76.67 158.13 35.68 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.549 2.166 . . . . 0.0 111.412 160.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.6 78.91 0.01 OUTLIER 'General case' 0 C--N 1.35 0.621 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.454 -95.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt -99.3 -47.14 5.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.556 -2.565 . . . . 0.0 110.845 -163.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -180.0 -65.71 0.01 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.673 -132.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' H ' ' HB1' ' A' ' 91' ' ' ALA . 9.1 mmtp . . . . . 0 C--N 1.348 0.52 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.916 159.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.723 0.773 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -91.52 84.35 5.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.272 -1.786 . . . . 0.0 109.616 148.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -25.66 68.15 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.706 147.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.4 m -58.61 -38.95 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.455 -158.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' H ' ' HG1' ' A' ' 19' ' ' THR . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.674 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.99 -41.25 71.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.06 -11.8 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.529 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.453 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -67.44 124.61 89.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 C-N-CA 117.429 -1.709 . . . . 0.0 109.79 159.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -66.49 -62.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.085 1.857 . . . . 0.0 111.825 130.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -129.49 43.55 3.12 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.951 -152.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.05 -69.25 0.76 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.334 156.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 135.58 138.03 3.8 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.561 174.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER -56.9 -50.33 72.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 117.512 -1.675 . . . . 0.0 112.143 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' C ' HD22 ' A' ' 52' ' ' ASN . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 48' ' ' VAL . 85.8 m-20 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.674 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.51 73.96 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.8 68.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.209 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.3 m -61.69 -40.24 94.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 117.794 -1.562 . . . . 0.0 112.008 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.94 -41.33 96.04 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 118.806 -1.157 . . . . 0.0 112.907 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -39.94 59.88 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.69 162.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.81 -46.1 78.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 116.809 -1.956 . . . . 0.0 112.594 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.12 -43.07 99.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 116.537 -2.065 . . . . 0.0 112.369 -161.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.76 -73.53 0.16 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 117.954 -1.498 . . . . 0.0 109.098 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -68.81 -74.37 0.13 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.298 -158.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 15.15 54.33 0.06 OUTLIER Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 113.144 -1.844 . . . . 0.0 113.996 -158.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.22 164.12 2.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.587 2.191 . . . . 0.0 111.496 -143.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 96' ' ' LYS . 22.0 mt-10 -56.04 75.33 0.0 OUTLIER 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.92 -67.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.18 -43.88 73.34 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 112.065 -2.334 . . . . 0.0 112.199 146.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.33 58.64 3.68 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.858 149.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.35 0.609 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.6 109.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.687 0.756 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 3' ' ' LYS . 8.8 t -177.31 158.97 1.52 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.655 -142.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.489 ' H ' ' HG ' ' A' ' 2' ' ' SER . 2.3 ptmt -64.09 -25.69 68.21 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.067 -1.878 . . . . 0.0 113.696 -154.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.76 -38.96 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.59 -156.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.747 ' CG1' ' HZ2' ' A' ' 59' ' ' LYS . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.488 ' H ' ' HG1' ' A' ' 19' ' ' THR . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASN . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HZ3' HG11 ' A' ' 48' ' ' VAL . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.488 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HZ2' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.721 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -71.05 -41.24 71.02 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.66 -12.79 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.266 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 108.74 1.72 Allowed Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 132.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.73 -59.85 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.525 2.15 . . . . 0.0 112.944 133.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.13 52.05 1.08 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.771 -163.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.1 -64.81 1.07 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.273 145.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 141.45 137.36 3.39 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.8 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -61.67 -50.04 74.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.56 -2.056 . . . . 0.0 112.108 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.564 HG11 ' HZ3' ' A' ' 18' ' ' LYS . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HZ2' ' CG1' ' A' ' 14' ' ' VAL . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.404 HD13 ' CB ' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.721 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.803 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.803 ' H ' ' HG1' ' A' ' 72' ' ' THR . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.45 74.32 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.73 68.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.052 -1.459 . . . . 0.0 112.311 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -61.71 -37.67 85.03 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.512 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.7 -40.2 96.19 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.039 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -41.47 61.2 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.576 159.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.8 92.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.214 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -56.13 -43.01 77.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 117.886 -1.525 . . . . 0.0 112.571 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -116.83 -55.47 2.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.225 -154.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.465 HD21 ' HA ' ' A' ' 91' ' ' ALA . 2.4 t30 -64.7 -60.97 2.5 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.625 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.465 ' HA ' HD21 ' A' ' 90' ' ' ASN . . . -28.29 121.83 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 O-C-N 125.489 1.743 . . . . 0.0 112.69 -155.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -72.72 165.9 31.44 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.734 1.623 . . . . 0.0 112.48 156.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -78.69 53.73 1.39 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.508 -78.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -38.27 -60.35 0.79 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.106 -1.861 . . . . 0.0 112.448 123.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -121.53 -56.44 1.88 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.01 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? . . . . . 0 C--N 1.35 0.611 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.784 -135.09 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 121.869 0.843 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 -65.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.96 -157.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -37.92 89.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.204 -152.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m -58.72 -38.97 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.432 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.529 HG13 ' HZ2' ' A' ' 59' ' ' LYS . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' H ' ' HG1' ' A' ' 19' ' ' THR . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.627 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 69' ' ' LEU . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 -71.22 -41.09 70.64 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.41 -55.81 15.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.899 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -56.41 122.98 53.44 Favored Pre-proline 0 N--CA 1.439 -1.001 0 O-C-N 124.782 1.301 . . . . 0.0 111.218 -147.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.3 -62.01 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.391 1.394 . . . . 0.0 112.213 144.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -137.91 51.66 1.88 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.135 -162.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -94.86 -68.7 0.79 Allowed 'General case' 0 C--N 1.349 0.547 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.502 151.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 126.53 128.96 3.23 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.783 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER -52.2 -50.28 62.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.569 -171.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' C ' HD22 ' A' ' 52' ' ' ASN . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.445 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.5 m-20 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HZ2' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.849 ' HG1' ' H ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.448 ' HA2' HE21 ' A' ' 76' ' ' GLN . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.849 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.448 HE21 ' HA2' ' A' ' 73' ' ' GLY . 34.9 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -44.98 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.62 -38.87 72.69 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 118.233 -1.387 . . . . 0.0 112.318 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.7 m -61.78 -39.55 92.08 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.326 -1.349 . . . . 0.0 112.358 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.06 -40.95 95.62 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.051 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.87 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.563 161.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.98 90.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.585 -1.646 . . . . 0.0 112.108 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 7.8 pt20 -56.0 -39.72 72.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.216 -1.394 . . . . 0.0 112.753 -174.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -117.69 -57.41 2.12 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.956 -151.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -62.64 -57.97 9.15 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.59 77.82 0.35 Allowed Pre-proline 0 C--N 1.348 0.516 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.728 144.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.68 -52.27 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 114.013 168.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -145.37 62.99 1.28 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.217 -162.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.95 -62.81 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.328 -135.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 88' ' ' GLN . 7.4 tp -130.53 -60.45 0.99 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-N 112.036 -2.347 . . . . 0.0 110.001 -170.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? . . . . . 0 C--N 1.348 0.521 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.597 123.24 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' H1 ' ' CG ' ' A' ' 90' ' ' ASN . 6.7 tpp . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.519 0.676 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t 51.6 49.02 21.77 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.301 -109.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.13 -52.29 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.428 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 m -59.02 -38.78 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.719 -162.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.612 ' H ' ' HG1' ' A' ' 19' ' ' THR . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CG ' ' A' ' 16' ' ' ASN . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.612 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.685 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 ' H ' ' A' ' 69' ' ' LEU . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 39' ' ' GLU . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 -71.07 -41.08 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.89 -53.15 46.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.154 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.9 124.52 52.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 124.665 1.228 . . . . 0.0 111.328 -160.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.59 -65.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.554 1.503 . . . . 0.0 111.666 134.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.36 44.61 2.71 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.856 -1.974 . . . . 0.0 110.666 -153.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -101.92 -72.67 0.68 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.847 159.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 133.82 137.51 3.85 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 119.361 -1.4 . . . . 0.0 111.052 175.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 46' ' ' ASN . 0.2 OUTLIER -56.29 -50.32 71.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.673 -1.611 . . . . 0.0 112.208 -178.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' C ' HD22 ' A' ' 52' ' ' ASN . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 48' ' ' VAL . 86.0 m-20 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.685 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.39 70.2 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.52 67.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.322 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 m -61.79 -41.04 97.22 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.57 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 62.8 mt -61.1 -37.48 82.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.446 -1.302 . . . . 0.0 113.351 177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.271 0.0 OUTLIER -57.4 -49.99 74.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.903 160.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.96 -38.71 65.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.74 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 4.9 pt20 -55.95 -37.48 69.07 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.06 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.75 -61.96 1.6 Allowed 'General case' 0 C--N 1.352 0.674 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.77 -164.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.487 ' CG ' ' H1 ' ' A' ' 1' ' ' MET . 9.5 t30 -73.32 -28.24 61.96 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.408 -1.723 . . . . 0.0 112.861 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 64.68 90.5 0.09 OUTLIER Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.1 145.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.4 145.21 14.83 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.486 2.124 . . . . 0.0 110.359 163.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.58 109.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.634 -107.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.16 -53.64 0.19 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 112.186 -2.279 . . . . 0.0 109.611 -148.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.34 -27.31 9.35 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.146 164.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.353 0.756 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -101.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.733 0.777 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.24 -63.32 0.22 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.333 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -64.05 -52.4 59.59 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.977 -150.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.98 -38.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' HZ2' ' A' ' 59' ' ' LYS . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' H ' HD21 ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.585 ' H ' ' HG1' ' A' ' 19' ' ' THR . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.585 ' HG1' ' H ' ' A' ' 16' ' ' ASN . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.07 -41.16 71.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.3 -12.26 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.33 -1.305 . . . . 0.0 113.531 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.415 ' HD1' ' C ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -67.2 124.12 88.12 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.853 161.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' C ' ' HD1' ' A' ' 41' ' ' HIS . 1.7 Cg_endo -64.08 -63.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.916 1.744 . . . . 0.0 111.669 131.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -132.66 44.23 2.89 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.939 -152.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.64 -66.3 0.94 Allowed 'General case' 0 C--N 1.35 0.622 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.586 155.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . 128.75 125.49 2.76 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.256 177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -54.02 -49.79 68.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.39 -1.724 . . . . 0.0 112.824 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 52' ' ' ASN . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.454 HD22 ' C ' ' A' ' 48' ' ' VAL . 87.1 m-20 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HZ2' ' CG1' ' A' ' 14' ' ' VAL . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.666 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.2 -47.22 74.61 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.65 67.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.291 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.7 m -61.7 -39.37 91.24 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.544 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -40.57 96.19 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.026 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -42.19 62.35 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.552 161.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.402 ' O ' ' CD1' ' A' ' 94' ' ' LEU . . . -61.99 -45.05 95.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 118.066 -1.454 . . . . 0.0 111.954 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.44 -43.06 83.57 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 117.721 -1.592 . . . . 0.0 112.507 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.65 -59.24 1.75 Allowed 'General case' 0 C--N 1.349 0.557 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.13 -162.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.22 -57.12 11.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 64.58 75.64 0.36 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.197 149.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.49 -57.93 1.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 O-C-N 124.185 1.623 . . . . 0.0 112.826 -147.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.53 -66.96 1.02 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.075 161.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.402 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER 38.15 -85.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 111.925 -2.398 . . . . 0.0 112.292 144.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.72 -58.98 1.47 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.8 -1.546 . . . . 0.0 109.767 -173.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.349 0.58 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.082 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 22.9 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.67 ' HA ' HD12 ' A' ' 8' ' ' ILE . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 24' ' ' ILE . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 5' ' ' THR . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.607 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' N ' HD11 ' A' ' 8' ' ' ILE . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.411 ' HB ' HD12 ' A' ' 15' ' ' LEU . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 49' ' ' VAL . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 56' ' ' LEU . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 7' ' ' ILE . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.801 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' A' ' 70' ' ' ILE . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.735 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 33' ' ' THR . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.547 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 37' ' ' VAL . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 56' ' ' LEU . 25.7 m120 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.606 HG21 ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.735 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 18.2 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.677 ' HA ' HD12 ' A' ' 8' ' ' ILE . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.732 HD13 ' HB1' ' A' ' 82' ' ' ALA . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 5' ' ' THR . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.591 ' C ' HD11 ' A' ' 8' ' ' ILE . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' THR . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.578 ' CG2' HD21 ' A' ' 52' ' ' ASN . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.685 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 49' ' ' VAL . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.738 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 33' ' ' THR . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 38' ' ' ARG . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.544 0.741 0 CA-C-O 121.614 0.721 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 22' ' ' ILE . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.578 HD21 ' CG2' ' A' ' 19' ' ' THR . 35.3 m120 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 26' ' ' ILE . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' HD22 ' A' ' 69' ' ' LEU . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.738 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.809 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.732 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.8 m . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 8' ' ' ILE . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.753 HD13 ' CB ' ' A' ' 82' ' ' ALA . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 5' ' ' THR . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 15' ' ' LEU . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 21' ' ' THR . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.838 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' VAL . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' THR . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.555 0.693 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 22' ' ' ILE . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.8 m120 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.727 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 26' ' ' ILE . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.696 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.753 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.776 ' HA ' HD12 ' A' ' 8' ' ' ILE . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 82' ' ' ALA . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 5' ' ' THR . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 15' ' ' LEU . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.583 ' C ' HD11 ' A' ' 8' ' ' ILE . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 49' ' ' VAL . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 75' ' ' ALA . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.532 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.917 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.833 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 25' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.486 ' N ' HG23 ' A' ' 32' ' ' ILE . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' THR . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 22' ' ' ILE . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.1 m120 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.72 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 26' ' ' ILE . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.438 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.833 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.483 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.748 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 21.2 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.905 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.746 HD13 ' HB1' ' A' ' 82' ' ' ALA . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.535 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 21' ' ' THR . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.43 ' CB ' HD12 ' A' ' 15' ' ' LEU . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.821 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.935 HG21 HG21 ' A' ' 62' ' ' VAL . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.826 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 70' ' ' ILE . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 33' ' ' THR . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.175 0.512 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 22' ' ' ILE . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.9 m120 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.674 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.935 HG21 HG21 ' A' ' 26' ' ' ILE . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.826 HD13 ' CB ' ' A' ' 27' ' ' ALA . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.746 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 29.6 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.838 ' HA ' HD12 ' A' ' 8' ' ' ILE . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 ' CB ' ' A' ' 82' ' ' ALA . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HD3' HG21 ' A' ' 48' ' ' VAL . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.458 ' CB ' HD12 ' A' ' 15' ' ' LEU . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.497 ' CD1' HG13 ' A' ' 49' ' ' VAL . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 7' ' ' ILE . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 25' ' ' THR . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.781 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 70' ' ' ILE . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.737 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 33' ' ' THR . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.412 HH11 ' CG ' ' A' ' 38' ' ' ARG . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 18' ' ' LYS . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG13 ' CD1' ' A' ' 22' ' ' ILE . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 56' ' ' LEU . 21.8 m120 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.595 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 55' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.737 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.781 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.702 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 8' ' ' ILE . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.734 HD13 ' HB1' ' A' ' 82' ' ' ALA . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 5' ' ' THR . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' C ' HD11 ' A' ' 8' ' ' ILE . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 4' ' ' VAL . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD12 ' A' ' 15' ' ' LEU . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 61' ' ' LEU . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 7' ' ' ILE . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.76 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.499 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' THR . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 38' ' ' ARG . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 25.7 m120 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG23 ' HE2' ' A' ' 58' ' ' LYS . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 55' ' ' VAL . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 26' ' ' ILE . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 72' ' ' THR . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' CB ' HD22 ' A' ' 69' ' ' LEU . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.76 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.3 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.879 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.814 HD13 ' CB ' ' A' ' 82' ' ' ALA . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG13 ' NZ ' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' THR . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 4' ' ' VAL . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.658 HD11 HG22 ' A' ' 49' ' ' VAL . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 70' ' ' ILE . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.746 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.47 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' THR . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG22 HD11 ' A' ' 22' ' ' ILE . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.6 m120 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.562 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.746 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.811 HD13 ' CB ' ' A' ' 27' ' ' ALA . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.9 m . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' HB1' ' A' ' 82' ' ' ALA . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 15' ' ' LEU . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.574 ' C ' HD11 ' A' ' 8' ' ' ILE . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.681 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.702 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.835 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HA ' HG22 ' A' ' 70' ' ' ILE . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.67 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 33' ' ' THR . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 22' ' ' ILE . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.427 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.8 m120 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.525 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 26' ' ' ILE . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' CG ' HG22 ' A' ' 72' ' ' THR . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CB ' HD22 ' A' ' 69' ' ' LEU . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.835 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 11' ' ' SER . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 79' ' ' ILE . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG11 ' HB ' ' A' ' 21' ' ' THR . 28.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 8' ' ' ILE . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 24' ' ' ILE . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 17' ' ' GLU . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 15' ' ' LEU . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' C ' HD11 ' A' ' 8' ' ' ILE . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' HD11 ' A' ' 8' ' ' ILE . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.477 ' CB ' HD12 ' A' ' 15' ' ' LEU . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.612 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 7' ' ' ILE . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.943 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' HG22 ' A' ' 70' ' ' ILE . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.512 HG23 ' CA ' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.512 ' CA ' HG23 ' A' ' 32' ' ' ILE . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' THR . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG22 HD11 ' A' ' 22' ' ' ILE . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 26.6 m120 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.813 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.689 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 24.9 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.904 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.747 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.474 ' HB ' HD22 ' A' ' 15' ' ' LEU . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' C ' HD11 ' A' ' 8' ' ' ILE . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 4' ' ' VAL . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.409 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.954 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.84 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 22' ' ' ILE . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HA ' HG12 ' A' ' 55' ' ' VAL . 24.4 m120 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.954 HG21 HG21 ' A' ' 26' ' ' ILE . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' CG ' HG22 ' A' ' 72' ' ' THR . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.84 HD13 ' CB ' ' A' ' 27' ' ' ALA . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.8 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.871 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.766 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 15' ' ' LEU . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.42 ' HB ' HG11 ' A' ' 4' ' ' VAL . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' HG13 ' A' ' 49' ' ' VAL . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 7' ' ' ILE . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.938 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 70' ' ' ILE . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.223 -0.341 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 49' ' ' VAL . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 ' CD1' ' A' ' 22' ' ' ILE . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HA ' HG12 ' A' ' 55' ' ' VAL . 24.3 m120 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.456 ' CD ' HG22 ' A' ' 72' ' ' THR . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.829 HD13 ' CB ' ' A' ' 27' ' ' ALA . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.0 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.803 ' HA ' HD12 ' A' ' 8' ' ' ILE . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.755 HD13 ' HB1' ' A' ' 82' ' ' ALA . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 5' ' ' THR . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG13 ' HE3' ' A' ' 59' ' ' LYS . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.605 ' C ' HD11 ' A' ' 8' ' ' ILE . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.578 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.992 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.702 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 49' ' ' VAL . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 38' ' ' ARG . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 . . . . . 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 22' ' ' ILE . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.1 m120 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HE3' HG13 ' A' ' 14' ' ' VAL . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.554 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.992 HG21 HG21 ' A' ' 26' ' ' ILE . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 72' ' ' THR . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.588 HG22 ' HG3' ' A' ' 63' ' ' GLU . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.832 ' HA ' HD12 ' A' ' 8' ' ' ILE . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 24' ' ' ILE . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 5' ' ' THR . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 15' ' ' LEU . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' THR . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.812 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 70' ' ' ILE . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.71 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 49' ' ' VAL . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 37' ' ' VAL . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.459 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.4 m120 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' CG ' HG22 ' A' ' 72' ' ' THR . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' CB ' HD22 ' A' ' 69' ' ' LEU . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.71 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.812 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 11.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.718 HD13 ' HB1' ' A' ' 82' ' ' ALA . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.599 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' C ' HD11 ' A' ' 8' ' ' ILE . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.569 ' OG1' HD12 ' A' ' 15' ' ' LEU . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 62' ' ' VAL . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 70' ' ' ILE . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 33' ' ' THR . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 22' ' ' ILE . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 HD21 ' CG2' ' A' ' 19' ' ' THR . 28.2 m120 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG21 ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.815 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 79' ' ' ILE . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.718 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.4 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.821 ' HA ' HD12 ' A' ' 8' ' ' ILE . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.738 HD13 ' CB ' ' A' ' 82' ' ' ALA . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.54 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.586 ' C ' HD11 ' A' ' 8' ' ' ILE . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' THR . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.928 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.847 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.505 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' THR . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.514 0.673 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 22' ' ' ILE . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.7 m120 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.62 HG21 ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.928 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' CD ' HG22 ' A' ' 72' ' ' THR . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.7 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.847 HD13 ' CB ' ' A' ' 27' ' ' ALA . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.604 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.738 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.2 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.888 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.858 HD13 ' CB ' ' A' ' 82' ' ' ALA . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' HD23 ' A' ' 15' ' ' LEU . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 19' ' ' THR . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 21' ' ' THR . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.496 ' CB ' HD12 ' A' ' 15' ' ' LEU . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.845 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.934 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.824 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.743 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.223 0.535 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.845 HG22 HD11 ' A' ' 22' ' ' ILE . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.5 m120 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.623 HG21 ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.934 HG21 HG21 ' A' ' 26' ' ' ILE . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.824 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.858 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 12.8 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.79 ' HA ' HD12 ' A' ' 8' ' ' ILE . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 24' ' ' ILE . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 5' ' ' THR . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 15' ' ' LEU . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.637 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' LEU . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 56' ' ' LEU . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 7' ' ' ILE . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.805 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 33' ' ' THR . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' THR . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.489 0.661 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 22' ' ' ILE . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.5 m120 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.577 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 30' ' ' ASP . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.805 HD13 ' CB ' ' A' ' 27' ' ' ALA . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 8' ' ' ILE . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.762 HD13 ' HB1' ' A' ' 82' ' ' ALA . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 21' ' ' THR . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 56' ' ' LEU . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 7' ' ' ILE . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.963 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.754 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.717 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 49' ' ' VAL . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 . . . . . 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.482 0.658 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HD11 ' A' ' 22' ' ' ILE . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' HD22 ' A' ' 56' ' ' LEU . 25.7 m120 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HE2' ' A' ' 58' ' ' LYS . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HE2' HG23 ' A' ' 55' ' ' VAL . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.963 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.754 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.762 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.2 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 8' ' ' ILE . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 24' ' ' ILE . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 5' ' ' THR . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' C ' HD11 ' A' ' 8' ' ' ILE . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 8' ' ' ILE . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.424 ' CB ' HD12 ' A' ' 15' ' ' LEU . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 7' ' ' ILE . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 62' ' ' VAL . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.819 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' HG22 ' A' ' 70' ' ' ILE . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.714 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 33' ' ' THR . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 22' ' ' ILE . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' O ' HD22 ' A' ' 56' ' ' LEU . 21.2 m120 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 26' ' ' ILE . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.669 ' CD ' HG22 ' A' ' 72' ' ' THR . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CB ' HD22 ' A' ' 69' ' ' LEU . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.714 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 63' ' ' GLU . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mmm . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.761 0.791 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 t 71.19 158.93 0.2 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.999 -1.91 . . . . 0.0 110.119 116.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -25.9 68.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.439 -119.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 22.9 m -58.66 -38.93 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.302 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.67 ' HA ' HD12 ' A' ' 8' ' ' ILE . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 24' ' ' ILE . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 5' ' ' THR . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.607 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' N ' HD11 ' A' ' 8' ' ' ILE . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.411 ' HB ' HD12 ' A' ' 15' ' ' LEU . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.945 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 56' ' ' LEU . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 7' ' ' ILE . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HG11 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.801 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' A' ' 70' ' ' ILE . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.735 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 33' ' ' THR . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.547 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 -71.21 -41.07 70.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 25' ' ' THR . 1.9 p -55.61 -55.36 17.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.074 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 49' ' ' VAL . 8.0 p80 -56.94 123.66 60.52 Favored Pre-proline 0 N--CA 1.439 -0.979 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.128 -145.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 3.9 Cg_exo -62.67 -62.51 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.508 1.472 . . . . 0.0 111.998 144.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.25 49.14 2.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 112.713 -2.039 . . . . 0.0 110.355 -160.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.945 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.4 mp -95.14 -66.04 0.94 Allowed 'General case' 0 C--N 1.35 0.607 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.733 154.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.94 114.47 2.66 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 113.954 -1.475 . . . . 0.0 111.043 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -51.92 -45.23 64.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 118.584 -1.246 . . . . 0.0 113.177 -161.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 45' ' ' GLY . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 56' ' ' LEU . 25.7 m120 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.606 HG21 ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.735 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.37 -47.48 73.23 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.46 67.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.039 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -61.45 -36.73 81.22 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.582 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.4 mt -68.33 -37.2 80.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.662 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -45.22 64.03 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.365 160.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -61.78 -39.76 92.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.155 -1.418 . . . . 0.0 112.413 -173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.94 -43.11 95.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.159 -1.816 . . . . 0.0 112.28 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -48.69 6.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.362 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -66.29 -64.72 0.8 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 116.668 -2.013 . . . . 0.0 110.18 165.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 95' ' ' LEU . . . 59.91 81.87 0.24 Allowed Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.577 -170.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.91 134.15 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.348 2.032 . . . . 0.0 111.075 157.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.71 119.87 11.38 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 118.087 -1.445 . . . . 0.0 109.752 -95.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD13 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -153.13 -55.89 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.821 -140.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.68 ' H ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 tm? -127.89 -62.61 1.06 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.631 -172.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.347 0.489 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.728 159.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 121.943 0.878 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -167.72 -69.39 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.858 -142.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -74.05 -52.29 13.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.106 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 18.2 m -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.788 -160.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.677 ' HA ' HD12 ' A' ' 8' ' ' ILE . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.732 HD13 ' HB1' ' A' ' 82' ' ' ALA . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 5' ' ' THR . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.591 ' C ' HD11 ' A' ' 8' ' ' ILE . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' THR . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.578 ' CG2' HD21 ' A' ' 52' ' ' ASN . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.685 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.911 ' CD1' HD23 ' A' ' 44' ' ' LEU . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.715 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.738 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 33' ' ' THR . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 38' ' ' ARG . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.93 -41.18 71.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 25' ' ' THR . 9.0 p -80.91 -13.74 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.497 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.53 123.52 85.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.872 163.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 -63.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.213 1.942 . . . . 0.0 111.386 126.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.41 -9.68 32.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.777 -144.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.7 mp -76.27 -69.1 0.52 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.049 -166.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 130.05 133.18 3.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.52 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.15 -50.25 67.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 117.758 -1.577 . . . . 0.0 111.893 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 45' ' ' GLY . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.578 HD21 ' CG2' ' A' ' 19' ' ' THR . 35.3 m120 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 26' ' ' ILE . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' HD22 ' A' ' 69' ' ' LEU . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.738 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.809 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.732 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.23 -47.44 73.8 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.89 -38.71 67.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.48 -1.237 . . . . 0.0 112.465 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 m -61.75 -42.63 99.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.13 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 85' ' ' LEU . 69.7 mt -60.06 -38.28 82.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.25 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -50.23 74.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.667 162.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.85 70.2 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.681 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -57.07 -43.12 81.76 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.544 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.0 -57.38 2.17 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.987 -150.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.13 -62.3 1.71 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.559 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.762 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 56.58 82.94 0.23 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 113.547 -1.661 . . . . 0.0 110.904 153.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -75.85 144.71 27.84 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.288 1.992 . . . . 0.0 111.327 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.85 111.87 3.48 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.639 -91.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.762 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 2.3 mt -134.19 -52.01 0.83 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.898 -153.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 91' ' ' ALA . 1.4 mp -62.37 -59.02 5.59 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 C--N 1.348 0.525 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.769 -114.032 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 122.003 0.906 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t -77.88 -63.54 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 112.783 -2.008 . . . . 0.0 110.171 -155.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -52.26 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.294 -155.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.8 m -58.88 -38.78 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.695 -160.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 8' ' ' ILE . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.753 HD13 ' CB ' ' A' ' 82' ' ' ALA . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 5' ' ' THR . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.683 ' HB2' HD12 ' A' ' 85' ' ' LEU . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 15' ' ' LEU . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 21' ' ' THR . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.767 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.566 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.838 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' VAL . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' THR . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.05 -41.17 71.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 25' ' ' THR . 9.4 p -82.64 -12.85 12.21 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.588 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.66 124.23 88.79 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 117.369 -1.732 . . . . 0.0 109.842 163.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 -63.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.964 1.776 . . . . 0.0 111.644 129.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.72 43.6 3.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.993 -151.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.767 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -96.96 -68.5 0.8 Allowed 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.63 159.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 131.96 134.0 3.52 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.655 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -56.44 -50.23 72.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.774 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 45' ' ' GLY . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.8 m120 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.727 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 26' ' ' ILE . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.696 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.753 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.3 -43.75 85.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.213 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.7 m -61.81 -38.01 86.53 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.48 168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 10' ' ' ALA . 75.7 mt -63.85 -35.95 82.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.597 177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -50.18 70.42 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.435 158.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.05 -40.34 76.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.585 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -55.93 -40.2 72.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.634 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 3.1 mm-40 -103.58 -41.41 5.97 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.831 -153.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -63.67 -64.99 0.75 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 117.201 -1.8 . . . . 0.0 110.109 153.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.701 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 55.34 82.92 0.23 Allowed Pre-proline 0 C--N 1.347 0.497 0 CA-C-N 112.866 -1.97 . . . . 0.0 111.29 -168.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -82.73 130.33 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.241 1.96 . . . . 0.0 111.656 160.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.79 133.79 48.82 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 117.085 -1.846 . . . . 0.0 109.515 -84.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.701 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -151.74 -57.9 0.15 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 112.581 -2.099 . . . . 0.0 109.656 -149.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' H ' ' HB3' ' A' ' 96' ' ' LYS . 1.3 tp -163.0 -63.94 0.04 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.726 -2.034 . . . . 0.0 109.994 -156.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 95' ' ' LEU . 5.2 pttt . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.556 129.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.829 0.823 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 64.34 173.34 0.19 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.172 -1.831 . . . . 0.0 110.04 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.1 -25.62 68.18 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.958 -175.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m -58.44 -38.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -140.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.776 ' HA ' HD12 ' A' ' 8' ' ' ILE . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 82' ' ' ALA . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 5' ' ' THR . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 15' ' ' LEU . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.583 ' C ' HD11 ' A' ' 8' ' ' ILE . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 49' ' ' VAL . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 75' ' ' ALA . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.67 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.917 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.833 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 25' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.486 ' N ' HG23 ' A' ' 32' ' ' ILE . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.71 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' THR . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.02 -41.2 71.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 36' ' ' GLU . 7.2 p -84.04 -11.23 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.552 -170.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.78 124.06 87.57 Favored Pre-proline 0 N--CA 1.442 -0.875 0 C-N-CA 117.572 -1.651 . . . . 0.0 109.86 161.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -63.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.022 1.815 . . . . 0.0 111.667 129.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.78 41.43 3.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.168 -150.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.7 mp -98.15 -69.05 0.77 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.576 160.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.819 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 130.27 135.12 3.79 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.355 175.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -58.19 -50.07 74.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 116.707 -1.997 . . . . 0.0 112.534 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 45' ' ' GLY . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.1 m120 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.72 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 26' ' ' ILE . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.438 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.833 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.748 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.12 -47.24 74.81 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.68 67.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 118.251 -1.38 . . . . 0.0 112.248 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.458 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 41.4 m -61.59 -37.0 82.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.746 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.55 -39.77 94.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.531 -1.267 . . . . 0.0 113.181 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -41.4 61.4 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.64 160.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.538 ' O ' HD13 ' A' ' 94' ' ' LEU . . . -62.81 -42.59 99.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.809 -1.557 . . . . 0.0 112.201 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -59.36 -43.12 92.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 117.005 -1.878 . . . . 0.0 112.435 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.44 -61.32 1.38 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.971 -166.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -62.8 -52.61 62.49 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 113.395 -1.73 . . . . 0.0 110.636 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 66.01 84.26 0.18 Allowed Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.191 145.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -74.15 147.59 38.16 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.723 2.282 . . . . 0.0 111.456 153.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.04 77.82 0.02 OUTLIER 'General case' 0 C--N 1.348 0.523 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.919 -91.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -102.96 -43.05 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 112.016 -2.356 . . . . 0.0 111.389 -150.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -59.94 0.76 Allowed 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.015 -154.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mttm . . . . . 0 C--N 1.349 0.572 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.899 -135.409 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.821 0.82 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -55.78 26.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.122 151.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.86 -52.29 60.71 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.884 -164.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 21.2 m -59.03 -41.21 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.288 -1.323 . . . . 0.0 112.524 -163.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.905 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.746 HD13 ' HB1' ' A' ' 82' ' ' ALA . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.535 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 21' ' ' THR . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.43 ' CB ' HD12 ' A' ' 15' ' ' LEU . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.511 HG23 HD21 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.821 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.935 HG21 HG21 ' A' ' 62' ' ' VAL . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.826 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 70' ' ' ILE . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.58 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 33' ' ' THR . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.03 -41.3 71.03 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 36' ' ' GLU . 9.0 p -91.58 -7.5 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.055 -173.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.87 109.46 2.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 109.071 134.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' CD ' ' O ' ' A' ' 40' ' ' VAL . 1.6 Cg_endo -67.66 -57.22 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.995 2.464 . . . . 0.0 112.168 127.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.03 -43.5 57.67 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.478 -2.146 . . . . 0.0 112.119 -156.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.9 mp -66.26 -65.49 0.67 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.273 -142.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 140.02 136.5 3.36 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.237 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.99 -50.1 72.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.613 -2.035 . . . . 0.0 112.081 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 22' ' ' ILE . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.9 m120 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.674 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.935 HG21 HG21 ' A' ' 26' ' ' ILE . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.826 HD13 ' CB ' ' A' ' 27' ' ' ALA . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.746 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.29 -48.14 71.34 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.66 68.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.374 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 m -61.55 -42.71 99.23 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.279 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 54.0 mt -58.92 -40.0 83.27 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 118.399 -1.321 . . . . 0.0 113.012 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -50.16 74.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.734 163.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -36.21 62.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.632 -168.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 6.3 pt20 -57.64 -43.2 84.71 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.485 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.51 -56.58 2.28 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.053 -156.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.22 -50.88 71.28 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 64.56 83.6 0.19 Allowed Pre-proline 0 C--N 1.348 0.504 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.475 145.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -75.44 141.99 26.06 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.684 2.256 . . . . 0.0 111.808 156.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.5 77.18 0.04 OUTLIER 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.678 -87.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -95.83 -44.49 7.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 111.812 -2.449 . . . . 0.0 111.201 -156.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.5 mt -64.87 -59.64 3.97 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.119 161.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.349 0.558 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.642 -98.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.25 0.547 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.85 -176.17 0.15 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.877 102.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -63.74 -48.1 78.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.278 -42.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 29.6 m -58.6 -38.37 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.391 -163.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.838 ' HA ' HD12 ' A' ' 8' ' ' ILE . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 ' CB ' ' A' ' 82' ' ' ALA . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HD3' HG21 ' A' ' 48' ' ' VAL . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.458 ' CB ' HD12 ' A' ' 15' ' ' LEU . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.937 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 7' ' ' ILE . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.781 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 70' ' ' ILE . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.737 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 33' ' ' THR . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.412 HH11 ' CG ' ' A' ' 38' ' ' ARG . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 -71.04 -41.14 71.18 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 25' ' ' THR . 2.4 p -54.81 -55.6 14.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.054 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.671 ' CD2' HG21 ' A' ' 49' ' ' VAL . 3.1 p80 -55.2 123.38 48.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 O-C-N 124.84 1.338 . . . . 0.0 111.224 -151.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 2.7 Cg_endo -62.48 -62.91 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 O-C-N 123.84 1.442 . . . . 0.0 111.921 141.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -135.59 47.63 2.27 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.711 -2.041 . . . . 0.0 110.384 -158.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.937 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.8 mp -89.93 -68.84 0.76 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.22 152.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 122.15 110.55 2.09 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.016 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -51.88 -46.76 64.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.988 -160.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 18' ' ' LYS . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 45' ' ' GLY . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 56' ' ' LEU . 21.8 m120 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 55' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.737 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.781 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.702 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.19 -47.98 72.17 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.47 67.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.157 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -61.73 -38.41 87.8 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.966 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.59 -40.96 98.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.01 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -43.15 62.71 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.221 160.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.14 -41.66 90.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.689 -172.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.894 ' O ' HD12 ' A' ' 95' ' ' LEU . 6.4 pt20 -55.86 -42.46 75.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.251 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.45 -57.09 2.33 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.398 -156.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -58.66 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.895 174.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 62.3 56.56 2.62 Favored Pre-proline 0 C--N 1.345 0.384 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.389 143.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.799 ' HD2' HD12 ' A' ' 94' ' ' LEU . 5.2 Cg_exo -57.84 -52.02 6.86 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 113.824 -146.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -142.28 105.26 4.57 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.483 144.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.799 HD12 ' HD2' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -171.98 -52.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 112.557 -2.111 . . . . 0.0 110.16 -142.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -112.64 -61.97 1.65 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.831 168.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? . . . . . 0 C--N 1.347 0.46 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.714 -115.028 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 121.994 0.902 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.4 p -81.42 -168.05 1.71 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.645 -160.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -63.91 -52.31 60.46 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.085 -166.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m -58.87 -38.68 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.666 -162.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 8' ' ' ILE . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.734 HD13 ' HB1' ' A' ' 82' ' ' ALA . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 5' ' ' THR . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' C ' HD11 ' A' ' 8' ' ' ILE . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 4' ' ' VAL . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD12 ' A' ' 15' ' ' LEU . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 44' ' ' LEU . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.924 ' CD1' HD23 ' A' ' 44' ' ' LEU . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 61' ' ' LEU . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 7' ' ' ILE . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.76 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.723 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.499 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' THR . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 38' ' ' ARG . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.13 -41.12 70.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 40' ' ' VAL . 9.1 p -85.17 -9.47 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.75 -171.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.24 123.96 87.76 Favored Pre-proline 0 N--CA 1.442 -0.838 0 C-N-CA 117.458 -1.697 . . . . 0.0 109.879 162.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.05 -63.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.025 1.817 . . . . 0.0 111.779 131.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.68 45.39 2.79 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.902 -152.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.8 mp -89.96 -64.52 1.12 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.956 157.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.839 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 120.79 114.37 2.37 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.869 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -51.95 -46.02 64.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.599 -1.24 . . . . 0.0 113.055 -162.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 45' ' ' GLY . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 25.7 m120 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG23 ' HE2' ' A' ' 58' ' ' LYS . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 55' ' ' VAL . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 26' ' ' ILE . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 72' ' ' THR . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' CB ' HD22 ' A' ' 69' ' ' LEU . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.76 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.32 -47.56 73.14 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.49 67.51 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.09 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 28.8 m -61.61 -37.62 84.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.726 171.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.32 -39.3 93.63 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 118.594 -1.243 . . . . 0.0 113.331 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -44.95 63.69 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.259 159.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -60.15 -44.89 94.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.915 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.98 -43.17 86.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 117.543 -1.663 . . . . 0.0 112.493 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -91.46 -61.94 1.54 Allowed 'General case' 0 C--N 1.35 0.624 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.161 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -53.28 58.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.756 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 62.51 99.65 0.04 OUTLIER Pre-proline 0 C--N 1.348 0.517 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.574 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -57.7 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.993 1.795 . . . . 0.0 113.159 155.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -134.8 59.32 1.74 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.709 -155.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -165.98 -65.06 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.312 -134.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 94' ' ' LEU . 4.0 mm? -131.2 -65.13 0.78 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.347 0.487 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.097 -176.127 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 121.886 0.85 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -174.13 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.749 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -71.48 -52.31 19.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.114 137.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.3 m -61.76 -39.47 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 118.2 -1.4 . . . . 0.0 112.563 -159.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.879 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.814 HD13 ' CB ' ' A' ' 82' ' ' ALA . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG13 ' NZ ' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' THR . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 4' ' ' VAL . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.526 HG21 HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 70' ' ' ILE . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.746 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.47 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' THR . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.9 -41.14 71.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 40' ' ' VAL . 8.6 p -85.38 -10.26 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.66 -171.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.49 124.12 87.4 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.904 160.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.69 -65.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.038 1.825 . . . . 0.0 111.637 130.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -126.68 41.27 3.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.252 -150.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.6 mp -91.95 -67.6 0.85 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.605 160.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.905 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 128.09 122.65 2.52 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.492 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -52.51 -49.73 64.2 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.958 -1.497 . . . . 0.0 112.942 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 45' ' ' GLY . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.6 m120 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.562 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.746 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.811 HD13 ' CB ' ' A' ' 27' ' ' ALA . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.26 -47.02 75.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.58 68.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.37 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 69.4 m -61.67 -36.86 82.06 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 117.434 -1.707 . . . . 0.0 112.219 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 82' ' ' ALA . 70.8 mt -64.75 -42.61 95.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.116 175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.9 -41.49 61.99 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.551 163.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.68 -46.11 87.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.178 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' O ' HD23 ' A' ' 95' ' ' LEU . 5.9 pt20 -61.08 -43.14 99.34 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.035 -1.866 . . . . 0.0 112.272 -170.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.6 mt-10 -92.68 -52.89 4.41 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.087 -171.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -56.41 22.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.817 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 61.31 84.2 0.2 Allowed Pre-proline 0 C--N 1.347 0.479 0 CA-C-N 113.363 -1.744 . . . . 0.0 110.692 152.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -73.75 140.05 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.718 2.279 . . . . 0.0 111.359 152.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.1 76.86 0.01 OUTLIER 'General case' 0 C--N 1.35 0.602 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.457 -100.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 2.1 mt -88.25 -56.67 3.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 111.825 -2.443 . . . . 0.0 110.716 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 88' ' ' GLN . 7.9 tp -144.47 59.65 1.33 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.777 -2.01 . . . . 0.0 109.82 -153.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm . . . . . 0 C--N 1.347 0.477 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.68 147.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 122.016 0.913 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -159.13 105.41 1.73 Allowed 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.363 -142.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HD3' HG21 ' A' ' 24' ' ' ILE . 6.8 ttmt -63.93 -52.51 59.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.983 171.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.9 m -61.02 -38.78 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.781 -165.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' HB1' ' A' ' 82' ' ' ALA . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 15' ' ' LEU . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.574 ' C ' HD11 ' A' ' 8' ' ' ILE . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.681 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.702 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.555 HG21 ' HD3' ' A' ' 3' ' ' LYS . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.705 HG21 HG11 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.835 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HA ' HG22 ' A' ' 70' ' ' ILE . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.67 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 33' ' ' THR . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.01 -41.13 71.32 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 25' ' ' THR . 7.3 p -85.21 -10.52 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.549 -170.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.6 123.79 86.66 Favored Pre-proline 0 N--CA 1.442 -0.855 0 C-N-CA 117.626 -1.63 . . . . 0.0 109.824 160.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.51 -64.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.88 1.72 . . . . 0.0 111.574 131.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -127.2 42.27 3.36 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.119 -151.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.681 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.6 mp -94.38 -66.35 0.92 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.521 160.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 126.52 128.46 3.17 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.155 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -53.62 -50.03 66.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 117.501 -1.679 . . . . 0.0 112.862 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 45' ' ' GLY . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 45' ' ' GLY . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.427 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.8 m120 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.525 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 26' ' ' ILE . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' CG ' HG22 ' A' ' 72' ' ' THR . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CB ' HD22 ' A' ' 69' ' ' LEU . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.835 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 11' ' ' SER . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 79' ' ' ILE . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.29 -48.47 70.29 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.37 67.33 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.045 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.4 m -61.73 -37.06 82.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 117.678 -1.609 . . . . 0.0 112.5 171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.74 -43.98 94.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.671 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -39.91 59.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.813 164.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -59.85 -46.21 90.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 118.211 -1.396 . . . . 0.0 112.207 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.98 -43.23 99.28 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.001 -1.88 . . . . 0.0 112.353 -168.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.3 -64.34 1.17 Allowed 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.607 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.91 41.3 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.62 -168.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 66.2 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.322 161.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.61 156.81 28.26 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.695 2.263 . . . . 0.0 111.462 154.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -48.84 79.46 0.0 OUTLIER 'General case' 0 C--N 1.351 0.66 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.211 -114.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.731 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 1.1 mt -110.68 -38.0 5.28 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.436 -2.62 . . . . 0.0 111.235 -160.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.7 tm? -149.74 -43.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.637 -139.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm . . . . . 0 C--N 1.351 0.633 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.851 -153.293 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.925 0.869 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -162.22 74.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.598 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.722 ' HD3' HD12 ' A' ' 24' ' ' ILE . 3.8 ttmm -63.96 -52.18 60.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.093 165.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG11 ' HB ' ' A' ' 21' ' ' THR . 28.3 m -58.85 -38.7 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.39 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 8' ' ' ILE . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 24' ' ' ILE . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 17' ' ' GLU . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 15' ' ' LEU . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' C ' HD11 ' A' ' 8' ' ' ILE . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' HD11 ' A' ' 8' ' ' ILE . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.477 ' CB ' HD12 ' A' ' 15' ' ' LEU . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.612 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 7' ' ' ILE . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.489 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.943 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' HG22 ' A' ' 70' ' ' ILE . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.512 HG23 ' CA ' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.512 ' CA ' HG23 ' A' ' 32' ' ' ILE . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' THR . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.14 -37.86 72.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG11 HG21 ' A' ' 25' ' ' THR . 2.1 p -52.91 -56.72 6.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.195 172.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -59.46 126.11 81.38 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.733 -144.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 2.1 Cg_endo -65.62 -62.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 O-C-N 123.923 1.486 . . . . 0.0 111.788 140.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.59 48.24 2.44 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.279 -158.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.6 mp -99.9 -75.83 0.56 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.96 152.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 129.22 136.41 4.1 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.76 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -56.98 -50.12 73.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.627 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 45' ' ' GLY . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 26.6 m120 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.813 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.689 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.17 -47.63 73.35 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.45 67.39 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.892 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 17.3 m -61.62 -36.94 82.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 118.254 -1.378 . . . . 0.0 112.59 172.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.45 -39.58 92.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 118.553 -1.259 . . . . 0.0 113.27 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.78 -41.56 61.74 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 159.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -60.68 -45.54 93.77 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 117.945 -1.502 . . . . 0.0 111.84 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -55.85 -43.14 76.78 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 117.099 -1.84 . . . . 0.0 112.392 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.69 -61.39 1.68 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.874 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -49.97 74.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 117.051 -1.859 . . . . 0.0 110.887 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 56.23 93.69 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.609 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.286 159.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -78.98 110.8 2.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.604 1.536 . . . . 0.0 113.929 166.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 96' ' ' LYS . 45.7 mt-10 -83.42 52.23 2.18 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.815 -96.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER 29.07 -73.5 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.435 -1.712 . . . . 0.0 113.317 103.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.7 mt -108.96 -61.86 1.56 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.698 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 93' ' ' GLU . 25.4 mttm . . . . . 0 C--N 1.352 0.677 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.482 -103.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.801 0.81 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.7 p -168.95 -65.0 0.02 OUTLIER 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.919 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -64.09 -52.35 59.67 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.99 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 24.9 m -61.8 -39.35 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.757 -162.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.904 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.747 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.474 ' HB ' HD22 ' A' ' 15' ' ' LEU . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' C ' HD11 ' A' ' 8' ' ' ILE . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 4' ' ' VAL . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.666 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.954 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.84 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.687 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.01 -41.24 71.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 36' ' ' GLU . 7.3 p -85.07 -9.61 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.524 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.3 122.62 82.39 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.812 157.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.22 -63.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.013 1.809 . . . . 0.0 111.729 132.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.14 47.28 2.43 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 112.674 -2.057 . . . . 0.0 110.715 -153.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.1 mp -96.35 -73.19 0.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.858 155.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 49' ' ' VAL . . . -122.92 -127.8 3.31 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.498 -159.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -66.63 -34.04 77.0 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 127.01 2.124 . . . . 0.0 115.397 7.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' HA2' ' A' ' 45' ' ' GLY . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.718 HG23 ' HA3' ' A' ' 45' ' ' GLY . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HA ' HG12 ' A' ' 55' ' ' VAL . 24.4 m120 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.954 HG21 HG21 ' A' ' 26' ' ' ILE . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' CG ' HG22 ' A' ' 72' ' ' THR . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.84 HD13 ' CB ' ' A' ' 27' ' ' ALA . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.08 -47.47 74.15 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.55 67.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.144 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 27.4 m -61.82 -40.34 94.95 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.523 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.87 -41.36 95.8 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.916 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.51 61.81 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.919 -1.492 . . . . 0.0 111.622 162.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -61.94 -45.27 94.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.139 -1.425 . . . . 0.0 111.979 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -57.75 -43.05 85.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 117.459 -1.696 . . . . 0.0 112.479 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.09 -60.55 1.52 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.037 -166.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -65.25 -56.73 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.095 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 67.15 76.59 0.27 Allowed Pre-proline 0 C--N 1.346 0.447 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.663 150.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.11 119.06 6.06 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.471 1.448 . . . . 0.0 112.106 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 26.95 45.42 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.631 -1.622 . . . . 0.0 114.241 -160.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.693 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 13.4 mt -103.2 -43.01 5.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.473 166.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 mt -52.79 -50.82 62.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.703 -1.589 . . . . 0.0 111.665 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 tttm . . . . . 0 C--N 1.349 0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.936 -110.344 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 121.769 0.795 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -76.21 65.69 2.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.018 170.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 7' ' ' ILE . 1.3 ttmt -67.38 -52.25 42.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.081 -1.872 . . . . 0.0 111.214 143.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.8 m -58.93 -38.94 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.685 -152.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.871 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.766 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 15' ' ' LEU . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.691 HG23 HD21 ' A' ' 44' ' ' LEU . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' HG13 ' A' ' 49' ' ' VAL . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 7' ' ' ILE . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.941 HG21 HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.938 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 70' ' ' ILE . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.06 -41.15 71.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 25' ' ' THR . 9.5 p -77.62 -15.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.378 -174.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.41 124.06 88.17 Favored Pre-proline 0 N--CA 1.441 -0.883 0 C-N-CA 117.521 -1.672 . . . . 0.0 109.754 163.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.38 -64.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.882 1.721 . . . . 0.0 111.808 131.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.26 48.38 2.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.604 -154.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HG23 ' A' ' 21' ' ' THR . 5.5 mp -96.39 -73.16 0.61 Allowed 'General case' 0 C--N 1.35 0.606 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.025 157.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 49' ' ' VAL . . . -126.37 -147.98 6.97 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -162.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.73 -50.17 63.65 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.816 2.446 . . . . 0.0 113.713 28.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 49' ' ' VAL . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 45' ' ' GLY . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HA ' HG12 ' A' ' 55' ' ' VAL . 24.3 m120 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.456 ' CD ' HG22 ' A' ' 72' ' ' THR . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.829 HD13 ' CB ' ' A' ' 27' ' ' ALA . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.18 -47.48 73.83 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.38 67.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.245 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.8 m -61.73 -39.18 90.63 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.881 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.38 -39.86 94.58 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 118.444 -1.302 . . . . 0.0 113.221 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -46.69 64.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.968 159.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.85 98.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.805 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' O ' HD12 ' A' ' 95' ' ' LEU . 8.0 pt20 -55.91 -43.01 76.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.384 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.8 mm-40 -97.96 -50.36 4.44 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.047 -162.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -63.71 -64.33 0.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 117.464 -1.694 . . . . 0.0 110.242 165.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 56.38 68.89 2.01 Favored Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.144 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 94' ' ' LEU . 5.2 Cg_exo -54.07 -53.34 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 O-C-N 123.778 1.409 . . . . 0.0 113.874 -178.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -151.85 86.81 1.32 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -176.45 -58.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 111.857 -2.429 . . . . 0.0 109.473 -133.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 94' ' ' LEU . 59.8 mt -130.49 -58.5 1.04 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.151 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 C--N 1.348 0.512 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.731 -105.306 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.916 0.865 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 5' ' ' THR . 13.9 t 63.52 60.23 1.13 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.659 160.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -68.66 -52.23 33.46 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.301 98.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.0 m -58.83 -38.73 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.756 -162.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.803 ' HA ' HD12 ' A' ' 8' ' ' ILE . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.755 HD13 ' HB1' ' A' ' 82' ' ' ALA . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 5' ' ' THR . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG13 ' HE3' ' A' ' 59' ' ' LYS . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.605 ' C ' HD11 ' A' ' 8' ' ' ILE . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.578 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.992 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.702 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 49' ' ' VAL . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 38' ' ' ARG . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 -71.21 -41.16 70.58 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 25' ' ' THR . 2.5 p -55.52 -55.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.97 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.506 ' CD2' HG21 ' A' ' 49' ' ' VAL . 9.2 p80 -56.22 122.71 50.51 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.204 -147.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.8 -62.57 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 O-C-N 123.802 1.422 . . . . 0.0 111.877 144.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.03 48.17 2.3 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.549 -159.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -96.56 -66.26 0.92 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.449 153.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.907 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 121.72 124.46 3.04 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.328 175.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -53.02 -49.04 67.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 117.858 -1.537 . . . . 0.0 112.982 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 45' ' ' GLY . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 45' ' ' GLY . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.1 m120 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HE3' HG13 ' A' ' 14' ' ' VAL . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.554 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.992 HG21 HG21 ' A' ' 26' ' ' ILE . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 72' ' ' THR . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.588 HG22 ' HG3' ' A' ' 63' ' ' GLU . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.13 -47.08 75.27 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.6 67.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.071 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 29.7 m -61.7 -39.76 92.6 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.537 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.85 -40.83 96.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 119.289 -0.964 . . . . 0.0 113.038 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -39.89 59.51 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.411 161.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -57.92 -46.49 84.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.03 -2.268 . . . . 0.0 112.004 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -58.7 -43.06 89.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 117.056 -1.858 . . . . 0.0 112.505 -164.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -70.82 -67.09 0.53 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.029 164.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -78.59 -79.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.63 -1.623 . . . . 0.0 109.878 -164.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.087 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . 22.93 47.9 0.09 OUTLIER Pre-proline 0 C--N 1.349 0.557 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.401 -158.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.76 173.12 2.38 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 O-C-N 124.036 1.546 . . . . 0.0 110.93 -138.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 102.57 0.08 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.858 -56.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.087 HD12 ' HB3' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -97.22 -52.02 3.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.03 177.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' C ' HD13 ' A' ' 95' ' ' LEU . 1.4 tm? -146.49 -56.17 0.27 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.043 -153.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.35 0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.354 158.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.612 ' H ' ' H ' ' A' ' 4' ' ' VAL . 3.0 t 176.29 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.348 0.535 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.569 48.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -25.55 67.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.263 -1.789 . . . . 0.0 113.805 154.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' H ' ' H ' ' A' ' 2' ' ' SER . 23.2 m -58.69 -38.61 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -151.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.832 ' HA ' HD12 ' A' ' 8' ' ' ILE . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 24' ' ' ILE . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 5' ' ' THR . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 15' ' ' LEU . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' THR . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.942 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.651 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.812 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 70' ' ' ILE . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.71 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 49' ' ' VAL . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 -71.15 -41.16 70.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.651 HG11 HG21 ' A' ' 25' ' ' THR . 2.4 p -55.04 -55.63 15.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.106 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.603 ' CD2' HG21 ' A' ' 49' ' ' VAL . 8.5 p80 -56.35 122.04 46.76 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.235 -147.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 6.1 Cg_exo -60.07 -61.3 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 O-C-N 123.657 1.346 . . . . 0.0 112.406 146.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -143.47 52.13 1.35 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.327 -164.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.7 mp -88.34 -64.32 1.16 Allowed 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.637 149.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.92 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 118.95 120.89 2.96 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.619 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -52.19 -47.48 65.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.204 -166.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLY . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.459 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.4 m120 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' CG ' HG22 ' A' ' 72' ' ' THR . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' CB ' HD22 ' A' ' 69' ' ' LEU . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.71 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.812 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.21 -48.32 71.01 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.48 67.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.295 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.5 m -61.74 -38.84 89.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 118.444 -1.302 . . . . 0.0 112.828 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 61.6 mt -64.2 -38.84 92.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 118.998 -1.081 . . . . 0.0 113.397 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -46.81 64.41 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.88 158.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.59 83.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.669 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.1 pt20 -55.91 -40.12 72.6 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.433 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -120.43 -44.56 2.46 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.651 -146.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -62.42 -66.14 0.58 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 117.741 -1.584 . . . . 0.0 109.767 151.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.97 65.72 4.13 Favored Pre-proline 0 C--N 1.346 0.452 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.481 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -52.1 -55.35 3.96 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 O-C-N 123.86 1.452 . . . . 0.0 113.52 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.62 64.49 1.24 Allowed 'General case' 0 C--N 1.345 0.384 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.178 -172.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -161.02 -64.47 0.06 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.213 -134.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -171.81 51.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.806 -2.452 . . . . 0.0 110.823 -155.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--N 1.35 0.593 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.588 -173.086 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.949 0.88 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -177.1 152.77 0.92 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.682 -140.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.91 -25.78 68.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.889 -162.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 11.4 m -58.62 -38.97 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.305 -157.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.718 HD13 ' HB1' ' A' ' 82' ' ' ALA . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.599 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' C ' HD11 ' A' ' 8' ' ' ILE . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.569 ' OG1' HD12 ' A' ' 15' ' ' LEU . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.933 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 62' ' ' VAL . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 70' ' ' ILE . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 33' ' ' THR . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.12 -41.13 70.95 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' GLU . 6.0 p -86.49 -9.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.449 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.86 124.4 88.53 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 117.423 -1.711 . . . . 0.0 109.904 160.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.81 -63.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.947 1.765 . . . . 0.0 111.536 129.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.19 43.06 3.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.079 -151.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.4 mp -98.66 -68.63 0.79 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.707 159.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 129.08 133.34 3.62 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.348 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -57.6 -50.07 74.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 116.487 -2.085 . . . . 0.0 112.6 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 45' ' ' GLY . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 HD21 ' CG2' ' A' ' 19' ' ' THR . 28.2 m120 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG21 ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.815 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 79' ' ' ILE . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.718 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.39 -47.61 72.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.58 67.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.599 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 m -61.54 -41.12 96.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.323 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.17 -43.01 96.16 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.727 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -50.13 69.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.872 165.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -30.24 45.39 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.934 -166.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -65.95 -43.16 88.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.534 -1.666 . . . . 0.0 112.548 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.1 -57.08 2.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.174 -156.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.02 -60.43 3.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.916 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 56.02 82.39 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.211 152.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -76.67 158.13 35.68 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.549 2.166 . . . . 0.0 111.412 160.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.6 78.91 0.01 OUTLIER 'General case' 0 C--N 1.35 0.621 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.454 -95.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 1.5 mt -99.3 -47.14 5.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.556 -2.565 . . . . 0.0 110.845 -163.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.572 ' C ' HD13 ' A' ' 95' ' ' LEU . 3.0 tm? -180.0 -65.71 0.01 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.673 -132.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' N ' HD13 ' A' ' 95' ' ' LEU . 9.1 mmtp . . . . . 0 C--N 1.348 0.52 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.916 159.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.723 0.773 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -91.52 84.35 5.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.272 -1.786 . . . . 0.0 109.616 148.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.27 -25.66 68.15 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.706 147.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.4 m -58.61 -38.95 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.455 -158.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.821 ' HA ' HD12 ' A' ' 8' ' ' ILE . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.738 HD13 ' CB ' ' A' ' 82' ' ' ALA . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.54 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.586 ' C ' HD11 ' A' ' 8' ' ' ILE . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' THR . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.928 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.847 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.505 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' THR . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.99 -41.25 71.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 40' ' ' VAL . 8.1 p -84.06 -11.8 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.529 -170.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.44 124.61 89.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 C-N-CA 117.429 -1.709 . . . . 0.0 109.79 159.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -62.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.085 1.857 . . . . 0.0 111.825 130.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -129.49 43.55 3.12 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.951 -152.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -95.05 -69.25 0.76 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.334 156.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 135.58 138.03 3.8 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.561 174.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -56.9 -50.33 72.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 117.512 -1.675 . . . . 0.0 112.143 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 22' ' ' ILE . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 56' ' ' LEU . 24.7 m120 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.62 HG21 ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.928 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' CD ' HG22 ' A' ' 72' ' ' THR . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.7 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.847 HD13 ' CB ' ' A' ' 27' ' ' ALA . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.604 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.738 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.1 -47.51 73.96 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.8 68.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.209 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 54.3 m -61.69 -40.24 94.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 117.794 -1.562 . . . . 0.0 112.008 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' ALA . 82.2 mt -60.94 -41.33 96.04 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 118.806 -1.157 . . . . 0.0 112.907 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -39.94 59.88 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.69 162.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -55.81 -46.1 78.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 116.809 -1.956 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.12 -43.07 99.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 116.537 -2.065 . . . . 0.0 112.369 -161.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 95' ' ' LEU . 3.9 mm-40 -69.76 -73.53 0.16 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 117.954 -1.498 . . . . 0.0 109.098 160.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -68.81 -74.37 0.13 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.298 -158.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' A' ' 94' ' ' LEU . . . 15.15 54.33 0.06 OUTLIER Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 113.144 -1.844 . . . . 0.0 113.996 -158.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.22 164.12 2.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.587 2.191 . . . . 0.0 111.496 -143.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 96' ' ' LYS . 22.0 mt-10 -56.04 75.33 0.0 OUTLIER 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.92 -67.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.755 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 1.1 tm? -69.18 -43.88 73.34 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 112.065 -2.334 . . . . 0.0 112.199 146.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.33 58.64 3.68 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.858 149.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.35 0.609 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.6 109.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.687 0.756 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -177.31 158.97 1.52 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.655 -142.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -64.09 -25.69 68.21 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.067 -1.878 . . . . 0.0 113.696 -154.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.2 m -58.76 -38.96 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.59 -156.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.888 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.858 HD13 ' CB ' ' A' ' 82' ' ' ALA . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' HD23 ' A' ' 15' ' ' LEU . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 19' ' ' THR . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 21' ' ' THR . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.496 ' CB ' HD12 ' A' ' 15' ' ' LEU . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.845 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.534 HG21 ' CG1' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.934 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.824 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.743 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.724 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -71.05 -41.24 71.02 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 36' ' ' GLU . 14.7 p -84.66 -12.79 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.266 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.84 108.74 1.72 Allowed Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 132.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.73 -59.85 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.525 2.15 . . . . 0.0 112.944 133.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.13 52.05 1.08 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.771 -163.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 21' ' ' THR . 7.0 mp -78.1 -64.81 1.07 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.273 145.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 141.45 137.36 3.39 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.8 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -61.67 -50.04 74.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.56 -2.056 . . . . 0.0 112.108 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.845 HG22 HD11 ' A' ' 22' ' ' ILE . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 56' ' ' LEU . 23.5 m120 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.623 HG21 ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.934 HG21 HG21 ' A' ' 26' ' ' ILE . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.824 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 79' ' ' ILE . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.858 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.05 -47.45 74.32 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.73 68.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.052 -1.459 . . . . 0.0 112.311 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 51.9 m -61.71 -37.67 85.03 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.512 171.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 86.6 mt -63.7 -40.2 96.19 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.039 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -41.47 61.2 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.576 159.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -64.69 -43.8 92.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.214 -173.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -56.13 -43.01 77.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 117.886 -1.525 . . . . 0.0 112.571 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -116.83 -55.47 2.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.225 -154.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -64.7 -60.97 2.5 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.625 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -28.29 121.83 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 O-C-N 125.489 1.743 . . . . 0.0 112.69 -155.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' LYS . 2.9 Cg_endo -72.72 165.9 31.44 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.734 1.623 . . . . 0.0 112.48 156.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -78.69 53.73 1.39 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.508 -78.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 91' ' ' ALA . 1.6 tm? -38.27 -60.35 0.79 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.106 -1.861 . . . . 0.0 112.448 123.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 94' ' ' LEU . 2.5 tm? -121.53 -56.44 1.88 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.01 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 92' ' ' PRO . 2.4 tmtm? . . . . . 0 C--N 1.35 0.611 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.784 -135.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 121.869 0.843 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 -65.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.96 -157.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -37.92 89.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.204 -152.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 12.8 m -58.72 -38.97 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.432 -171.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.79 ' HA ' HD12 ' A' ' 8' ' ' ILE . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 24' ' ' ILE . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 5' ' ' THR . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 15' ' ' LEU . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.637 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' LEU . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.833 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 56' ' ' LEU . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 7' ' ' ILE . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.701 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.805 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 33' ' ' THR . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' THR . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 -71.22 -41.09 70.64 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 25' ' ' THR . 2.1 p -55.41 -55.81 15.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.899 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 6.5 p80 -56.41 122.98 53.44 Favored Pre-proline 0 N--CA 1.439 -1.001 0 O-C-N 124.782 1.301 . . . . 0.0 111.218 -147.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 3.6 Cg_exo -62.3 -62.01 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.391 1.394 . . . . 0.0 112.213 144.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -137.91 51.66 1.88 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.135 -162.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.833 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.8 mp -94.86 -68.7 0.79 Allowed 'General case' 0 C--N 1.349 0.547 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.502 151.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 126.53 128.96 3.23 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.783 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -52.2 -50.28 62.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.569 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 45' ' ' GLY . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.5 m120 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.577 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 30' ' ' ASP . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.805 HD13 ' CB ' ' A' ' 27' ' ' ALA . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . -66.34 -44.98 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.62 -38.87 72.69 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 118.233 -1.387 . . . . 0.0 112.318 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.7 m -61.78 -39.55 92.08 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.326 -1.349 . . . . 0.0 112.358 172.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.06 -40.95 95.62 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.051 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.87 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.563 161.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -62.77 -45.98 90.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.585 -1.646 . . . . 0.0 112.108 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.738 ' O ' HD13 ' A' ' 95' ' ' LEU . 7.8 pt20 -56.0 -39.72 72.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.216 -1.394 . . . . 0.0 112.753 -174.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.6 mm-40 -117.69 -57.41 2.12 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.956 -151.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -62.64 -57.97 9.15 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.59 77.82 0.35 Allowed Pre-proline 0 C--N 1.348 0.516 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.728 144.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.68 -52.27 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 114.013 168.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -145.37 62.99 1.28 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.217 -162.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.95 -62.81 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.328 -135.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 88' ' ' GLN . 7.4 tp -130.53 -60.45 0.99 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-N 112.036 -2.347 . . . . 0.0 110.001 -170.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? . . . . . 0 C--N 1.348 0.521 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.597 123.24 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.519 0.676 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t 51.6 49.02 21.77 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.301 -109.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HD2' HG21 ' A' ' 24' ' ' ILE . 4.8 ttmt -74.13 -52.29 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.428 172.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m -59.02 -38.78 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.719 -162.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 8' ' ' ILE . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.762 HD13 ' HB1' ' A' ' 82' ' ' ALA . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 21' ' ' THR . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 44' ' ' LEU . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 56' ' ' LEU . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 7' ' ' ILE . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.724 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.963 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.754 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.717 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 49' ' ' VAL . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 -71.07 -41.08 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 25' ' ' THR . 2.2 p -56.89 -53.15 46.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.154 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -54.9 124.52 52.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 124.665 1.228 . . . . 0.0 111.328 -160.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.59 -65.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.554 1.503 . . . . 0.0 111.666 134.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.36 44.61 2.71 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.856 -1.974 . . . . 0.0 110.666 -153.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 21' ' ' THR . 7.7 mp -101.92 -72.67 0.68 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.847 159.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 133.82 137.51 3.85 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 119.361 -1.4 . . . . 0.0 111.052 175.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -56.29 -50.32 71.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.673 -1.611 . . . . 0.0 112.208 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HD11 ' A' ' 22' ' ' ILE . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' HD22 ' A' ' 56' ' ' LEU . 25.7 m120 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HE2' ' A' ' 58' ' ' LYS . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HE2' HG23 ' A' ' 55' ' ' VAL . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.963 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.754 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.762 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.42 -48.39 70.2 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.52 67.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.322 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.0 m -61.79 -41.04 97.22 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.57 169.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 62.8 mt -61.1 -37.48 82.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.446 -1.302 . . . . 0.0 113.351 177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.271 0.0 OUTLIER -57.4 -49.99 74.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.903 160.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -53.96 -38.71 65.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.74 -172.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 4.9 pt20 -55.95 -37.48 69.07 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.06 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.75 -61.96 1.6 Allowed 'General case' 0 C--N 1.352 0.674 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.77 -164.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -73.32 -28.24 61.96 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.408 -1.723 . . . . 0.0 112.861 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 64.68 90.5 0.09 OUTLIER Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.1 145.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HD2' HD12 ' A' ' 94' ' ' LEU . 9.3 Cg_endo -81.4 145.21 14.83 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.486 2.124 . . . . 0.0 110.359 163.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.58 109.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.634 -107.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.815 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -148.16 -53.64 0.19 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 112.186 -2.279 . . . . 0.0 109.611 -148.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.8 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -51.34 -27.31 9.35 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.146 164.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.353 0.756 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -101.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.733 0.777 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.24 -63.32 0.22 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.333 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -64.05 -52.4 59.59 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.977 -150.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.2 m -65.98 -38.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.489 -173.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 8' ' ' ILE . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 24' ' ' ILE . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 5' ' ' THR . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' C ' HD11 ' A' ' 8' ' ' ILE . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 8' ' ' ILE . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.424 ' CB ' HD12 ' A' ' 15' ' ' LEU . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 7' ' ' ILE . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.709 HG21 HG11 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 62' ' ' VAL . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.819 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' HG22 ' A' ' 70' ' ' ILE . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.714 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 33' ' ' THR . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.07 -41.16 71.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.709 HG11 HG21 ' A' ' 25' ' ' THR . 7.2 p -83.3 -12.26 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.33 -1.305 . . . . 0.0 113.531 -171.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.2 124.12 88.12 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.853 161.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.08 -63.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.916 1.744 . . . . 0.0 111.669 131.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -132.66 44.23 2.89 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.939 -152.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -89.64 -66.3 0.94 Allowed 'General case' 0 C--N 1.35 0.622 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.586 155.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 128.75 125.49 2.76 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.256 177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -54.02 -49.79 68.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.39 -1.724 . . . . 0.0 112.824 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 45' ' ' GLY . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLY . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' O ' HD22 ' A' ' 56' ' ' LEU . 21.2 m120 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 26' ' ' ILE . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.669 ' CD ' HG22 ' A' ' 72' ' ' THR . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CB ' HD22 ' A' ' 69' ' ' LEU . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.714 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 63' ' ' GLU . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . -66.2 -47.22 74.61 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.65 67.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.291 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.7 m -61.7 -39.37 91.24 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.544 171.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -40.57 96.19 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.026 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -42.19 62.35 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.552 161.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -61.99 -45.05 95.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 118.066 -1.454 . . . . 0.0 111.954 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.44 -43.06 83.57 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 117.721 -1.592 . . . . 0.0 112.507 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.65 -59.24 1.75 Allowed 'General case' 0 C--N 1.349 0.557 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.13 -162.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.22 -57.12 11.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 96' ' ' LYS . . . 64.58 75.64 0.36 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.197 149.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.49 -57.93 1.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 O-C-N 124.185 1.623 . . . . 0.0 112.826 -147.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.53 -66.96 1.02 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.075 161.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.402 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER 38.15 -85.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 111.925 -2.398 . . . . 0.0 112.292 144.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.72 -58.98 1.47 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.8 -1.546 . . . . 0.0 109.767 -173.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' H ' ' HB3' ' A' ' 91' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.349 0.58 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.082 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 22.9 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.67 ' HA ' HD12 ' A' ' 8' ' ' ILE . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 24' ' ' ILE . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 5' ' ' THR . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.607 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' N ' HD11 ' A' ' 8' ' ' ILE . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.411 ' HB ' HD12 ' A' ' 15' ' ' LEU . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 49' ' ' VAL . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 56' ' ' LEU . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 7' ' ' ILE . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.801 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' A' ' 70' ' ' ILE . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.735 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 33' ' ' THR . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.547 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.597 HG23 HD21 ' A' ' 52' ' ' ASN . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 37' ' ' VAL . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.597 HD21 HG23 ' A' ' 48' ' ' VAL . 82.4 m-20 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.606 HG21 ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.735 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 18.2 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.677 ' HA ' HD12 ' A' ' 8' ' ' ILE . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.732 HD13 ' HB1' ' A' ' 82' ' ' ALA . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 5' ' ' THR . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.591 ' C ' HD11 ' A' ' 8' ' ' ILE . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' THR . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.685 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 49' ' ' VAL . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.738 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 33' ' ' THR . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 38' ' ' ARG . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.544 0.741 0 CA-C-O 121.614 0.721 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.637 HG22 HD11 ' A' ' 22' ' ' ILE . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 49' ' ' VAL . 76.2 m-20 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 26' ' ' ILE . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' HD22 ' A' ' 69' ' ' LEU . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.738 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.809 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.732 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.8 m . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 8' ' ' ILE . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.753 HD13 ' CB ' ' A' ' 82' ' ' ALA . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 5' ' ' THR . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 15' ' ' LEU . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 21' ' ' THR . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.838 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' VAL . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' THR . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.555 0.693 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 22' ' ' ILE . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.5 m-20 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.727 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 26' ' ' ILE . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.696 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.753 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.776 ' HA ' HD12 ' A' ' 8' ' ' ILE . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 82' ' ' ALA . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 5' ' ' THR . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 15' ' ' LEU . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.583 ' C ' HD11 ' A' ' 8' ' ' ILE . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 49' ' ' VAL . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 75' ' ' ALA . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.532 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.917 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.833 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 25' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.486 ' N ' HG23 ' A' ' 32' ' ' ILE . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' THR . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 50' ' ' ASN . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 22' ' ' ILE . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.424 HD22 ' CZ ' ' A' ' 38' ' ' ARG . 1.5 t-20 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.5 m-20 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.72 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 26' ' ' ILE . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.438 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.833 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.748 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 21.2 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.905 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.746 HD13 ' HB1' ' A' ' 82' ' ' ALA . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.535 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 21' ' ' THR . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.43 ' CB ' HD12 ' A' ' 15' ' ' LEU . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.821 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.935 HG21 HG21 ' A' ' 62' ' ' VAL . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.826 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 70' ' ' ILE . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 33' ' ' THR . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.175 0.512 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 22' ' ' ILE . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.9 m-20 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.674 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.935 HG21 HG21 ' A' ' 26' ' ' ILE . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.826 HD13 ' CB ' ' A' ' 27' ' ' ALA . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.746 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 29.6 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.838 ' HA ' HD12 ' A' ' 8' ' ' ILE . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 ' CB ' ' A' ' 82' ' ' ALA . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HD3' HG21 ' A' ' 48' ' ' VAL . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.458 ' CB ' HD12 ' A' ' 15' ' ' LEU . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.497 ' CD1' HG13 ' A' ' 49' ' ' VAL . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 7' ' ' ILE . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 25' ' ' THR . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.781 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 70' ' ' ILE . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.737 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 33' ' ' THR . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' A' ' 38' ' ' ARG . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 18' ' ' LYS . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG13 ' CD1' ' A' ' 22' ' ' ILE . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 48' ' ' VAL . 87.9 m-20 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.595 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 55' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.737 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.781 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.702 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 8' ' ' ILE . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.734 HD13 ' HB1' ' A' ' 82' ' ' ALA . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 5' ' ' THR . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' C ' HD11 ' A' ' 8' ' ' ILE . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 4' ' ' VAL . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD12 ' A' ' 15' ' ' LEU . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 61' ' ' LEU . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 7' ' ' ILE . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.76 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.499 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' THR . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 38' ' ' ARG . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG23 HD21 ' A' ' 52' ' ' ASN . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 85.9 m-20 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG23 ' HE2' ' A' ' 58' ' ' LYS . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 55' ' ' VAL . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 26' ' ' ILE . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 72' ' ' THR . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' CB ' HD22 ' A' ' 69' ' ' LEU . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.76 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.3 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.879 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.814 HD13 ' CB ' ' A' ' 82' ' ' ALA . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG13 ' NZ ' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' THR . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 4' ' ' VAL . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.658 HD11 HG22 ' A' ' 49' ' ' VAL . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 70' ' ' ILE . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.746 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.47 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' THR . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.455 HG23 HD21 ' A' ' 52' ' ' ASN . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG22 HD11 ' A' ' 22' ' ' ILE . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.455 HD21 HG23 ' A' ' 48' ' ' VAL . 82.0 m-20 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.562 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.746 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.811 HD13 ' CB ' ' A' ' 27' ' ' ALA . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.9 m . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' HB1' ' A' ' 82' ' ' ALA . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 15' ' ' LEU . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.574 ' C ' HD11 ' A' ' 8' ' ' ILE . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.681 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.702 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.835 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HA ' HG22 ' A' ' 70' ' ' ILE . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.67 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 33' ' ' THR . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 22' ' ' ILE . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.427 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.5 m-20 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.525 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 26' ' ' ILE . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' CG ' HG22 ' A' ' 72' ' ' THR . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CB ' HD22 ' A' ' 69' ' ' LEU . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.835 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 11' ' ' SER . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG11 ' HB ' ' A' ' 21' ' ' THR . 28.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 8' ' ' ILE . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 24' ' ' ILE . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 17' ' ' GLU . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 15' ' ' LEU . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' C ' HD11 ' A' ' 8' ' ' ILE . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' HD11 ' A' ' 8' ' ' ILE . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.477 ' CB ' HD12 ' A' ' 15' ' ' LEU . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.612 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 7' ' ' ILE . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.943 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' HG22 ' A' ' 70' ' ' ILE . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.512 HG23 ' CA ' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.512 ' CA ' HG23 ' A' ' 32' ' ' ILE . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' THR . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG22 HD11 ' A' ' 22' ' ' ILE . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 84.5 m-20 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.813 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.689 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 24.9 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.904 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.747 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.474 ' HB ' HD22 ' A' ' 15' ' ' LEU . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' C ' HD11 ' A' ' 8' ' ' ILE . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 4' ' ' VAL . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.409 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.954 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.84 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 22' ' ' ILE . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HA ' HG12 ' A' ' 55' ' ' VAL . 85.0 m-20 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.954 HG21 HG21 ' A' ' 26' ' ' ILE . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' CG ' HG22 ' A' ' 72' ' ' THR . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.84 HD13 ' CB ' ' A' ' 27' ' ' ALA . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.8 m . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.871 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.766 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 15' ' ' LEU . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.42 ' HB ' HG11 ' A' ' 4' ' ' VAL . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' HG13 ' A' ' 49' ' ' VAL . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 7' ' ' ILE . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.938 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 70' ' ' ILE . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HE ' HD21 ' A' ' 46' ' ' ASN . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.696 HD21 ' HE ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.223 -0.341 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 49' ' ' VAL . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 ' CD1' ' A' ' 22' ' ' ILE . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HA ' HG12 ' A' ' 55' ' ' VAL . 86.0 m-20 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.456 ' CD ' HG22 ' A' ' 72' ' ' THR . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.829 HD13 ' CB ' ' A' ' 27' ' ' ALA . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.0 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.803 ' HA ' HD12 ' A' ' 8' ' ' ILE . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.755 HD13 ' HB1' ' A' ' 82' ' ' ALA . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 5' ' ' THR . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG13 ' HE3' ' A' ' 59' ' ' LYS . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.605 ' C ' HD11 ' A' ' 8' ' ' ILE . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.578 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.992 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.702 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 49' ' ' VAL . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 38' ' ' ARG . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 . . . . . 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG22 HD11 ' A' ' 22' ' ' ILE . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.0 m-20 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HE3' HG13 ' A' ' 14' ' ' VAL . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.554 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.992 HG21 HG21 ' A' ' 26' ' ' ILE . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 72' ' ' THR . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.588 HG22 ' HG3' ' A' ' 63' ' ' GLU . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.832 ' HA ' HD12 ' A' ' 8' ' ' ILE . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 24' ' ' ILE . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 5' ' ' THR . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 15' ' ' LEU . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' THR . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.812 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 70' ' ' ILE . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.71 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 49' ' ' VAL . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG23 HD21 ' A' ' 52' ' ' ASN . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 37' ' ' VAL . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.464 HD21 HG23 ' A' ' 48' ' ' VAL . 85.5 m-20 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' CG ' HG22 ' A' ' 72' ' ' THR . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' CB ' HD22 ' A' ' 69' ' ' LEU . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.71 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.812 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 11.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.718 HD13 ' HB1' ' A' ' 82' ' ' ALA . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.599 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' C ' HD11 ' A' ' 8' ' ' ILE . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.569 ' OG1' HD12 ' A' ' 15' ' ' LEU . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 62' ' ' VAL . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 70' ' ' ILE . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 33' ' ' THR . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 22' ' ' ILE . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 49' ' ' VAL . 83.9 m-20 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG21 ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.815 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.718 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.4 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.821 ' HA ' HD12 ' A' ' 8' ' ' ILE . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.738 HD13 ' CB ' ' A' ' 82' ' ' ALA . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.54 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.586 ' C ' HD11 ' A' ' 8' ' ' ILE . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' THR . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.928 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.847 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.505 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' THR . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.514 0.673 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 22' ' ' ILE . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 56' ' ' LEU . 85.8 m-20 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.62 HG21 ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.928 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' CD ' HG22 ' A' ' 72' ' ' THR . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.7 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.847 HD13 ' CB ' ' A' ' 27' ' ' ALA . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.604 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.738 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.2 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.888 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.858 HD13 ' CB ' ' A' ' 82' ' ' ALA . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' HD23 ' A' ' 15' ' ' LEU . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 19' ' ' THR . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 21' ' ' THR . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.496 ' CB ' HD12 ' A' ' 15' ' ' LEU . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.845 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.934 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.824 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.743 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.223 0.535 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.845 HG22 HD11 ' A' ' 22' ' ' ILE . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.0 m-20 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.623 HG21 ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.934 HG21 HG21 ' A' ' 26' ' ' ILE . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.824 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.858 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 12.8 m . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.79 ' HA ' HD12 ' A' ' 8' ' ' ILE . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 24' ' ' ILE . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 5' ' ' THR . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 15' ' ' LEU . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.637 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' LEU . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 49' ' ' VAL . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 56' ' ' LEU . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 7' ' ' ILE . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.805 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 33' ' ' THR . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' THR . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.489 0.661 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 22' ' ' ILE . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.5 m-20 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.577 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 30' ' ' ASP . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.805 HD13 ' CB ' ' A' ' 27' ' ' ALA . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 8' ' ' ILE . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.762 HD13 ' HB1' ' A' ' 82' ' ' ALA . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 21' ' ' THR . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 56' ' ' LEU . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 7' ' ' ILE . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.963 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.754 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.717 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 49' ' ' VAL . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 . . . . . 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 121.482 0.658 . . . . 0.0 112.208 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HD11 ' A' ' 22' ' ' ILE . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 49' ' ' VAL . 86.0 m-20 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HE2' ' A' ' 58' ' ' LYS . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HE2' HG23 ' A' ' 55' ' ' VAL . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.963 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.754 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.762 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . . . . . . 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.2 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 8' ' ' ILE . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 24' ' ' ILE . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 5' ' ' THR . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' C ' HD11 ' A' ' 8' ' ' ILE . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 8' ' ' ILE . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.424 ' CB ' HD12 ' A' ' 15' ' ' LEU . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 7' ' ' ILE . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 62' ' ' VAL . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.819 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' HG22 ' A' ' 70' ' ' ILE . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.714 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 33' ' ' THR . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 22' ' ' ILE . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.1 m-20 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 26' ' ' ILE . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.669 ' CD ' HG22 ' A' ' 72' ' ' THR . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CB ' HD22 ' A' ' 69' ' ' LEU . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.714 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 63' ' ' GLU . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mmm . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.761 0.791 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 t 71.19 158.93 0.2 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.999 -1.91 . . . . 0.0 110.119 116.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -25.9 68.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.439 -119.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 22.9 m -58.66 -38.93 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.302 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.67 ' HA ' HD12 ' A' ' 8' ' ' ILE . 23.4 m -58.57 -38.91 78.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.832 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -66.0 -37.57 86.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.306 170.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 24' ' ' ILE . 21.1 mm -56.92 -46.27 83.75 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.971 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 5' ' ' THR . 60.6 mt -55.82 -44.21 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.51 173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -51.38 70.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.639 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.25 -46.2 67.88 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.294 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 18.3 t -51.73 -46.54 64.03 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.47 174.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.9 t-20 105.52 68.05 0.0 OUTLIER 'General case' 0 C--N 1.352 0.694 0 CA-C-N 112.866 -1.97 . . . . 0.0 109.567 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 45.61 48.05 11.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.433 -2.167 . . . . 0.0 112.596 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.5 t -94.05 -61.78 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.603 159.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.0 mm? -64.99 167.39 7.87 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.601 -168.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.607 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.5 m120 -96.26 -162.07 0.92 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.705 -2.043 . . . . 0.0 108.672 150.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' N ' HD11 ' A' ' 8' ' ' ILE . 40.7 mt-10 -51.75 -52.07 51.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.124 150.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -64.18 -49.21 72.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.78 -162.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.411 ' HB ' HD12 ' A' ' 15' ' ' LEU . 42.8 p -70.17 -32.25 70.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.438 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.75 -46.39 89.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.867 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.5 t -67.22 -37.93 84.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 118.679 -1.209 . . . . 0.0 112.796 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.945 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.4 mm -68.2 -51.17 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.347 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 56' ' ' LEU . 18.7 tp -51.66 -37.48 50.65 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.235 170.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.924 HD11 HD11 ' A' ' 7' ' ' ILE . 2.6 mm -64.15 -46.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.039 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.611 HG21 HG11 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -61.42 -47.9 83.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.262 -174.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 6.1 mt -60.34 -50.2 81.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.616 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.801 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -47.15 67.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.159 -169.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.16 -57.73 10.02 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.055 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -94.04 121.17 35.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.541 -164.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' A' ' 70' ' ' ILE . 4.3 m-20 -91.18 109.68 20.95 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.756 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.735 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.79 58.71 1.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.563 -160.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -50.46 -161.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.791 134.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.2 p -144.28 -175.76 4.76 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.739 139.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.46 72.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.661 -1.608 . . . . 0.0 112.752 159.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' HH21 ' A' ' 38' ' ' ARG . . . -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.843 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.7 tt0 -61.87 -40.81 96.68 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 117.153 -1.819 . . . . 0.0 112.167 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 33' ' ' THR . 64.5 t -59.67 -40.7 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 118.846 -1.142 . . . . 0.0 112.058 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.547 HH21 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -54.46 -45.61 73.16 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.543 164.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.2 mm-40 -71.21 -41.07 70.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.544 -163.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 25' ' ' THR . 1.9 p -55.61 -55.36 17.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.074 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 49' ' ' VAL . 8.0 p80 -56.94 123.66 60.52 Favored Pre-proline 0 N--CA 1.439 -0.979 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.128 -145.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 3.9 Cg_exo -62.67 -62.51 0.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.508 1.472 . . . . 0.0 111.998 144.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.25 49.14 2.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 112.713 -2.039 . . . . 0.0 110.355 -160.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.945 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.4 mp -95.14 -66.04 0.94 Allowed 'General case' 0 C--N 1.35 0.607 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.733 154.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.94 114.47 2.66 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 113.954 -1.475 . . . . 0.0 111.043 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -51.92 -45.23 64.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 118.584 -1.246 . . . . 0.0 113.177 -161.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.27 90.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.017 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG23 HD21 ' A' ' 52' ' ' ASN . 4.0 m -63.78 -36.92 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 116.42 -2.112 . . . . 0.0 111.714 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 45' ' ' GLY . 98.3 t -59.38 -43.76 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.983 -172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -53.94 -47.17 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.951 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -62.91 -43.15 99.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 117.827 -1.549 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.597 HD21 HG23 ' A' ' 48' ' ' VAL . 82.4 m-20 -68.14 -38.89 82.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -168.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.606 HG21 ' CD1' ' A' ' 69' ' ' LEU . 39.3 mt -66.46 -49.14 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.281 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -42.75 96.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 119.124 -1.513 . . . . 0.0 113.362 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.11 -35.96 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.511 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.91 -47.67 74.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.287 162.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.31 -42.28 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 117.997 -1.481 . . . . 0.0 112.254 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -23.41 62.12 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.505 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -73.64 -50.08 22.83 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.884 164.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.63 99.43 0.06 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -122.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -158.88 97.81 1.44 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.533 -1.833 . . . . 0.0 107.355 70.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 10.4 p -147.65 150.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 126.743 2.017 . . . . 0.0 107.586 105.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.42 125.31 50.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.086 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.84 117.13 21.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.625 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -113.0 106.63 14.92 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.581 -2.1 . . . . 0.0 109.17 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.99 87.17 0.57 Allowed Glycine 0 C--N 1.347 1.168 0 C-N-CA 118.627 -1.749 . . . . 0.0 110.781 -125.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -150.14 62.18 0.97 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.915 72.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.16 172.62 29.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 113.485 -1.689 . . . . 0.0 110.365 134.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.65 139.01 36.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.605 -1.797 . . . . 0.0 108.174 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.735 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.1 pt -154.11 149.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 117.313 -1.755 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.8 pt -93.16 158.85 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.988 -156.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 p -77.75 176.45 9.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 111.579 -2.555 . . . . 0.0 109.181 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.64 -38.13 58.11 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 112.935 -1.939 . . . . 0.0 113.534 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.92 -48.48 78.15 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 117.838 -1.545 . . . . 0.0 111.765 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.56 -48.16 80.08 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.477 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -54.45 -35.82 63.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.646 -1.221 . . . . 0.0 112.977 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.04 -44.95 78.9 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.346 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.67 -45.13 99.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.615 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.18 -46.12 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.57 -175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.84 -47.06 86.17 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.924 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.36 -45.31 91.77 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.564 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.37 -47.48 73.23 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.146 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.46 67.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.039 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -61.45 -36.73 81.22 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.582 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.4 mt -68.33 -37.2 80.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.662 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -45.22 64.03 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.365 160.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -61.78 -39.76 92.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.155 -1.418 . . . . 0.0 112.413 -173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.94 -43.11 95.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.159 -1.816 . . . . 0.0 112.28 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -48.69 6.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.362 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -66.29 -64.72 0.8 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 116.668 -2.013 . . . . 0.0 110.18 165.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 95' ' ' LEU . . . 59.91 81.87 0.24 Allowed Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.577 -170.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.91 134.15 9.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.348 2.032 . . . . 0.0 111.075 157.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.71 119.87 11.38 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 118.087 -1.445 . . . . 0.0 109.752 -95.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD13 ' HB1' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -153.13 -55.89 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.821 -140.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.68 ' H ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 tm? -127.89 -62.61 1.06 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 112.794 -2.003 . . . . 0.0 109.631 -172.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.347 0.489 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.728 159.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 121.943 0.878 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -167.72 -69.39 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.858 -142.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -74.05 -52.29 13.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.106 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 18.2 m -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.788 -160.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.677 ' HA ' HD12 ' A' ' 8' ' ' ILE . 33.8 m -58.45 -39.0 78.69 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.988 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -64.17 -37.76 88.63 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.23 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.732 HD13 ' HB1' ' A' ' 82' ' ' ALA . 30.8 mm -58.75 -46.4 90.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.631 174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 5' ' ' THR . 63.9 mt -55.86 -50.02 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.34 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.97 -51.09 67.26 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.901 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.58 -46.17 70.08 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.176 -172.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 27.3 t -53.17 -46.36 68.89 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.675 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' SER . 15.1 t-20 107.82 64.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.95 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 51.81 48.68 22.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.067 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.8 t -97.43 -61.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.804 158.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.8 163.58 13.92 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.66 -168.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.591 ' C ' HD11 ' A' ' 8' ' ' ILE . 84.0 m-20 -90.99 -156.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.478 156.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.77 -57.25 13.27 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.409 147.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' THR . 31.9 mttm -64.11 -49.37 72.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.909 -156.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.2 p -63.01 -35.79 81.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.116 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.685 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.29 90.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.925 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.2 t -67.09 -37.88 84.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.8 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.911 ' CD1' HD23 ' A' ' 44' ' ' LEU . 2.2 mm -69.95 -51.13 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.463 -176.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.7 tp -51.55 -37.73 50.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.063 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.4 mm -61.13 -49.57 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.422 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.715 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.09 -46.8 88.38 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.629 -172.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.71 -50.14 80.23 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.678 168.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.77 -47.18 67.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.132 -1.849 . . . . 0.0 112.499 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -58.14 9.03 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.891 176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -94.28 125.99 39.26 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 113.262 -1.79 . . . . 0.0 109.393 -164.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 m-20 -92.28 110.82 22.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.798 -176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.738 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 8.4 m-30 61.44 59.13 1.95 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.356 -1.747 . . . . 0.0 109.518 -160.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.9 -162.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.739 136.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 32' ' ' ILE . 23.2 p -144.36 -174.13 4.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.754 141.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.67 69.55 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.022 158.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.89 -50.09 75.32 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.694 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -62.33 -41.15 98.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.177 -1.409 . . . . 0.0 112.239 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 33' ' ' THR . 80.0 t -59.73 -45.49 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 117.579 -1.649 . . . . 0.0 111.612 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 38' ' ' ARG . 1.2 mtt85 -52.93 -45.31 67.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.358 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.93 -41.18 71.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.202 -1.363 . . . . 0.0 112.083 -170.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 25' ' ' THR . 9.0 p -80.91 -13.74 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.497 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.53 123.52 85.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.872 163.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 -63.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.213 1.942 . . . . 0.0 111.386 126.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.41 -9.68 32.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.777 -144.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.911 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.7 mp -76.27 -69.1 0.52 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.049 -166.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 130.05 133.18 3.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.52 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 46' ' ' ASN . 2.4 m-80 -54.15 -50.25 67.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 117.758 -1.577 . . . . 0.0 111.893 -174.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -46.25 74.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.766 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 m -61.91 -41.56 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 116.402 -2.119 . . . . 0.0 111.658 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 45' ' ' GLY . 67.8 t -58.85 -41.44 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.102 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.89 -47.22 71.35 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.217 168.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 t -63.28 -43.06 98.99 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.787 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 49' ' ' VAL . 76.2 m-20 -68.0 -39.01 83.31 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 69' ' ' LEU . 45.1 mt -66.98 -49.34 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.967 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -41.84 96.35 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.627 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.01 -35.69 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.499 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.8 -47.51 73.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.425 162.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 mm -61.79 -42.33 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 117.695 -1.602 . . . . 0.0 112.199 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.13 -23.99 62.19 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.596 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -73.75 -49.7 24.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.906 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.64 99.54 0.05 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -121.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.88 97.8 1.44 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 112.63 -1.785 . . . . 0.0 107.425 69.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 26' ' ' ILE . 13.1 p -147.82 150.86 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.887 2.075 . . . . 0.0 107.743 107.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.04 123.64 47.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.352 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' HD22 ' A' ' 69' ' ' LEU . 17.7 ttpt -80.8 118.17 22.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.398 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -116.2 106.63 13.91 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.549 -2.114 . . . . 0.0 109.109 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.81 87.88 0.66 Allowed Glycine 0 C--N 1.347 1.171 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.621 -125.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -150.1 61.0 0.98 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.099 -1.551 . . . . 0.0 110.104 72.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.22 173.05 29.98 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.44 136.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.0 mt -100.8 138.78 37.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.598 -1.801 . . . . 0.0 108.129 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.738 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.5 pt -153.98 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 C-N-CA 117.24 -1.784 . . . . 0.0 109.604 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.809 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.2 pt -94.67 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.364 -1.744 . . . . 0.0 110.151 -157.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -77.7 176.46 8.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 111.551 -2.568 . . . . 0.0 109.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.46 55.36 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 113.043 -1.889 . . . . 0.0 113.546 163.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.95 -49.68 74.95 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.716 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.49 -47.93 80.57 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.264 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -54.29 -35.82 63.02 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.852 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -67.08 -45.17 78.13 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.433 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.84 -47.09 94.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.528 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.3 mm -65.32 -46.06 91.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.938 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -58.85 -47.08 86.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.714 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.85 -45.54 74.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.339 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.732 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.23 -47.44 73.8 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 118.589 -1.245 . . . . 0.0 112.259 -172.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.89 -38.71 67.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.48 -1.237 . . . . 0.0 112.465 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 m -61.75 -42.63 99.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.13 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 85' ' ' LEU . 69.7 mt -60.06 -38.28 82.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.25 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -50.23 74.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.667 162.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.85 70.2 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.681 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -57.07 -43.12 81.76 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.544 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.0 -57.38 2.17 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.987 -150.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.13 -62.3 1.71 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.559 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.762 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 56.58 82.94 0.23 Allowed Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 113.547 -1.661 . . . . 0.0 110.904 153.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -75.85 144.71 27.84 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.288 1.992 . . . . 0.0 111.327 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.85 111.87 3.48 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.639 -91.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.762 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 2.3 mt -134.19 -52.01 0.83 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.898 -153.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 91' ' ' ALA . 1.4 mp -62.37 -59.02 5.59 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 C--N 1.348 0.525 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.769 -114.032 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 122.003 0.906 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t -77.88 -63.54 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 112.783 -2.008 . . . . 0.0 110.171 -155.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -52.26 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.294 -155.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.8 m -58.88 -38.78 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.695 -160.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.797 ' HA ' HD12 ' A' ' 8' ' ' ILE . 19.2 m -58.36 -38.94 78.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 118.954 -1.098 . . . . 0.0 111.947 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 49.0 m-85 -64.42 -37.69 88.41 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.23 172.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.753 HD13 ' CB ' ' A' ' 82' ' ' ALA . 41.7 mm -57.34 -46.63 85.37 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.903 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 5' ' ' THR . 53.8 mt -55.98 -49.52 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.433 174.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -51.11 66.9 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.945 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.683 ' HB2' HD12 ' A' ' 85' ' ' LEU . . . -69.07 -46.17 68.48 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.195 -170.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -51.81 -46.58 64.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.648 172.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.2 t-20 109.33 63.72 0.0 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.02 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 t0 51.97 49.01 21.6 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 112.878 -1.964 . . . . 0.0 112.024 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 15' ' ' LEU . 73.4 t -97.44 -61.63 2.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.749 158.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.95 166.2 9.63 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 113.573 -1.648 . . . . 0.0 109.615 -167.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.2 m-80 -95.42 -159.18 0.7 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.577 153.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -53.65 -56.67 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.453 149.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 21' ' ' THR . 48.6 mttt -64.19 -49.38 72.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.694 -159.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -66.14 -33.64 76.23 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.033 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.33 90.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.112 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.6 t -67.16 -37.96 84.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.931 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.767 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.6 mm -67.36 -51.16 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.233 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.71 -37.54 51.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.19 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.4 -47.96 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.81 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.566 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -58.99 -47.05 86.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.499 -175.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -59.29 -50.16 80.83 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.812 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.838 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.7 -47.17 67.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.482 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -58.27 8.73 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.938 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.15 119.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.523 -160.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.3 m-20 -90.52 106.88 18.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.934 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.3 m-30 61.9 58.81 1.84 Allowed 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.616 -1.629 . . . . 0.0 109.665 -161.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -51.85 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.597 134.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' VAL . 8.3 p -144.17 -176.99 5.23 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.784 139.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.89 64.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.747 -1.57 . . . . 0.0 112.486 159.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.67 -50.08 69.07 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.814 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.95 -41.22 97.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 117.87 -1.532 . . . . 0.0 112.273 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' THR . 96.0 t -59.7 -40.88 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 117.688 -1.605 . . . . 0.0 111.849 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -52.9 -44.41 66.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.462 166.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.05 -41.17 71.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.165 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 25' ' ' THR . 9.4 p -82.64 -12.85 12.21 Favored 'Isoleucine or valine' 0 C--N 1.349 0.561 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.588 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.66 124.23 88.79 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 117.369 -1.732 . . . . 0.0 109.842 163.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 -63.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.964 1.776 . . . . 0.0 111.644 129.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.72 43.6 3.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.993 -151.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.767 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -96.96 -68.5 0.8 Allowed 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.63 159.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 131.96 134.0 3.52 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.655 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' ND2' ' H ' ' A' ' 46' ' ' ASN . 3.3 m-80 -56.44 -50.23 72.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.774 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.19 75.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.722 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -63.8 -41.07 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 116.573 -2.051 . . . . 0.0 111.615 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 45' ' ' GLY . 68.6 t -58.95 -42.98 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -53.73 -47.1 70.93 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.827 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 t -62.87 -43.2 99.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.413 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.5 m-20 -68.21 -38.95 82.45 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -168.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.53 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 42.3 mt -67.49 -49.21 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.186 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.1 96.44 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.223 -1.465 . . . . 0.0 113.551 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.06 -35.96 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.511 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.86 -47.64 73.95 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.293 162.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.14 -42.24 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 117.885 -1.526 . . . . 0.0 112.126 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -24.25 62.27 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.61 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -73.77 -49.07 27.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.015 167.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.727 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.73 99.48 0.06 OUTLIER Glycine 0 C--N 1.349 1.28 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -121.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -161.11 97.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.758 -1.721 . . . . 0.0 106.918 69.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 26' ' ' ILE . 14.5 p -147.84 150.42 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.002 -1.908 . . . . 0.0 107.743 107.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.16 121.76 44.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.15 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -81.22 116.72 21.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.833 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t -113.49 106.61 14.76 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 112.474 -2.148 . . . . 0.0 109.15 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.38 96.91 2.21 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 118.225 -1.941 . . . . 0.0 110.716 -134.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.94 -42.65 7.43 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.244 -1.478 . . . . 0.0 112.195 66.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.92 160.9 13.18 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -148.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.1 mt -95.92 138.13 34.0 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 112.715 -1.743 . . . . 0.0 107.179 -164.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.696 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.2 pt -154.2 149.4 12.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 117.163 -1.815 . . . . 0.0 109.696 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.4 pt -94.89 153.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.924 -153.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 169.84 17.6 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.113 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.94 -25.96 25.26 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.826 171.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.31 -52.05 67.31 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 117.33 -1.748 . . . . 0.0 111.217 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.73 -48.14 80.44 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.487 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -54.38 -35.85 63.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.016 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -44.91 79.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.32 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.89 -46.94 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.318 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.1 mm -64.6 -46.2 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.954 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -59.65 -47.19 86.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.044 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.57 -45.17 88.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.591 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.753 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.3 -43.75 85.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.359 -173.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.213 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.7 m -61.81 -38.01 86.53 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.48 168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 10' ' ' ALA . 75.7 mt -63.85 -35.95 82.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.597 177.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -50.18 70.42 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.435 158.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.05 -40.34 76.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.585 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.3 pt20 -55.93 -40.2 72.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.634 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 3.1 mm-40 -103.58 -41.41 5.97 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.831 -153.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -63.67 -64.99 0.75 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 117.201 -1.8 . . . . 0.0 110.109 153.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.701 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 55.34 82.92 0.23 Allowed Pre-proline 0 C--N 1.347 0.497 0 CA-C-N 112.866 -1.97 . . . . 0.0 111.29 -168.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -82.73 130.33 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.241 1.96 . . . . 0.0 111.656 160.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.79 133.79 48.82 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 117.085 -1.846 . . . . 0.0 109.515 -84.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.701 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -151.74 -57.9 0.15 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 112.581 -2.099 . . . . 0.0 109.656 -149.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' H ' ' HB3' ' A' ' 96' ' ' LYS . 1.3 tp -163.0 -63.94 0.04 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.726 -2.034 . . . . 0.0 109.994 -156.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 95' ' ' LEU . 5.2 pttt . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.556 129.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.829 0.823 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 64.34 173.34 0.19 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.172 -1.831 . . . . 0.0 110.04 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.1 -25.62 68.18 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.958 -175.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 23.2 m -58.44 -38.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -140.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.776 ' HA ' HD12 ' A' ' 8' ' ' ILE . 60.6 m -58.31 -38.83 77.87 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.834 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -64.33 -37.7 88.43 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.01 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 82' ' ' ALA . 42.9 mm -57.87 -45.28 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.835 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 5' ' ' THR . 52.0 mt -55.92 -50.06 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 113.879 -1.509 . . . . 0.0 111.234 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -54.84 -51.25 66.48 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.855 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.22 68.46 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.314 -171.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 24.1 t -52.14 -46.57 65.45 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.585 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 14.8 t-20 109.45 63.68 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 CA-C-N 112.782 -2.008 . . . . 0.0 110.027 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t70 51.62 49.53 20.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 112.882 -1.963 . . . . 0.0 111.974 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' HD22 ' A' ' 15' ' ' LEU . 64.7 t -97.31 -62.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.68 158.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm? -65.55 166.86 9.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.442 -168.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.583 ' C ' HD11 ' A' ' 8' ' ' ILE . 8.9 m-20 -93.44 -159.35 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.605 153.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -51.95 -54.78 25.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.783 145.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -64.1 -49.33 72.64 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.604 -1.634 . . . . 0.0 111.784 -159.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.1 p -69.47 -31.16 69.27 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.399 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.84 -46.22 90.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.008 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -67.11 -41.92 85.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.336 -1.346 . . . . 0.0 112.965 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 49' ' ' VAL . 1.8 mm -61.6 -51.25 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.472 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 75' ' ' ALA . 13.7 tp -51.8 -38.9 57.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.3 171.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -66.07 -44.42 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 119.018 -1.073 . . . . 0.0 112.343 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.67 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -59.32 -50.04 75.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 118.166 -1.414 . . . . 0.0 111.515 -177.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.917 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -59.17 -50.13 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.605 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.833 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.54 -47.11 66.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.034 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -58.51 7.36 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.914 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -95.69 124.09 39.56 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.295 -164.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 31.6 m-20 -92.36 113.49 25.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.499 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 77.3 m-85 59.18 60.67 2.31 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.873 -156.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 25' ' ' THR . 4.7 tt -52.26 -161.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 112.906 -1.952 . . . . 0.0 110.69 135.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.486 ' N ' HG23 ' A' ' 32' ' ' ILE . 15.2 p -144.45 -175.74 4.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.709 138.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.07 68.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.573 -1.649 . . . . 0.0 112.844 159.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.4 -50.12 74.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.813 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.71 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.1 tt0 -62.05 -40.12 94.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 118.091 -1.444 . . . . 0.0 112.379 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' THR . 81.9 t -59.66 -46.41 93.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 117.834 -1.546 . . . . 0.0 111.426 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 50' ' ' ASN . 7.7 mtt180 -52.96 -44.15 66.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.441 170.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.02 -41.2 71.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.13 -171.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 36' ' ' GLU . 7.2 p -84.04 -11.23 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.552 -170.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.78 124.06 87.57 Favored Pre-proline 0 N--CA 1.442 -0.875 0 C-N-CA 117.572 -1.651 . . . . 0.0 109.86 161.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -63.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.022 1.815 . . . . 0.0 111.667 129.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -125.78 41.43 3.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.168 -150.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.7 mp -98.15 -69.05 0.77 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.576 160.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.819 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 130.27 135.12 3.79 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.355 175.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -58.19 -50.07 74.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 116.707 -1.997 . . . . 0.0 112.534 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -46.16 88.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.707 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -64.37 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 C-N-CA 116.796 -1.962 . . . . 0.0 111.629 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 45' ' ' GLY . 53.3 t -58.95 -43.1 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.198 0.937 . . . . 0.0 112.235 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.424 HD22 ' CZ ' ' A' ' 38' ' ' ARG . 1.5 t-20 -53.82 -47.15 71.16 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.915 170.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.96 -43.12 99.67 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.5 m-20 -68.23 -40.76 81.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.171 -168.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.1 mt -66.44 -48.06 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.578 174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.04 96.91 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 118.821 -1.657 . . . . 0.0 113.493 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 5.3 p -68.05 -35.8 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 118.999 -1.081 . . . . 0.0 112.335 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -54.63 -47.49 73.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.068 162.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -63.11 -42.17 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 118.265 -1.374 . . . . 0.0 112.217 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.72 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 1.8 pttt -66.39 -29.08 69.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.261 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -73.59 -48.45 32.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.071 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.37 99.5 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.15 97.63 1.26 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.617 -1.792 . . . . 0.0 107.067 68.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 26' ' ' ILE . 12.7 p -147.72 150.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 127.033 2.133 . . . . 0.0 107.461 104.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -104.87 128.68 53.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.755 168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.75 122.75 27.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.086 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 t -117.15 106.74 13.66 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.045 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.26 87.22 0.57 Allowed Glycine 0 C--N 1.349 1.263 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.793 -124.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.04 62.28 0.98 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 112.88 -1.66 . . . . 0.0 109.93 73.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.438 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.17 174.36 29.61 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.426 134.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.57 138.84 37.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.412 -1.894 . . . . 0.0 108.27 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.6 pt -153.21 149.57 13.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 117.256 -1.777 . . . . 0.0 110.283 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.833 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -94.33 148.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 112.964 -1.925 . . . . 0.0 110.402 -153.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 p -78.7 168.06 20.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.967 -1.924 . . . . 0.0 108.667 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.48 -25.84 43.15 Favored Glycine 0 CA--C 1.547 2.086 0 C-N-CA 117.759 -2.163 . . . . 0.0 113.858 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -50.36 72.72 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 118.363 -1.335 . . . . 0.0 111.549 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -48.06 80.11 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.384 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -54.31 -35.7 62.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.951 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.25 -45.03 77.92 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.672 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mm -63.0 -46.97 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.375 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.61 -46.18 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.946 -175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -47.19 86.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.214 -1.394 . . . . 0.0 111.971 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.35 -45.2 80.99 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.008 -1.477 . . . . 0.0 111.678 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.748 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.12 -47.24 74.81 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.933 -172.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.68 67.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 118.251 -1.38 . . . . 0.0 112.248 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.458 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 41.4 m -61.59 -37.0 82.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.746 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.55 -39.77 94.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.531 -1.267 . . . . 0.0 113.181 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -41.4 61.4 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.64 160.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.538 ' O ' HD13 ' A' ' 94' ' ' LEU . . . -62.81 -42.59 99.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.809 -1.557 . . . . 0.0 112.201 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -59.36 -43.12 92.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 117.005 -1.878 . . . . 0.0 112.435 -176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.44 -61.32 1.38 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.971 -166.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.8 -52.61 62.49 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 113.395 -1.73 . . . . 0.0 110.636 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 66.01 84.26 0.18 Allowed Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.191 145.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -74.15 147.59 38.16 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.723 2.282 . . . . 0.0 111.456 153.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.04 77.82 0.02 OUTLIER 'General case' 0 C--N 1.348 0.523 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.919 -91.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -102.96 -43.05 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 112.016 -2.356 . . . . 0.0 111.389 -150.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -59.94 0.76 Allowed 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.015 -154.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 mttm . . . . . 0 C--N 1.349 0.572 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.899 -135.409 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.821 0.82 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -55.78 26.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.122 151.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.86 -52.29 60.71 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.884 -164.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 21.2 m -59.03 -41.21 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.288 -1.323 . . . . 0.0 112.524 -163.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.905 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.2 t -58.9 -38.82 79.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.213 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -59.78 -37.82 80.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.163 170.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.746 HD13 ' HB1' ' A' ' 82' ' ' ALA . 31.0 mm -61.28 -44.59 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.814 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 5' ' ' THR . 46.3 mt -55.93 -50.09 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.23 172.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -54.82 -51.33 66.19 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.728 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.9 -46.01 69.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.316 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 22.7 t -50.28 -48.95 54.75 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 118.576 -1.249 . . . . 0.0 112.598 172.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 11' ' ' SER . 16.6 t-20 108.5 64.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t0 50.84 48.19 23.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.804 -1.998 . . . . 0.0 112.211 174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.3 t -96.88 -61.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.755 159.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -65.49 165.8 11.5 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.474 -167.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.535 ' C ' HD11 ' A' ' 8' ' ' ILE . 20.0 m-80 -91.9 -156.71 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.914 -1.948 . . . . 0.0 108.463 155.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.82 -56.61 17.5 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.547 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 21' ' ' THR . 11.2 mttp -64.22 -49.43 71.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.791 -157.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.43 ' CB ' HD12 ' A' ' 15' ' ' LEU . 56.5 p -64.93 -33.31 75.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.096 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.74 -46.18 90.75 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.844 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.511 HG23 HD21 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -67.02 -37.94 85.05 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.595 177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.821 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -69.08 -51.11 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.134 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.2 tp -51.63 -39.96 59.05 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.975 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -61.67 -47.51 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.411 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -47.95 83.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.572 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.935 HG21 HG21 ' A' ' 62' ' ' VAL . 5.7 mt -58.75 -50.2 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.712 168.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.826 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.2 67.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.396 -168.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -54.41 -55.9 24.08 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.156 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.21 122.54 36.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.477 -163.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 70' ' ' ILE . 30.0 m-20 -92.57 108.15 19.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.746 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.89 59.23 1.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.31 -1.768 . . . . 0.0 109.414 -160.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 5.0 tt -51.62 -160.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.69 134.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.9 p -144.82 -174.23 4.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.609 140.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.49 73.77 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.618 158.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.59 -50.27 73.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.779 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.58 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.5 tt0 -62.0 -41.42 98.04 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 117.648 -1.621 . . . . 0.0 112.108 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 33' ' ' THR . 54.2 t -59.48 -40.89 82.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 117.472 -1.691 . . . . 0.0 111.415 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -52.89 -45.24 67.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 118.696 -1.202 . . . . 0.0 112.478 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.03 -41.3 71.03 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.609 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 36' ' ' GLU . 9.0 p -91.58 -7.5 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.055 -173.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.87 109.46 2.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 109.071 134.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' CD ' ' O ' ' A' ' 40' ' ' VAL . 1.6 Cg_endo -67.66 -57.22 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.995 2.464 . . . . 0.0 112.168 127.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.03 -43.5 57.67 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.478 -2.146 . . . . 0.0 112.119 -156.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.9 mp -66.26 -65.49 0.67 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.273 -142.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 140.02 136.5 3.36 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 113.255 -1.793 . . . . 0.0 110.237 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -62.99 -50.1 72.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.613 -2.035 . . . . 0.0 112.081 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.14 91.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.67 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.48 -44.42 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 116.657 -2.017 . . . . 0.0 110.99 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.821 HG22 HD11 ' A' ' 22' ' ' ILE . 38.8 t -58.9 -42.33 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 124.396 1.06 . . . . 0.0 111.959 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -53.72 -47.27 70.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.143 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -62.9 -43.19 99.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.467 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 86.9 m-20 -68.25 -39.37 82.26 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.113 -0.949 . . . . 0.0 113.436 -168.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 69' ' ' LEU . 32.6 mt -68.05 -49.09 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.395 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.32 96.43 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.232 -1.461 . . . . 0.0 113.595 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 6.1 p -68.14 -35.72 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.55 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.92 -47.5 74.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.405 162.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.05 -42.31 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.117 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.0 62.19 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.593 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.674 ' NZ ' HG22 ' A' ' 55' ' ' VAL . 37.8 mttp -73.81 -50.78 18.84 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.738 165.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.06 99.42 0.08 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -122.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.03 97.88 1.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.774 -1.713 . . . . 0.0 107.125 68.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.935 HG21 HG21 ' A' ' 26' ' ' ILE . 11.0 p -147.7 150.4 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 112.927 -1.942 . . . . 0.0 107.635 105.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -103.97 124.93 49.89 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.0 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 117.72 21.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.583 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 t -114.14 106.59 14.55 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.54 86.12 0.5 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.757 -123.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -150.02 63.87 0.98 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.084 -1.558 . . . . 0.0 109.786 73.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.05 172.9 29.87 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.458 133.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.7 mt -100.77 138.53 37.69 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.756 -1.722 . . . . 0.0 108.261 -173.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 19.6 pt -154.07 149.58 12.69 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 117.356 -1.737 . . . . 0.0 109.797 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.826 HD13 ' CB ' ' A' ' 27' ' ' ALA . 38.8 pt -93.47 153.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.927 -155.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.89 172.49 13.38 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.956 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.68 -28.74 39.0 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 112.703 -2.044 . . . . 0.0 113.671 171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -52.14 66.79 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 117.667 -1.613 . . . . 0.0 111.386 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.57 -47.66 81.47 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.398 174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -54.28 -35.8 62.97 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.864 -171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.15 -45.01 78.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.478 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.88 -47.23 93.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.424 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -63.38 -45.0 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.032 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -58.77 -47.03 86.1 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.977 -1.489 . . . . 0.0 111.841 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.29 -45.37 69.75 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 117.205 -1.798 . . . . 0.0 111.557 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.746 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.29 -48.14 71.34 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.0 -173.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.66 68.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.374 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 m -61.55 -42.71 99.23 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.279 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 54.0 mt -58.92 -40.0 83.27 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 118.399 -1.321 . . . . 0.0 113.012 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -50.16 74.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.734 163.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -36.21 62.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.632 -168.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 6.3 pt20 -57.64 -43.2 84.71 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.485 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.51 -56.58 2.28 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.053 -156.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.22 -50.88 71.28 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 64.56 83.6 0.19 Allowed Pre-proline 0 C--N 1.348 0.504 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.475 145.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -75.44 141.99 26.06 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.684 2.256 . . . . 0.0 111.808 156.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.5 77.18 0.04 OUTLIER 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.678 -87.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -95.83 -44.49 7.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 111.812 -2.449 . . . . 0.0 111.201 -156.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.5 mt -64.87 -59.64 3.97 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.119 161.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.349 0.558 0 CA-C-N 113.341 -1.754 . . . . 0.0 109.642 -98.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.25 0.547 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.85 -176.17 0.15 Allowed 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.877 102.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -63.74 -48.1 78.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.278 -42.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 29.6 m -58.6 -38.37 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.391 -163.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.838 ' HA ' HD12 ' A' ' 8' ' ' ILE . 68.2 m -58.36 -38.81 77.97 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.977 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -62.98 -37.73 88.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.55 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 ' CB ' ' A' ' 82' ' ' ALA . 35.2 mm -59.05 -46.02 92.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.631 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.4 mt -55.97 -50.43 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.254 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -51.3 70.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.592 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -63.17 -46.06 88.9 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.217 -176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.8 t -50.1 -55.96 12.85 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 118.641 -1.224 . . . . 0.0 112.224 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.53 -25.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.154 -1.839 . . . . 0.0 114.12 -174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 58.91 67.82 0.88 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 110.548 -118.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.3 t -96.98 -64.67 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.42 141.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.4 mm? -61.98 169.26 2.72 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.667 -160.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -98.64 -161.5 0.88 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.632 153.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -53.21 -55.09 27.08 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.704 153.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HD3' HG21 ' A' ' 48' ' ' VAL . 30.2 mttt -64.23 -49.3 72.48 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.54 -161.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.458 ' CB ' HD12 ' A' ' 15' ' ' LEU . 63.6 p -67.68 -33.89 75.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 118.25 -1.38 . . . . 0.0 113.192 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.37 90.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.11 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.2 -40.25 86.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 118.059 -1.457 . . . . 0.0 112.76 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.937 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.8 mm -64.4 -51.17 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.301 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.7 tp -51.73 -39.62 58.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.154 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 7' ' ' ILE . 2.8 mm -66.05 -42.79 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 119.059 -1.056 . . . . 0.0 112.188 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.45 -47.83 84.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.247 -177.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -60.31 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.657 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.781 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.07 67.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.067 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -53.73 -57.68 9.98 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.108 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -95.23 121.07 36.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.074 -1.875 . . . . 0.0 109.643 -165.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 70' ' ' ILE . 21.9 m-20 -90.28 113.11 24.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.737 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.0 m-85 59.04 59.55 2.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.866 -159.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 5.1 tt -51.19 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 112.909 -1.95 . . . . 0.0 110.639 134.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -144.32 -176.94 5.23 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.779 139.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.63 68.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.725 160.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.33 -50.04 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.782 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -41.04 97.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.23 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 33' ' ' THR . 95.5 t -59.71 -40.62 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.137 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' A' ' 38' ' ' ARG . 8.1 mtt-85 -54.57 -45.59 73.57 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.597 164.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.4 mm-40 -71.04 -41.14 71.18 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.422 -163.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 25' ' ' THR . 2.4 p -54.81 -55.6 14.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.054 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.671 ' CD2' HG21 ' A' ' 49' ' ' VAL . 3.1 p80 -55.2 123.38 48.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 O-C-N 124.84 1.338 . . . . 0.0 111.224 -151.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 2.7 Cg_endo -62.48 -62.91 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 O-C-N 123.84 1.442 . . . . 0.0 111.921 141.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -135.59 47.63 2.27 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.711 -2.041 . . . . 0.0 110.384 -158.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.937 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.8 mp -89.93 -68.84 0.76 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.22 152.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 122.15 110.55 2.09 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.016 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -51.88 -46.76 64.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.988 -160.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.14 90.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.234 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 18' ' ' LYS . 2.5 m -63.64 -36.91 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 116.848 -1.941 . . . . 0.0 111.691 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 45' ' ' GLY . 98.1 t -59.43 -43.44 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 124.346 1.028 . . . . 0.0 112.005 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.89 -47.23 71.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 168.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -62.84 -43.01 99.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.291 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 48' ' ' VAL . 87.9 m-20 -68.13 -38.93 82.75 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.421 -167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG21 ' CD1' ' A' ' 69' ' ' LEU . 36.3 mt -67.53 -49.09 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.447 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.82 -42.17 96.42 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 119.02 -1.562 . . . . 0.0 113.522 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' NZ ' ' A' ' 58' ' ' LYS . 7.5 p -68.03 -35.91 73.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.516 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.89 -47.59 74.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.321 162.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.24 -42.22 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.145 -174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' NZ ' HG23 ' A' ' 55' ' ' VAL . 2.7 pttt -68.72 -26.28 65.19 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.349 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 55' ' ' VAL . 83.4 mttt -73.56 -48.27 34.22 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.972 169.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.72 99.52 0.04 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -122.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.1 97.86 1.28 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.653 -1.774 . . . . 0.0 107.263 69.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.7 150.44 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 0.0 107.704 104.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -104.28 125.33 50.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.134 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.1 tmtp? -80.86 116.76 21.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.586 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -114.14 106.65 14.62 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.043 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.4 87.93 0.58 Allowed Glycine 0 C--N 1.347 1.142 0 C-N-CA 118.671 -1.728 . . . . 0.0 110.717 -125.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -148.99 62.91 1.05 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.964 -1.618 . . . . 0.0 109.94 72.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.15 173.31 29.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.486 132.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.595 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.76 139.0 36.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 112.476 -1.862 . . . . 0.0 108.029 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.737 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 20.1 pt -153.82 149.61 12.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 117.312 -1.755 . . . . 0.0 109.534 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.781 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.0 pt -92.45 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.95 -157.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 p -77.79 176.42 9.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 111.523 -2.58 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.38 -37.69 55.98 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.381 -1.866 . . . . 0.0 113.537 162.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -57.02 -49.54 75.47 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 118.036 -1.466 . . . . 0.0 111.681 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.44 -47.08 82.75 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 118.761 -1.175 . . . . 0.0 111.344 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -54.32 -35.65 62.9 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 118.832 -1.147 . . . . 0.0 112.848 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.01 -45.11 78.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.331 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 mm -62.84 -47.03 94.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.478 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.86 -46.12 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.116 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -58.95 -47.02 86.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.052 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.6 -45.27 75.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 117.706 -1.597 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.702 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.19 -47.98 72.17 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.015 -174.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.47 67.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.157 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -61.73 -38.41 87.8 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.966 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.59 -40.96 98.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.01 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -43.15 62.71 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.221 160.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.14 -41.66 90.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.689 -172.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.894 ' O ' HD12 ' A' ' 95' ' ' LEU . 6.4 pt20 -55.86 -42.46 75.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.251 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.45 -57.09 2.33 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.398 -156.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -58.66 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.895 174.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 62.3 56.56 2.62 Favored Pre-proline 0 C--N 1.345 0.384 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.389 143.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.799 ' HD2' HD12 ' A' ' 94' ' ' LEU . 5.2 Cg_exo -57.84 -52.02 6.86 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 113.824 -146.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -142.28 105.26 4.57 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.483 144.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.799 HD12 ' HD2' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -171.98 -52.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 112.557 -2.111 . . . . 0.0 110.16 -142.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -112.64 -61.97 1.65 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 113.481 -1.691 . . . . 0.0 109.831 168.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? . . . . . 0 C--N 1.347 0.46 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.714 -115.028 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 121.994 0.902 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.4 p -81.42 -168.05 1.71 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.645 -160.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -63.91 -52.31 60.46 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.085 -166.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m -58.87 -38.68 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.666 -162.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 8' ' ' ILE . 85.8 m -58.42 -38.92 78.44 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.829 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -63.76 -37.83 88.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.342 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.734 HD13 ' HB1' ' A' ' 82' ' ' ALA . 32.4 mm -59.27 -46.85 92.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.689 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 5' ' ' THR . 70.1 mt -55.87 -49.97 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.46 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -51.11 67.19 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.816 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.95 -46.12 69.02 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.243 -171.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 29.0 t -53.51 -45.24 69.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.411 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.6 t-20 106.68 63.49 0.0 OUTLIER 'General case' 0 C--N 1.352 0.68 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.026 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 52.31 49.17 21.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.02 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.7 t -96.96 -61.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.816 157.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.8 mm? -64.59 168.36 6.07 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 113.516 -1.675 . . . . 0.0 109.431 -170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' C ' HD11 ' A' ' 8' ' ' ILE . 19.1 m-80 -96.84 -158.45 0.66 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.635 153.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 4' ' ' VAL . 3.2 mp0 -50.92 -54.39 24.53 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.79 144.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 15.6 mttm -63.95 -49.53 72.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.652 -157.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD12 ' A' ' 15' ' ' LEU . 29.8 p -72.03 -29.83 64.57 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.558 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.43 89.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.056 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 44' ' ' LEU . 4.6 t -67.19 -44.01 80.71 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.828 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.924 ' CD1' HD23 ' A' ' 44' ' ' LEU . 2.3 mm -62.07 -51.11 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.639 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 61' ' ' LEU . 24.0 tp -51.53 -44.73 62.71 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.346 173.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 7' ' ' ILE . 3.3 mm -60.62 -50.62 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.429 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.89 -43.07 90.9 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.814 -172.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.56 -50.19 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.723 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.76 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.74 -46.61 67.54 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.507 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -55.61 -60.68 3.1 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.845 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -91.08 118.83 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.464 -166.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.8 m-20 -90.42 113.63 25.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.005 -1.907 . . . . 0.0 109.67 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.723 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 79.8 m-85 58.81 60.07 2.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.457 -1.701 . . . . 0.0 109.816 -156.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.499 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.2 tt -51.3 -160.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.716 132.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.9 p -144.56 -177.05 5.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.561 137.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.65 67.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.399 159.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.09 -50.07 65.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.8 tt0 -61.87 -41.81 98.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 117.719 -1.592 . . . . 0.0 112.08 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 33' ' ' THR . 96.7 t -59.65 -40.98 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.877 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 38' ' ' ARG . 16.2 mtm-85 -52.93 -45.01 67.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.499 166.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.13 -41.12 70.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.136 -168.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 40' ' ' VAL . 9.1 p -85.17 -9.47 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.244 -1.344 . . . . 0.0 113.75 -171.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.687 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.24 123.96 87.76 Favored Pre-proline 0 N--CA 1.442 -0.838 0 C-N-CA 117.458 -1.697 . . . . 0.0 109.879 162.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.05 -63.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.025 1.817 . . . . 0.0 111.779 131.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.68 45.39 2.79 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.902 -152.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.8 mp -89.96 -64.52 1.12 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.883 -1.508 . . . . 0.0 109.956 157.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.839 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 120.79 114.37 2.37 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.869 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -51.95 -46.02 64.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.599 -1.24 . . . . 0.0 113.055 -162.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.26 91.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.877 -1.529 . . . . 0.0 112.143 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.0 m -64.01 -36.94 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 116.534 -2.066 . . . . 0.0 111.74 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 45' ' ' GLY . 96.5 t -60.17 -44.03 94.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.897 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.92 -47.02 71.63 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.997 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 t -62.98 -43.05 99.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.272 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 85.9 m-20 -68.11 -44.39 76.28 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.522 -168.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 58.6 mt -59.26 -49.44 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.268 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.95 -45.34 95.27 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.25 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG23 ' HE2' ' A' ' 58' ' ' LYS . 4.8 p -68.16 -35.93 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 117.799 -1.56 . . . . 0.0 111.741 -171.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ASN . 12.1 mt -55.15 -47.65 74.81 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.808 163.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -60.57 -42.23 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.295 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 55' ' ' VAL . 10.9 pttt -70.73 -27.0 63.63 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.353 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -73.67 -47.83 36.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.892 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.07 99.55 0.09 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -122.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -162.61 97.7 0.98 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.006 -1.597 . . . . 0.0 107.532 66.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 26' ' ' ILE . 10.9 p -147.64 150.52 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.648 1.979 . . . . 0.0 107.747 104.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 72' ' ' THR . 38.4 mt-10 -104.06 126.37 51.12 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.083 170.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' CB ' HD22 ' A' ' 69' ' ' LEU . 10.5 ttpp -80.86 118.81 22.69 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.558 -1.656 . . . . 0.0 109.443 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.8 t -115.71 106.7 14.18 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.083 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.23 87.55 0.59 Allowed Glycine 0 C--N 1.347 1.191 0 C-N-CA 118.621 -1.752 . . . . 0.0 110.67 -125.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -150.13 62.04 0.97 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.865 -1.667 . . . . 0.0 109.87 73.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.07 173.93 29.63 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.474 134.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.8 mt -100.41 138.38 37.54 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.697 -1.751 . . . . 0.0 108.333 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 24.8 pt -153.21 149.59 13.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.546 0 C-N-CA 117.791 -1.563 . . . . 0.0 109.484 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.76 HD13 ' CB ' ' A' ' 27' ' ' ALA . 24.7 pt -94.48 152.67 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.754 -156.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -77.97 176.2 9.36 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.128 177.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.71 -32.42 47.22 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 112.77 -2.014 . . . . 0.0 113.584 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.88 -51.48 68.9 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 118.37 -1.332 . . . . 0.0 111.443 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.5 -47.5 81.77 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.4 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -54.29 -35.78 62.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.892 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.15 -45.09 78.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.397 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.8 -47.03 94.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.503 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -63.43 -46.1 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.149 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 m -58.83 -46.37 87.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 117.923 -1.511 . . . . 0.0 111.941 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.15 -45.12 74.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.761 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.32 -47.56 73.14 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.015 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.49 67.51 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 118.755 -1.178 . . . . 0.0 112.09 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 28.8 m -61.61 -37.62 84.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.726 171.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.32 -39.3 93.63 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 118.594 -1.243 . . . . 0.0 113.331 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -44.95 63.69 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.259 159.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -60.15 -44.89 94.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.915 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.98 -43.17 86.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 117.543 -1.663 . . . . 0.0 112.493 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -91.46 -61.94 1.54 Allowed 'General case' 0 C--N 1.35 0.624 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.161 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -53.28 58.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.756 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 62.51 99.65 0.04 OUTLIER Pre-proline 0 C--N 1.348 0.517 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.574 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -57.7 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.993 1.795 . . . . 0.0 113.159 155.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -134.8 59.32 1.74 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.709 -155.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -165.98 -65.06 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.312 -134.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 94' ' ' LEU . 4.0 mm? -131.2 -65.13 0.78 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.223 -2.262 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.347 0.487 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.097 -176.127 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 121.886 0.85 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -174.13 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.749 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -71.48 -52.31 19.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.114 137.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.3 m -61.76 -39.47 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 118.2 -1.4 . . . . 0.0 112.563 -159.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.879 ' HA ' HD12 ' A' ' 8' ' ' ILE . 3.6 t -58.76 -38.82 79.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.097 -1.841 . . . . 0.0 113.086 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 43.6 m-85 -59.29 -37.86 78.76 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.453 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.814 HD13 ' CB ' ' A' ' 82' ' ' ALA . 40.3 mm -58.69 -46.51 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.932 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.3 mt -55.86 -48.39 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.29 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -51.29 66.77 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.974 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.04 -46.15 68.64 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.11 -167.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.8 t -51.11 -47.57 61.92 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.802 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.0 t-20 107.58 63.62 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.117 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 51.84 47.28 25.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.045 -1.889 . . . . 0.0 112.132 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG13 ' NZ ' ' A' ' 59' ' ' LYS . 52.8 t -92.79 -63.45 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.556 0 CA-C-N 113.912 -1.495 . . . . 0.0 109.357 155.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.19 170.12 3.96 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.76 -168.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.88 -172.37 2.03 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.458 -2.156 . . . . 0.0 108.775 142.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.3 mp0 -28.69 -65.79 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.108 -1.405 . . . . 0.0 112.837 157.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 21' ' ' THR . 14.9 mttm -64.43 -49.34 71.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 112.584 -2.098 . . . . 0.0 112.05 -164.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -69.36 -32.24 71.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.116 -1.402 . . . . 0.0 113.142 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.38 90.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.993 -1.083 . . . . 0.0 112.09 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HG11 ' A' ' 4' ' ' VAL . 4.1 t -67.2 -39.11 86.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.798 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.3 mm -67.31 -51.13 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.9 tp -51.68 -40.24 59.72 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.98 172.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.416 ' CG1' ' O ' ' A' ' 20' ' ' ALA . 2.9 mm -61.51 -51.56 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.391 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.526 HG21 HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -58.98 -43.34 91.4 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.829 -172.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 62' ' ' VAL . 5.8 mt -59.21 -50.25 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 118.649 -1.221 . . . . 0.0 111.662 166.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.67 -47.07 67.41 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.386 -169.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -55.26 -59.52 4.68 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.877 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -93.76 125.98 38.69 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.312 -163.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 70' ' ' ILE . 6.6 m-20 -95.1 108.57 20.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.829 -173.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.746 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.7 m-30 62.63 59.53 1.45 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.201 -158.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' CA ' ' A' ' 33' ' ' THR . 5.1 tt -51.52 -160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.614 0 CA-C-N 112.932 -1.94 . . . . 0.0 110.502 135.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.6 p -143.88 -176.04 4.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.629 138.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.98 -45.18 67.69 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.564 158.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.47 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.49 -49.94 66.42 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.019 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 40' ' ' VAL . 4.0 tt0 -61.87 -42.26 98.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.833 -1.547 . . . . 0.0 112.002 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' THR . 97.6 t -59.68 -40.85 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 117.654 -1.619 . . . . 0.0 111.899 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -52.9 -45.12 67.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.437 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.9 -41.14 71.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.012 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.6 p -85.38 -10.26 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.66 -171.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.49 124.12 87.4 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.904 160.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.69 -65.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.038 1.825 . . . . 0.0 111.637 130.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -126.68 41.27 3.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.252 -150.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.6 mp -91.95 -67.6 0.85 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.605 160.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.905 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 128.09 122.65 2.52 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.492 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -52.51 -49.73 64.2 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.958 -1.497 . . . . 0.0 112.942 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.24 88.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.035 -1.466 . . . . 0.0 111.797 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.455 HG23 HD21 ' A' ' 52' ' ' ASN . 4.4 m -63.96 -37.04 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 116.665 -2.014 . . . . 0.0 111.691 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 45' ' ' GLY . 71.4 t -62.16 -42.47 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.176 -172.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -53.91 -47.17 71.45 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.838 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.9 t -62.94 -43.19 99.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.068 -1.453 . . . . 0.0 112.484 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.455 HD21 HG23 ' A' ' 48' ' ' VAL . 82.0 m-20 -68.12 -38.97 82.81 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.985 0.897 . . . . 0.0 113.241 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 69' ' ' LEU . 63.2 mt -63.86 -49.18 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.167 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.92 -43.24 96.87 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 119.135 -1.507 . . . . 0.0 113.358 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.06 -35.99 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.419 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.93 -47.76 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.147 163.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.84 -42.28 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.215 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -24.66 62.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.301 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.562 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.0 mttm -73.89 -51.05 17.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.998 164.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 74.71 99.51 0.1 OUTLIER Glycine 0 C--N 1.348 1.237 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -122.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.09 97.89 1.56 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 112.783 -1.708 . . . . 0.0 107.16 68.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.83 150.41 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 127.041 2.136 . . . . 0.0 107.623 104.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -103.94 124.2 48.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.133 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.85 116.95 21.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.469 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.6 t -113.53 106.6 14.74 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 112.641 -2.072 . . . . 0.0 109.186 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.25 86.73 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 118.783 -1.675 . . . . 0.0 110.679 -123.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.15 62.42 0.97 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 112.952 -1.624 . . . . 0.0 110.013 72.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 171.18 30.09 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.333 135.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.1 mt -99.88 139.36 35.66 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.533 -1.833 . . . . 0.0 108.118 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.746 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.99 149.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 117.209 -1.796 . . . . 0.0 109.573 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.811 HD13 ' CB ' ' A' ' 27' ' ' ALA . 42.2 pt -92.23 159.18 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.283 -1.78 . . . . 0.0 110.097 -158.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -77.86 176.45 9.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.152 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.89 -38.33 54.46 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.541 162.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.93 -49.52 75.36 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 117.981 -1.488 . . . . 0.0 111.776 -175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.43 -48.04 80.18 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.338 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.31 -35.66 62.89 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 118.565 -1.254 . . . . 0.0 112.855 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -67.02 -44.84 79.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.466 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.58 -47.14 94.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.275 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.7 mm -64.29 -46.2 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.0 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.96 -47.1 86.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 118.278 -1.369 . . . . 0.0 112.008 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -45.15 88.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.643 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.26 -47.02 75.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.848 -171.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.58 68.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.37 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 69.4 m -61.67 -36.86 82.06 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 117.434 -1.707 . . . . 0.0 112.219 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 82' ' ' ALA . 70.8 mt -64.75 -42.61 95.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.116 175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.9 -41.49 61.99 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.551 163.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.68 -46.11 87.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.178 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' O ' HD23 ' A' ' 95' ' ' LEU . 5.9 pt20 -61.08 -43.14 99.34 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.035 -1.866 . . . . 0.0 112.272 -170.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.6 mt-10 -92.68 -52.89 4.41 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.087 -171.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -56.41 22.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.817 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 61.31 84.2 0.2 Allowed Pre-proline 0 C--N 1.347 0.479 0 CA-C-N 113.363 -1.744 . . . . 0.0 110.692 152.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -73.75 140.05 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.718 2.279 . . . . 0.0 111.359 152.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.1 76.86 0.01 OUTLIER 'General case' 0 C--N 1.35 0.602 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.457 -100.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 2.1 mt -88.25 -56.67 3.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 111.825 -2.443 . . . . 0.0 110.716 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 88' ' ' GLN . 7.9 tp -144.47 59.65 1.33 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.777 -2.01 . . . . 0.0 109.82 -153.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm . . . . . 0 C--N 1.347 0.477 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.68 147.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 122.016 0.913 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -159.13 105.41 1.73 Allowed 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.02 -1.9 . . . . 0.0 109.363 -142.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HD3' HG21 ' A' ' 24' ' ' ILE . 6.8 ttmt -63.93 -52.51 59.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.983 171.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.9 m -61.02 -38.78 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.781 -165.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.564 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.9 m -58.41 -39.92 81.03 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.8 -37.81 88.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.177 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' HB1' ' A' ' 82' ' ' ALA . 25.7 mm -60.49 -46.17 95.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 O-C-N 123.949 0.781 . . . . 0.0 111.748 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' ASN . 69.8 mt -55.84 -49.81 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.336 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -55.01 -51.25 66.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.17 -46.09 68.39 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.397 -172.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.5 t -54.61 -44.98 73.56 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.512 173.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 10.3 t-20 104.06 65.53 0.0 OUTLIER 'General case' 0 C--N 1.351 0.658 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.945 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 53.43 47.53 23.9 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 112.745 -2.025 . . . . 0.0 112.056 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 15' ' ' LEU . 75.9 t -97.49 -60.71 2.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.93 158.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.6 167.08 7.66 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.65 -169.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.574 ' C ' HD11 ' A' ' 8' ' ' ILE . 85.1 m-20 -93.77 -156.5 0.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 112.848 -1.978 . . . . 0.0 108.513 153.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 5.7 mp0 -55.68 -56.57 18.89 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.55 147.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 6.8 mttp -64.09 -49.38 72.49 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.461 -1.7 . . . . 0.0 111.776 -157.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.2 p -65.28 -32.79 74.63 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.069 -1.423 . . . . 0.0 113.381 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.681 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.66 -46.31 90.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.075 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -67.15 -45.07 78.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 118.006 -1.478 . . . . 0.0 112.781 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.702 HD11 HG22 ' A' ' 49' ' ' VAL . 1.6 mm -59.05 -51.14 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.421 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 56' ' ' LEU . 14.3 tp -51.85 -40.54 60.71 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.133 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.555 HG21 ' HD3' ' A' ' 3' ' ' LYS . 3.0 mm -65.54 -46.34 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.918 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.705 HG21 HG11 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -58.92 -46.75 87.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 118.121 -1.432 . . . . 0.0 111.578 -176.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 62' ' ' VAL . 5.5 mt -59.86 -50.14 81.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.904 170.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.835 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.92 -47.1 68.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.201 -1.818 . . . . 0.0 112.512 -170.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -57.84 10.96 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.832 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -91.49 120.89 32.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.406 -164.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HA ' HG22 ' A' ' 70' ' ' ILE . 67.0 m-20 -87.97 106.62 18.25 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.842 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.67 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.2 m-30 63.22 59.88 1.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.493 -161.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -50.28 -162.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.883 134.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.1 p -143.91 -176.49 5.01 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.149 141.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -40.18 60.51 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.984 158.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.38 -50.13 73.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.829 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.2 tt0 -62.1 -43.51 98.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.123 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 33' ' ' THR . 70.2 t -59.8 -41.94 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.732 -1.587 . . . . 0.0 111.754 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -53.0 -44.87 67.57 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.498 166.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.01 -41.13 71.32 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.209 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 25' ' ' THR . 7.3 p -85.21 -10.52 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.549 -170.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.6 123.79 86.66 Favored Pre-proline 0 N--CA 1.442 -0.855 0 C-N-CA 117.626 -1.63 . . . . 0.0 109.824 160.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.51 -64.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.88 1.72 . . . . 0.0 111.574 131.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -127.2 42.27 3.36 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.119 -151.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.681 HD23 ' CD1' ' A' ' 22' ' ' ILE . 4.6 mp -94.38 -66.35 0.92 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.521 160.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 126.52 128.46 3.17 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.155 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -53.62 -50.03 66.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 117.501 -1.679 . . . . 0.0 112.862 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.19 87.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.184 -1.407 . . . . 0.0 111.85 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 45' ' ' GLY . 5.8 m -63.81 -37.05 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 116.823 -1.951 . . . . 0.0 111.751 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 45' ' ' GLY . 79.0 t -62.58 -41.5 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 124.29 0.993 . . . . 0.0 112.107 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.82 -47.08 71.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.833 168.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -62.86 -43.09 99.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 118.239 -1.385 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.427 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.5 m-20 -67.97 -38.95 83.34 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.461 -168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.4 mt -66.96 -49.0 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.412 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.2 96.55 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 119.074 -1.536 . . . . 0.0 113.574 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.23 -35.75 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.488 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.83 -47.5 74.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.215 162.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 117.635 -1.626 . . . . 0.0 112.023 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -23.38 62.08 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.579 -173.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -73.66 -49.03 27.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.136 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.525 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.87 99.55 0.04 OUTLIER Glycine 0 C--N 1.349 1.284 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -121.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.05 97.68 1.28 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 112.463 -1.869 . . . . 0.0 107.024 69.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 26' ' ' ILE . 13.0 p -147.99 150.46 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 126.35 1.86 . . . . 0.0 107.919 107.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' CG ' HG22 ' A' ' 72' ' ' THR . 27.4 mt-10 -106.21 123.73 48.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.088 0.947 . . . . 0.0 110.241 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CB ' HD22 ' A' ' 69' ' ' LEU . 9.9 ttpt -80.98 119.84 24.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.451 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.1 t -115.55 106.65 14.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 112.523 -2.126 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.59 97.39 2.3 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 118.205 -1.95 . . . . 0.0 110.64 -136.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -97.83 -41.83 7.86 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.25 66.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.8 15.41 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -147.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.5 mt -92.93 140.58 29.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.781 -1.709 . . . . 0.0 107.254 -161.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.7 pt -154.28 149.44 12.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.529 0 C-N-CA 116.895 -1.922 . . . . 0.0 110.252 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.835 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.6 pt -96.12 149.28 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.547 -150.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -79.54 161.23 26.12 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.187 -1.824 . . . . 0.0 108.602 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.76 -25.63 22.96 Favored Glycine 0 CA--C 1.549 2.171 0 C-N-CA 118.281 -1.914 . . . . 0.0 113.481 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -47.99 78.28 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 118.774 -1.17 . . . . 0.0 111.763 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.47 -47.36 82.07 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.715 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -53.99 -35.79 62.23 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.666 -173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.04 -45.16 78.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.305 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 11' ' ' SER . 2.4 mm -63.17 -47.21 93.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.804 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -66.2 -43.98 91.67 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.233 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -58.69 -47.04 85.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 117.632 -1.627 . . . . 0.0 111.645 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -70.01 -45.4 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 117.289 -1.764 . . . . 0.0 111.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.29 -48.47 70.29 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.072 -173.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.37 67.33 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.045 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.4 m -61.73 -37.06 82.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 117.678 -1.609 . . . . 0.0 112.5 171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.74 -43.98 94.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.671 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -39.91 59.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.813 164.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -59.85 -46.21 90.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 118.211 -1.396 . . . . 0.0 112.207 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.98 -43.23 99.28 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.001 -1.88 . . . . 0.0 112.353 -168.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.3 -64.34 1.17 Allowed 'General case' 0 C--N 1.349 0.556 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.607 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.91 41.3 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.62 -168.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' HB1' ' CB ' ' A' ' 94' ' ' LEU . . . 66.2 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.593 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.322 161.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.61 156.81 28.26 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.695 2.263 . . . . 0.0 111.462 154.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -48.84 79.46 0.0 OUTLIER 'General case' 0 C--N 1.351 0.66 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.211 -114.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.731 ' CB ' ' HB1' ' A' ' 91' ' ' ALA . 1.1 mt -110.68 -38.0 5.28 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.436 -2.62 . . . . 0.0 111.235 -160.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.712 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.7 tm? -149.74 -43.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.637 -139.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm . . . . . 0 C--N 1.351 0.633 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.851 -153.293 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.925 0.869 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -162.22 74.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.598 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.722 ' HD3' HD12 ' A' ' 24' ' ' ILE . 3.8 ttmm -63.96 -52.18 60.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.093 165.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG11 ' HB ' ' A' ' 21' ' ' THR . 28.3 m -58.85 -38.7 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.39 -164.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 8' ' ' ILE . 48.1 m -58.42 -38.85 78.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.725 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -62.31 -37.72 86.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.302 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 24' ' ' ILE . 20.6 mm -59.8 -48.38 87.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.851 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 17' ' ' GLU . 70.6 mt -55.85 -42.13 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.526 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -51.43 69.62 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.72 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.34 -46.2 67.63 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.399 -165.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 15' ' ' LEU . 24.3 t -48.12 -55.71 9.63 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.992 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.81 -25.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.061 -1.881 . . . . 0.0 113.91 -174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 63.91 66.34 0.66 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.968 -120.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HB ' HD22 ' A' ' 15' ' ' LEU . 78.7 t -100.23 -64.65 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.542 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.649 142.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.0 mm? -61.18 175.78 0.51 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.814 -156.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' C ' HD11 ' A' ' 8' ' ' ILE . 21.7 m-80 -105.67 -165.19 1.09 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.778 149.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' HD11 ' A' ' 8' ' ' ILE . 12.1 mp0 -51.94 -54.33 30.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.783 160.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . 21.1 mttm -64.1 -49.45 72.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.766 -164.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.477 ' CB ' HD12 ' A' ' 15' ' ' LEU . 54.2 p -67.92 -33.42 74.66 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.979 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.56 -46.42 89.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.104 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.612 ' HB ' HG11 ' A' ' 4' ' ' VAL . 1.3 t -67.22 -37.96 84.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.816 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.82 -51.33 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.291 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.1 tp -51.78 -38.96 57.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.227 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.944 HD11 HD11 ' A' ' 7' ' ' ILE . 3.8 mm -59.93 -52.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.478 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.489 HG21 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -60.34 -44.62 95.34 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.498 -170.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.943 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.54 -50.23 80.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.623 167.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.1 67.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.477 -1.692 . . . . 0.0 112.435 -169.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -55.87 -57.01 13.88 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.192 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -93.1 123.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.392 -167.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' HG22 ' A' ' 70' ' ' ILE . 61.8 m-20 -90.51 114.47 26.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.562 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.732 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 89.9 m-85 58.64 59.26 2.97 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.949 -160.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.512 HG23 ' CA ' ' A' ' 33' ' ' THR . 4.8 tt -51.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 112.825 -1.989 . . . . 0.0 110.72 135.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.512 ' CA ' HG23 ' A' ' 32' ' ' ILE . 6.8 p -144.66 -177.85 5.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.673 137.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.94 70.37 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.676 160.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.64 -49.9 69.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.841 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.76 -40.64 95.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 116.901 -1.92 . . . . 0.0 112.323 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' THR . 87.1 t -59.58 -40.7 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.176 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -54.24 -44.84 72.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.661 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.14 -37.86 72.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.653 -164.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG11 HG21 ' A' ' 25' ' ' THR . 2.1 p -52.91 -56.72 6.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.195 172.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -59.46 126.11 81.38 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 117.683 -1.607 . . . . 0.0 110.733 -144.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 2.1 Cg_endo -65.62 -62.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 O-C-N 123.923 1.486 . . . . 0.0 111.788 140.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.59 48.24 2.44 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.279 -158.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.6 mp -99.9 -75.83 0.56 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.96 152.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 129.22 136.41 4.1 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.76 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -56.98 -50.12 73.66 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.627 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.11 80.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.668 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 m -63.91 -40.43 89.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 C-N-CA 116.925 -1.91 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 45' ' ' GLY . 55.0 t -59.42 -41.67 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 124.24 0.962 . . . . 0.0 112.332 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.83 -47.12 71.23 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.788 170.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -63.58 -43.22 97.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.05 -1.46 . . . . 0.0 112.696 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 84.5 m-20 -68.34 -39.96 81.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 ' CD1' ' A' ' 69' ' ' LEU . 37.2 mt -67.57 -49.12 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.252 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.47 96.6 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.453 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.17 -35.85 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.548 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.9 -47.68 74.01 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.258 162.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.01 -42.2 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 117.693 -1.603 . . . . 0.0 112.201 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -71.16 -23.05 61.99 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.614 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -73.68 -48.68 30.36 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.944 165.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 69.28 99.47 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -122.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -160.12 97.87 1.28 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.537 70.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 26' ' ' ILE . 11.2 p -147.79 150.54 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 126.995 2.118 . . . . 0.0 107.721 105.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.0 125.41 50.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.195 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.3 tmmm? -80.89 116.57 20.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.625 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -113.86 106.58 14.62 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.5 88.44 0.71 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.687 -127.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.01 60.44 0.98 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.977 72.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.11 173.65 29.74 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 113.723 -1.581 . . . . 0.0 110.45 134.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -100.15 138.97 36.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.577 -1.811 . . . . 0.0 108.031 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.732 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 21.8 pt -153.59 149.61 12.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.359 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.813 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.3 pt -94.39 158.77 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.961 -157.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 p -77.78 176.44 9.04 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 111.605 -2.543 . . . . 0.0 109.165 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.99 -38.39 55.35 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.001 -1.909 . . . . 0.0 113.493 163.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.88 -49.3 75.92 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.989 -1.485 . . . . 0.0 111.754 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.05 82.71 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.4 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -54.27 -35.85 63.0 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.854 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.16 -45.24 77.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.474 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mm -62.97 -47.16 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.61 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.0 mm -63.19 -46.03 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.271 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -58.81 -46.48 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 118.08 -1.448 . . . . 0.0 111.983 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.05 -45.31 77.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.887 -1.525 . . . . 0.0 111.914 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.689 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.17 -47.63 73.35 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.014 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.45 67.39 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.892 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 17.3 m -61.62 -36.94 82.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 118.254 -1.378 . . . . 0.0 112.59 172.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.45 -39.58 92.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 118.553 -1.259 . . . . 0.0 113.27 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.78 -41.56 61.74 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 159.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -60.68 -45.54 93.77 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 117.945 -1.502 . . . . 0.0 111.84 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -55.85 -43.14 76.78 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 117.099 -1.84 . . . . 0.0 112.392 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.69 -61.39 1.68 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.874 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -49.97 74.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 117.051 -1.859 . . . . 0.0 110.887 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 56.23 93.69 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.609 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.286 159.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -78.98 110.8 2.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.604 1.536 . . . . 0.0 113.929 166.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 96' ' ' LYS . 45.7 mt-10 -83.42 52.23 2.18 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.815 -96.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER 29.07 -73.5 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.435 -1.712 . . . . 0.0 113.317 103.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.7 mt -108.96 -61.86 1.56 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.698 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 93' ' ' GLU . 25.4 mttm . . . . . 0 C--N 1.352 0.677 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.482 -103.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.801 0.81 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.7 p -168.95 -65.0 0.02 OUTLIER 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.919 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -64.09 -52.35 59.67 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.99 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 24.9 m -61.8 -39.35 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.757 -162.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.904 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.6 t -58.82 -39.02 79.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 117.962 -1.495 . . . . 0.0 113.213 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.48 -37.93 82.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 118.574 -1.251 . . . . 0.0 112.318 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.747 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.2 mm -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.657 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 5' ' ' THR . 44.0 mt -55.96 -50.07 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.305 173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -51.16 68.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.864 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.65 -46.03 70.25 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 113.848 -1.524 . . . . 0.0 111.184 -172.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 25.0 t -53.16 -45.98 68.69 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.37 -1.332 . . . . 0.0 112.59 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.5 OUTLIER 105.6 65.99 0.0 OUTLIER 'General case' 0 C--N 1.353 0.718 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.666 176.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 51.98 48.57 22.48 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 112.719 -2.037 . . . . 0.0 112.062 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.474 ' HB ' HD22 ' A' ' 15' ' ' LEU . 55.7 t -96.26 -62.52 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.529 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.618 157.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm? -65.83 167.22 9.8 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.475 -168.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' C ' HD11 ' A' ' 8' ' ' ILE . 61.1 m-20 -94.31 -158.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.76 -2.018 . . . . 0.0 108.51 153.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 4' ' ' VAL . 23.6 mt-10 -52.97 -54.82 29.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.819 146.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' NZ ' HG11 ' A' ' 48' ' ' VAL . 36.5 mttt -64.13 -49.34 72.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.798 -159.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -67.91 -31.9 71.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.299 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.21 90.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.038 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 t -67.05 -40.19 87.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 117.469 -1.692 . . . . 0.0 113.234 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.666 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.7 mm -63.89 -51.38 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.332 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.3 tp -51.95 -38.8 57.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.137 171.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -66.02 -45.4 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.055 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -58.97 -48.34 81.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 118.133 -1.427 . . . . 0.0 111.622 -177.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.954 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.82 -50.13 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.863 171.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.84 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.04 67.9 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.266 -170.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -56.39 -57.44 12.29 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.929 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -93.09 119.91 32.81 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.408 -164.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.2 m-20 -86.25 112.94 21.85 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.602 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.3 m-85 58.06 58.98 3.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.257 -161.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -48.66 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 112.955 -1.93 . . . . 0.0 111.123 135.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG23 ' A' ' 32' ' ' ILE . 11.6 p -144.56 -178.97 6.26 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.057 139.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.41 60.06 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.932 161.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.98 -49.15 77.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.675 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.687 ' O ' HG12 ' A' ' 40' ' ' VAL . 1.4 tt0 -62.19 -40.84 97.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 118.113 -1.435 . . . . 0.0 112.242 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -59.72 -46.05 93.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.567 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -43.89 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.302 171.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.01 -41.24 71.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.153 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 36' ' ' GLU . 7.3 p -85.07 -9.61 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.524 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.3 122.62 82.39 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.812 157.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.22 -63.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.013 1.809 . . . . 0.0 111.729 132.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.14 47.28 2.43 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 112.674 -2.057 . . . . 0.0 110.715 -153.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.1 mp -96.35 -73.19 0.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.858 155.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 49' ' ' VAL . . . -122.92 -127.8 3.31 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.498 -159.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -66.63 -34.04 77.0 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 127.01 2.124 . . . . 0.0 115.397 7.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.85 -46.02 82.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 117.476 -1.689 . . . . 0.0 112.282 -161.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' HA2' ' A' ' 45' ' ' GLY . 17.2 m -60.98 -39.15 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 117.911 -1.516 . . . . 0.0 112.15 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.718 HG23 ' HA3' ' A' ' 45' ' ' GLY . 92.4 t -58.87 -42.52 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.099 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.91 -47.24 71.36 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.997 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -62.92 -43.16 99.54 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 117.978 -1.489 . . . . 0.0 112.608 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HA ' HG12 ' A' ' 55' ' ' VAL . 85.0 m-20 -68.25 -38.9 82.29 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' CD1' ' A' ' 69' ' ' LEU . 41.2 mt -66.05 -49.04 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.156 174.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -42.57 96.71 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 119.021 -1.561 . . . . 0.0 113.589 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.6 p -68.02 -35.89 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.537 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.78 -47.49 73.88 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.338 161.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.96 -42.23 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 117.763 -1.575 . . . . 0.0 112.157 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -23.33 62.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.589 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -73.76 -49.48 25.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.115 166.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.52 99.45 0.05 OUTLIER Glycine 0 C--N 1.349 1.304 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -121.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -160.04 97.66 1.28 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 112.589 -1.806 . . . . 0.0 106.943 69.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.954 HG21 HG21 ' A' ' 26' ' ' ILE . 13.9 p -147.87 150.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 126.305 1.842 . . . . 0.0 107.647 107.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' CG ' HG22 ' A' ' 72' ' ' THR . 15.3 mt-10 -105.61 121.96 45.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.025 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 2.8 tmtt? -80.95 113.9 19.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.707 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.7 t -112.83 106.64 15.01 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.896 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.55 87.85 0.63 Allowed Glycine 0 C--N 1.347 1.19 0 C-N-CA 118.577 -1.773 . . . . 0.0 110.741 -126.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -150.16 61.78 0.97 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 112.969 -1.615 . . . . 0.0 110.039 73.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -149.99 175.62 29.01 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.182 133.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -99.62 140.54 33.66 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.894 -1.653 . . . . 0.0 107.895 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.701 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.0 pt -154.27 149.42 12.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.274 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.84 HD13 ' CB ' ' A' ' 27' ' ' ALA . 37.4 pt -94.23 151.05 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.379 -152.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.5 p -80.57 164.44 22.93 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 113.096 -1.865 . . . . 0.0 108.738 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.96 -25.91 25.25 Favored Glycine 0 CA--C 1.547 2.042 0 C-N-CA 118.079 -2.01 . . . . 0.0 113.83 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -50.91 71.28 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.217 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.48 -48.03 80.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.296 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -54.34 -35.75 63.07 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.899 -172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.09 -45.09 78.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.58 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.89 -47.18 94.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.374 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.986 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 m -58.86 -47.18 85.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.932 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -68.16 -45.17 74.26 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 117.7 -1.6 . . . . 0.0 111.525 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.08 -47.47 74.15 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.797 -172.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.55 67.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.144 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 27.4 m -61.82 -40.34 94.95 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 118.442 -1.303 . . . . 0.0 112.523 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.87 -41.36 95.8 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.916 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.51 61.81 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.919 -1.492 . . . . 0.0 111.622 162.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -61.94 -45.27 94.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 118.139 -1.425 . . . . 0.0 111.979 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -57.75 -43.05 85.16 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 117.459 -1.696 . . . . 0.0 112.479 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.09 -60.55 1.52 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.037 -166.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -65.25 -56.73 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.095 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 67.15 76.59 0.27 Allowed Pre-proline 0 C--N 1.346 0.447 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.663 150.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.11 119.06 6.06 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.471 1.448 . . . . 0.0 112.106 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 26.95 45.42 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.631 -1.622 . . . . 0.0 114.241 -160.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.693 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 13.4 mt -103.2 -43.01 5.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.48 -1.691 . . . . 0.0 111.473 166.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 mt -52.79 -50.82 62.81 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.703 -1.589 . . . . 0.0 111.665 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 tttm . . . . . 0 C--N 1.349 0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.936 -110.344 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 121.769 0.795 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -76.21 65.69 2.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.018 170.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 7' ' ' ILE . 1.3 ttmt -67.38 -52.25 42.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.081 -1.872 . . . . 0.0 111.214 143.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.8 m -58.93 -38.94 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.685 -152.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.871 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.73 -38.52 78.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 117.355 -1.738 . . . . 0.0 112.882 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' OH ' ' CG ' ' A' ' 89' ' ' GLU . 34.8 m-85 -58.8 -37.89 77.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.356 169.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.766 HD13 ' HB1' ' A' ' 82' ' ' ALA . 38.4 mm -60.46 -44.43 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.75 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 5' ' ' THR . 42.8 mt -55.87 -49.99 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.254 172.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -54.96 -51.27 66.67 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.883 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.06 68.65 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.301 -171.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 16.6 t -50.14 -46.73 54.17 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.689 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 11' ' ' SER . 17.9 t-20 113.51 61.61 0.0 OUTLIER 'General case' 0 C--N 1.352 0.716 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.092 172.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 t70 51.64 50.43 18.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.865 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.6 t -96.54 -64.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.576 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.337 157.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -64.66 167.42 7.32 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.504 -164.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -93.98 -163.42 1.05 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.702 152.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -50.67 -51.83 45.61 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.05 146.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -64.09 -49.36 72.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.862 -162.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 15' ' ' LEU . 41.0 p -71.64 -32.55 68.06 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.125 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.26 90.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.811 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.691 HG23 HD21 ' A' ' 44' ' ' LEU . 3.2 t -66.27 -38.3 87.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 117.749 -1.581 . . . . 0.0 112.723 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' HG13 ' A' ' 49' ' ' VAL . 2.3 mm -67.26 -51.27 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.229 -177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 20.2 tp -51.83 -40.73 61.0 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.375 171.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 7' ' ' ILE . 3.8 mm -66.04 -44.93 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.359 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.941 HG21 HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -59.74 -48.47 81.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.764 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.938 HG21 HG21 ' A' ' 62' ' ' VAL . 6.0 mt -58.82 -49.99 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.755 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.73 -47.12 67.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.259 -1.791 . . . . 0.0 112.329 -173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -58.3 8.38 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.067 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 124.8 38.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 112.566 -2.106 . . . . 0.0 109.351 -168.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 70' ' ' ILE . 72.6 m-20 -88.34 115.19 25.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.985 -1.916 . . . . 0.0 109.494 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.703 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 88.5 m-85 58.04 57.2 4.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.445 -164.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 33' ' ' THR . 5.4 tt -50.74 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 113.095 -1.866 . . . . 0.0 110.869 138.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.3 p -143.75 -176.78 5.11 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.218 139.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.9 -42.56 62.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.684 159.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.01 -49.95 67.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.932 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -61.95 -41.55 98.1 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.094 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.71 -41.39 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 117.801 -1.56 . . . . 0.0 111.872 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.696 ' HE ' HD21 ' A' ' 46' ' ' ASN . 16.0 mtt85 -54.51 -43.17 71.63 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.039 -1.065 . . . . 0.0 112.452 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.06 -41.15 71.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.254 -170.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 25' ' ' THR . 9.5 p -77.62 -15.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.378 -174.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.41 124.06 88.17 Favored Pre-proline 0 N--CA 1.441 -0.883 0 C-N-CA 117.521 -1.672 . . . . 0.0 109.754 163.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.38 -64.13 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.882 1.721 . . . . 0.0 111.808 131.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.26 48.38 2.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.604 -154.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HG23 ' A' ' 21' ' ' THR . 5.5 mp -96.39 -73.16 0.61 Allowed 'General case' 0 C--N 1.35 0.606 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.025 157.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 49' ' ' VAL . . . -126.37 -147.98 6.97 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -162.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.696 HD21 ' HE ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -66.73 -50.17 63.65 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 127.816 2.446 . . . . 0.0 113.713 28.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.02 84.15 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.825 -151.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 49' ' ' VAL . 13.8 m -60.84 -42.35 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 45' ' ' GLY . 91.7 t -58.91 -43.61 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.794 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.0 -47.17 71.72 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.934 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 t -62.97 -42.95 99.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 117.915 -1.514 . . . . 0.0 112.392 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HA ' HG12 ' A' ' 55' ' ' VAL . 86.0 m-20 -68.28 -38.92 82.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 124.249 0.968 . . . . 0.0 113.548 -169.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' CD1' ' A' ' 69' ' ' LEU . 52.6 mt -64.81 -49.07 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.071 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.22 96.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 119.32 -1.419 . . . . 0.0 113.559 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 52' ' ' ASN . 4.2 p -68.01 -35.81 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.521 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.43 74.08 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 162.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.13 -42.2 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.154 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -21.74 62.19 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.681 -173.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -73.64 -49.84 24.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.999 164.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.5 99.39 0.03 OUTLIER Glycine 0 C--N 1.35 1.336 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -121.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -158.45 97.83 1.5 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.17 70.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.95 150.46 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.897 106.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.456 ' CD ' HG22 ' A' ' 72' ' ' THR . 19.8 mt-10 -105.08 121.99 44.94 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.145 0.974 . . . . 0.0 110.07 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -80.96 114.68 20.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.598 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 t -116.04 106.74 14.09 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.037 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 88.23 0.68 Allowed Glycine 0 C--N 1.346 1.136 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.757 -127.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -150.08 61.22 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 113.0 -1.6 . . . . 0.0 110.105 73.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 177.21 28.39 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.055 133.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -100.26 141.08 33.6 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.877 -1.662 . . . . 0.0 107.874 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 14.7 pt -154.21 149.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 117.018 -1.873 . . . . 0.0 110.23 177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.829 HD13 ' CB ' ' A' ' 27' ' ' ALA . 47.1 pt -95.66 151.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.31 -152.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.35 164.64 23.89 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.0 -1.909 . . . . 0.0 108.813 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.07 -25.84 25.83 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 118.116 -1.992 . . . . 0.0 113.843 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.85 -50.86 71.16 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.382 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.4 -47.71 81.0 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.556 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -54.23 -35.7 62.72 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 118.871 -1.131 . . . . 0.0 112.764 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.05 -45.08 78.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.423 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mm -62.86 -47.15 94.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.431 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.9 mm -63.8 -46.09 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.096 -176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -58.88 -47.13 86.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 118.094 -1.442 . . . . 0.0 111.893 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.79 -45.23 79.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 117.495 -1.682 . . . . 0.0 111.698 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.18 -47.48 73.83 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.112 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.38 67.3 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.245 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.8 m -61.73 -39.18 90.63 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.881 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.38 -39.86 94.58 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 118.444 -1.302 . . . . 0.0 113.221 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -46.69 64.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.968 159.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.85 98.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.805 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' O ' HD12 ' A' ' 95' ' ' LEU . 8.0 pt20 -55.91 -43.01 76.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.384 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 1.8 mm-40 -97.96 -50.36 4.44 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.047 -162.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -63.71 -64.33 0.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 117.464 -1.694 . . . . 0.0 110.242 165.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 56.38 68.89 2.01 Favored Pre-proline 0 C--N 1.347 0.467 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.144 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 94' ' ' LEU . 5.2 Cg_exo -54.07 -53.34 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 O-C-N 123.778 1.409 . . . . 0.0 113.874 -178.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -151.85 86.81 1.32 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -176.45 -58.84 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 111.857 -2.429 . . . . 0.0 109.473 -133.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 94' ' ' LEU . 59.8 mt -130.49 -58.5 1.04 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.151 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 C--N 1.348 0.512 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.731 -105.306 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptm . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.916 0.865 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 5' ' ' THR . 13.9 t 63.52 60.23 1.13 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.659 160.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -68.66 -52.23 33.46 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.301 98.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 20.0 m -58.83 -38.73 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.756 -162.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.803 ' HA ' HD12 ' A' ' 8' ' ' ILE . 91.1 m -58.44 -38.86 78.35 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.831 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -62.36 -37.95 87.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.022 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.755 HD13 ' HB1' ' A' ' 82' ' ' ALA . 36.2 mm -59.42 -46.12 92.99 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 175.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 5' ' ' THR . 55.1 mt -55.93 -50.08 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.391 173.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.14 67.05 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.914 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.06 -46.1 68.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.149 -171.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.6 t -50.94 -48.31 60.91 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.711 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 11' ' ' SER . 11.6 t-20 109.07 64.37 0.0 OUTLIER 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.044 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 50.95 47.72 24.3 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.188 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG13 ' HE3' ' A' ' 59' ' ' LYS . 48.0 t -95.13 -63.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.539 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.275 159.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.0 mm? -65.65 165.39 12.56 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.335 -165.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.605 ' C ' HD11 ' A' ' 8' ' ' ILE . 36.4 m120 -91.15 -157.86 0.52 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 112.966 -1.925 . . . . 0.0 108.43 154.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 5.6 mp0 -53.5 -55.38 25.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.724 145.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -64.06 -49.37 72.58 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.796 -158.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 p -66.93 -32.75 74.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.434 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.83 -46.27 90.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.943 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 t -67.22 -39.01 86.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 118.167 -1.413 . . . . 0.0 112.949 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -66.16 -51.25 61.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.381 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.578 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.8 tp -51.7 -38.39 54.88 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.095 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.0 mm -65.86 -45.66 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.949 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -59.0 -46.25 88.63 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.473 -176.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.992 HG21 HG21 ' A' ' 62' ' ' VAL . 5.3 mt -61.22 -50.33 80.92 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.805 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.84 -47.22 67.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.256 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -57.53 11.99 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.872 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -90.19 117.9 29.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.253 -1.794 . . . . 0.0 109.449 -164.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.2 m-20 -88.0 111.77 21.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.986 -1.915 . . . . 0.0 109.56 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.702 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 75.3 m-85 57.87 60.94 2.55 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.894 -158.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 33' ' ' THR . 4.5 tt -51.04 -165.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.659 131.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 9.2 p -143.73 178.02 8.1 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.836 140.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.02 51.58 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.046 161.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.28 -50.03 75.04 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.543 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.75 -42.44 98.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 117.453 -1.699 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 49' ' ' VAL . 94.6 t -59.81 -40.64 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.192 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 38' ' ' ARG . 16.5 mtt85 -55.61 -45.1 77.53 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.6 164.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.5 mm-40 -71.21 -41.16 70.58 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.477 -164.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 25' ' ' THR . 2.5 p -55.52 -55.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.97 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.506 ' CD2' HG21 ' A' ' 49' ' ' VAL . 9.2 p80 -56.22 122.71 50.51 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.204 -147.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.8 -62.57 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 O-C-N 123.802 1.422 . . . . 0.0 111.877 144.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.03 48.17 2.3 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.549 -159.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -96.56 -66.26 0.92 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.449 153.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.907 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 121.72 124.46 3.04 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.328 175.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -53.02 -49.04 67.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 117.858 -1.537 . . . . 0.0 112.982 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -46.17 88.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.877 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 45' ' ' GLY . 6.2 m -63.47 -36.93 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 116.577 -2.049 . . . . 0.0 111.796 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 45' ' ' GLY . 70.2 t -62.77 -42.03 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 124.452 1.095 . . . . 0.0 112.065 -171.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.82 -47.09 71.23 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.817 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 t -63.0 -43.28 99.21 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 117.591 -1.643 . . . . 0.0 112.479 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.0 m-20 -68.25 -39.0 82.37 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -168.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 69' ' ' LEU . 47.8 mt -68.03 -49.04 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.338 174.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.03 -42.05 96.76 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 119.095 -1.526 . . . . 0.0 113.441 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.07 -36.0 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.495 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.81 -47.67 73.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.307 162.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.53 -42.29 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.128 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -23.55 62.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.484 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HE3' HG13 ' A' ' 14' ' ' VAL . 15.0 mttm -73.79 -50.58 19.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.018 164.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.554 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.55 99.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -122.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.57 97.93 1.49 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 112.693 -1.754 . . . . 0.0 107.153 69.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.992 HG21 HG21 ' A' ' 26' ' ' ILE . 14.8 p -147.91 150.5 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 126.484 1.914 . . . . 0.0 107.854 107.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 72' ' ' THR . 25.7 mt-10 -104.71 121.84 44.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.011 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.92 115.43 20.39 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.881 178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 t -115.21 106.76 14.44 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.163 -2.29 . . . . 0.0 108.704 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.56 98.27 2.41 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.552 -140.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -96.85 -41.68 8.32 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.286 -1.457 . . . . 0.0 112.457 67.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.32 165.33 12.06 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -151.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.3 mt -95.69 137.91 34.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.722 -1.739 . . . . 0.0 107.237 -172.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 11.9 pt -154.26 149.43 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 117.266 -1.773 . . . . 0.0 109.743 176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 ' CB ' ' A' ' 27' ' ' ALA . 39.5 pt -92.9 159.73 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.86 -154.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.588 HG22 ' HG3' ' A' ' 63' ' ' GLU . 16.0 p -77.74 176.46 9.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 111.763 -2.471 . . . . 0.0 108.873 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.05 -38.44 55.8 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.443 163.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.91 -49.74 74.67 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.796 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -46.85 83.15 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.371 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -54.41 -35.68 63.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 118.929 -1.108 . . . . 0.0 112.809 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.12 -45.06 78.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.324 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.78 -47.12 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.479 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -64.47 -46.18 93.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.03 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.3 m -58.88 -47.15 85.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.987 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.31 -45.2 77.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.701 -1.599 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.13 -47.08 75.27 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.033 -173.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.6 67.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.071 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 29.7 m -61.7 -39.76 92.6 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 118.821 -1.152 . . . . 0.0 112.537 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.85 -40.83 96.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 119.289 -0.964 . . . . 0.0 113.038 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -39.89 59.51 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.411 161.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -57.92 -46.49 84.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.03 -2.268 . . . . 0.0 112.004 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -58.7 -43.06 89.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 117.056 -1.858 . . . . 0.0 112.505 -164.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -70.82 -67.09 0.53 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.029 164.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -78.59 -79.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.63 -1.623 . . . . 0.0 109.878 -164.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.087 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . 22.93 47.9 0.09 OUTLIER Pre-proline 0 C--N 1.349 0.557 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.401 -158.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.76 173.12 2.38 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 O-C-N 124.036 1.546 . . . . 0.0 110.93 -138.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 102.57 0.08 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.858 -56.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.087 HD12 ' HB3' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -97.22 -52.02 3.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 112.53 -2.123 . . . . 0.0 111.03 177.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.596 HD13 ' C ' ' A' ' 95' ' ' LEU . 1.4 tm? -146.49 -56.17 0.27 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.043 -153.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.35 0.592 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.354 158.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.612 ' H ' ' H ' ' A' ' 4' ' ' VAL . 3.0 t 176.29 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.348 0.535 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.569 48.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -25.55 67.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.263 -1.789 . . . . 0.0 113.805 154.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' H ' ' H ' ' A' ' 2' ' ' SER . 23.2 m -58.69 -38.61 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -151.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.832 ' HA ' HD12 ' A' ' 8' ' ' ILE . 31.3 m -58.25 -38.78 77.58 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.9 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.62 -37.49 86.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.368 170.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 24' ' ' ILE . 15.3 mm -57.72 -47.74 85.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 118.096 -1.441 . . . . 0.0 111.715 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 5' ' ' THR . 43.3 mt -55.85 -40.69 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.666 175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -63.51 -51.3 66.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.696 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.23 -46.11 68.15 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.05 -166.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 13.4 t -51.28 -47.3 62.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.624 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.4 t-20 107.79 64.97 0.0 OUTLIER 'General case' 0 C--N 1.353 0.738 0 CA-C-N 112.944 -1.934 . . . . 0.0 109.983 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 t70 50.91 47.52 24.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.232 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 15' ' ' LEU . 48.3 t -93.75 -63.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.283 157.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.5 mm? -62.98 170.78 2.52 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.145 -1.843 . . . . 0.0 109.85 -166.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -114.21 -174.16 2.42 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.348 -2.205 . . . . 0.0 108.807 141.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 8' ' ' ILE . 5.7 mp0 -25.75 -64.71 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.032 158.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' THR . 7.0 mttp -64.32 -49.46 71.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 112.634 -2.075 . . . . 0.0 112.028 -164.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -71.94 -32.12 67.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.227 -1.352 . . . . 0.0 113.03 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.76 -46.4 89.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.161 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.3 t -67.2 -37.78 84.23 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 118.554 -1.258 . . . . 0.0 112.928 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.942 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.6 mm -68.88 -51.19 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.333 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.1 tp -51.64 -38.68 55.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.138 172.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 mm -61.0 -49.4 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.642 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.651 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.9 -45.81 89.38 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.294 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.986 HG21 HG21 ' A' ' 62' ' ' VAL . 4.8 mt -61.2 -50.16 81.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.731 168.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.812 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.68 -46.98 67.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.128 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.87 -60.12 4.03 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.644 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -91.01 116.37 28.74 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.408 -163.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 70' ' ' ILE . 69.8 m-20 -85.92 111.64 20.43 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.768 -2.014 . . . . 0.0 109.473 -175.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.71 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 84.3 m-85 58.86 61.9 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.844 -156.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -51.08 -162.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.772 -2.013 . . . . 0.0 110.915 134.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.5 p -144.79 179.17 7.49 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.89 139.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.54 -37.71 58.26 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.07 161.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -58.36 -50.06 75.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.569 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.88 -42.33 98.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.633 -1.627 . . . . 0.0 111.952 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 49' ' ' VAL . 90.7 t -59.83 -40.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.964 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -56.14 -44.64 79.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.591 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 2.0 mm-40 -71.15 -41.16 70.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.533 -164.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.651 HG11 HG21 ' A' ' 25' ' ' THR . 2.4 p -55.04 -55.63 15.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.106 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.603 ' CD2' HG21 ' A' ' 49' ' ' VAL . 8.5 p80 -56.35 122.04 46.76 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.235 -147.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 6.1 Cg_exo -60.07 -61.3 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 O-C-N 123.657 1.346 . . . . 0.0 112.406 146.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -143.47 52.13 1.35 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.327 -164.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 ' CD1' ' A' ' 22' ' ' ILE . 5.7 mp -88.34 -64.32 1.16 Allowed 'General case' 0 C--N 1.348 0.52 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.637 149.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.92 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 118.95 120.89 2.96 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.619 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -52.19 -47.48 65.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.204 -166.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.15 89.34 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.873 -1.531 . . . . 0.0 111.897 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 45' ' ' GLY . 4.5 m -62.97 -36.94 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 116.671 -2.011 . . . . 0.0 111.826 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLY . 95.5 t -62.56 -42.42 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.926 -171.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -53.85 -47.16 71.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.99 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -63.11 -43.16 99.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 117.931 -1.507 . . . . 0.0 112.539 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.464 HD21 HG23 ' A' ' 48' ' ' VAL . 85.5 m-20 -68.19 -38.97 82.56 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.393 -168.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 69' ' ' LEU . 35.9 mt -67.15 -49.05 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.223 173.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.84 -42.17 96.46 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 119.035 -1.555 . . . . 0.0 113.448 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.22 -35.96 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.395 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.89 -47.56 74.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.24 162.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.35 -42.28 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.138 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -24.05 62.2 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.361 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 11.8 mttm -73.82 -51.04 17.64 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.086 165.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 73.94 99.58 0.09 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -122.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -159.07 97.77 1.41 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.601 -1.8 . . . . 0.0 107.049 68.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG21 HG21 ' A' ' 26' ' ' ILE . 14.6 p -147.84 150.32 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 113.049 -1.887 . . . . 0.0 107.627 107.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' CG ' HG22 ' A' ' 72' ' ' THR . 16.6 mt-10 -106.2 122.43 46.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.912 173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' CB ' HD22 ' A' ' 69' ' ' LEU . 13.4 ttpp -80.92 115.35 20.35 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.498 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -113.33 106.56 14.74 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 112.46 -2.155 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.14 88.16 0.71 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.803 -128.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -150.06 61.43 0.98 Allowed 'General case' 0 C--N 1.345 0.376 0 CA-C-N 113.086 -1.557 . . . . 0.0 110.022 72.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.14 176.89 28.58 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.254 134.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.4 mt -99.8 140.31 34.2 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.861 -1.669 . . . . 0.0 107.956 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.71 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.8 pt -154.27 149.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 117.328 -1.749 . . . . 0.0 110.06 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.812 HD13 ' CB ' ' A' ' 27' ' ' ALA . 41.1 pt -94.14 151.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.275 -152.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.508 HG22 ' CG ' ' A' ' 63' ' ' GLU . 1.2 p -78.44 166.78 22.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.085 -1.871 . . . . 0.0 108.809 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.84 -25.98 39.01 Favored Glycine 0 CA--C 1.546 1.988 0 C-N-CA 117.828 -2.129 . . . . 0.0 113.711 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.93 -52.02 66.82 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.349 175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.45 -46.91 83.09 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.313 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -54.23 -35.83 62.88 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.773 -173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.14 -45.16 77.91 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.554 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.04 -47.05 94.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.606 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.1 mm -63.98 -46.16 94.77 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.086 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 m -58.86 -46.48 87.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.889 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.14 -45.24 70.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 117.457 -1.697 . . . . 0.0 111.867 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.21 -48.32 71.01 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.82 -173.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.48 67.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.295 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.5 m -61.74 -38.84 89.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 118.444 -1.302 . . . . 0.0 112.828 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 61.6 mt -64.2 -38.84 92.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 118.998 -1.081 . . . . 0.0 113.397 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -46.81 64.41 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.88 158.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.59 83.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.669 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 8.1 pt20 -55.91 -40.12 72.6 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.433 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -120.43 -44.56 2.46 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.651 -146.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -62.42 -66.14 0.58 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 117.741 -1.584 . . . . 0.0 109.767 151.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 55.97 65.72 4.13 Favored Pre-proline 0 C--N 1.346 0.452 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.481 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -52.1 -55.35 3.96 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 O-C-N 123.86 1.452 . . . . 0.0 113.52 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.62 64.49 1.24 Allowed 'General case' 0 C--N 1.345 0.384 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.178 -172.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -161.02 -64.47 0.06 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.552 -2.113 . . . . 0.0 109.213 -134.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.7 OUTLIER -171.81 51.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.806 -2.452 . . . . 0.0 110.823 -155.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--N 1.35 0.593 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.588 -173.086 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.949 0.88 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -177.1 152.77 0.92 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.682 -140.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.91 -25.78 68.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.889 -162.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 11.4 m -58.62 -38.97 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.305 -157.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 m -58.46 -41.68 85.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.794 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -63.4 -37.84 88.85 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.79 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.718 HD13 ' HB1' ' A' ' 82' ' ' ALA . 24.5 mm -60.26 -46.6 94.58 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.504 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 5' ' ' THR . 40.0 mt -55.88 -50.32 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.036 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -51.1 67.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.734 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -67.06 -46.02 75.59 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 113.616 -1.629 . . . . 0.0 111.264 -174.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 26.1 t -49.7 -54.51 18.31 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.631 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 11' ' ' SER . 2.0 p-10 147.02 24.06 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 O-C-N 126.108 2.13 . . . . 0.0 114.039 172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 49.17 62.3 2.68 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.661 0.743 . . . . 0.0 111.683 -148.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.599 ' HB ' HD22 ' A' ' 15' ' ' LEU . 57.4 t -81.62 -65.65 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.345 138.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD22 ' HB ' ' A' ' 14' ' ' VAL . 3.6 mm? -64.95 172.41 2.9 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.672 -152.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' C ' HD11 ' A' ' 8' ' ' ILE . 27.3 m120 -96.39 -159.41 0.73 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.573 155.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -55.9 -56.81 16.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.446 149.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 25.6 mttm -64.2 -49.38 72.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.81 -157.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.569 ' OG1' HD12 ' A' ' 15' ' ' LEU . 75.3 p -65.7 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.094 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.58 -46.32 90.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.104 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -37.91 84.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.723 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.933 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -69.4 -51.16 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.383 -175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' HD21 ' A' ' 56' ' ' LEU . 15.3 tp -51.66 -39.16 57.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.971 173.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 ' CD1' ' A' ' 7' ' ' ILE . 3.2 mm -61.24 -48.77 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.495 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -47.05 88.08 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.403 -172.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 62' ' ' VAL . 6.5 mt -58.33 -50.24 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.629 168.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.8 -47.24 67.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 113.095 -1.866 . . . . 0.0 112.482 -169.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -57.52 10.83 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.072 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -93.11 120.28 33.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.792 -2.003 . . . . 0.0 109.5 -163.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 70' ' ' ILE . 73.9 m-20 -93.31 107.62 19.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.696 -174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.4 m-30 62.83 58.95 1.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.441 -159.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 tt -52.57 -160.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.604 133.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 37' ' ' VAL . 7.8 p -143.91 -175.34 4.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.706 139.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.93 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.409 159.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.9 -50.07 69.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.885 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' O ' HG12 ' A' ' 40' ' ' VAL . 3.7 tt0 -62.01 -42.06 98.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.149 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 33' ' ' THR . 84.8 t -59.7 -40.97 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 117.537 -1.665 . . . . 0.0 111.887 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -52.88 -44.96 67.26 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.563 166.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.12 -41.13 70.95 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.139 -169.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 36' ' ' GLU . 6.0 p -86.49 -9.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.449 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -66.86 124.4 88.53 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 117.423 -1.711 . . . . 0.0 109.904 160.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.81 -63.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.947 1.765 . . . . 0.0 111.536 129.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.19 43.06 3.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.079 -151.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.4 mp -98.66 -68.63 0.79 Allowed 'General case' 0 C--N 1.351 0.664 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.707 159.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 129.08 133.34 3.62 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.348 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -57.6 -50.07 74.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 116.487 -2.085 . . . . 0.0 112.6 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.21 86.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 118.253 -1.379 . . . . 0.0 111.68 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 m -64.01 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 116.822 -1.951 . . . . 0.0 111.586 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 45' ' ' GLY . 68.7 t -59.02 -42.19 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.253 -173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.82 -47.07 71.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.884 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.5 t -62.92 -43.13 99.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.507 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 49' ' ' VAL . 83.9 m-20 -68.18 -42.69 79.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.057 0.932 . . . . 0.0 113.161 -169.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG21 ' CD1' ' A' ' 69' ' ' LEU . 29.5 mt -65.48 -49.05 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.147 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.55 96.64 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 119.281 -1.438 . . . . 0.0 113.52 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.12 -35.8 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.621 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -54.84 -47.51 74.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.552 161.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.92 -42.33 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 117.494 -1.682 . . . . 0.0 112.159 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.53 62.1 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.643 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -73.67 -49.82 24.0 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.853 165.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 70.78 99.54 0.05 OUTLIER Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -121.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.57 97.69 1.34 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 112.614 -1.793 . . . . 0.0 107.432 70.006 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.88 150.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 126.937 2.095 . . . . 0.0 107.719 106.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.0 127.76 51.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.153 168.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -80.94 118.64 22.61 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.868 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -113.42 106.66 14.84 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.472 -2.149 . . . . 0.0 109.037 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.46 97.23 2.28 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 118.096 -2.002 . . . . 0.0 110.561 -136.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.47 -41.74 8.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.245 -1.477 . . . . 0.0 112.374 67.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.59 13.1 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -148.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.8 mt -96.86 136.69 37.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.497 -1.851 . . . . 0.0 107.551 -163.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 17.5 pt -154.07 149.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 117.288 -1.765 . . . . 0.0 109.533 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.815 HD13 ' CB ' ' A' ' 27' ' ' ALA . 27.6 pt -95.01 151.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 112.974 -1.921 . . . . 0.0 109.93 -154.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -77.95 176.22 9.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.519 -2.128 . . . . 0.0 108.633 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -30.24 60.62 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 117.519 -2.277 . . . . 0.0 113.753 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -56.85 -52.05 66.63 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 118.209 -1.396 . . . . 0.0 111.255 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.42 -46.58 83.37 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.186 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -54.34 -35.91 63.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 118.924 -1.111 . . . . 0.0 112.833 -171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.44 -45.19 76.76 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.713 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.04 -47.16 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.587 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -63.83 -45.4 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.116 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -58.84 -47.1 86.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 117.343 -1.743 . . . . 0.0 111.854 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.09 -45.59 66.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 116.924 -1.91 . . . . 0.0 111.463 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.718 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.39 -47.61 72.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.176 -173.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.58 67.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.599 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 m -61.54 -41.12 96.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 118.281 -1.368 . . . . 0.0 112.323 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.17 -43.01 96.16 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.727 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -50.13 69.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.872 165.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.91 -30.24 45.39 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.934 -166.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -65.95 -43.16 88.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 117.534 -1.666 . . . . 0.0 112.548 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.1 -57.08 2.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.174 -156.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.02 -60.43 3.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.916 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' HB2' ' A' ' 94' ' ' LEU . . . 56.02 82.39 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.211 152.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -76.67 158.13 35.68 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.549 2.166 . . . . 0.0 111.412 160.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.6 78.91 0.01 OUTLIER 'General case' 0 C--N 1.35 0.621 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.454 -95.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.683 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 1.5 mt -99.3 -47.14 5.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.556 -2.565 . . . . 0.0 110.845 -163.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.572 HD13 ' C ' ' A' ' 95' ' ' LEU . 3.0 tm? -180.0 -65.71 0.01 OUTLIER 'General case' 0 C--N 1.347 0.46 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.673 -132.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' N ' HD13 ' A' ' 95' ' ' LEU . 9.1 mmtp . . . . . 0 C--N 1.348 0.52 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.916 159.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.723 0.773 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -91.52 84.35 5.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.272 -1.786 . . . . 0.0 109.616 148.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.27 -25.66 68.15 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.706 147.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.4 m -58.61 -38.95 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.455 -158.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.821 ' HA ' HD12 ' A' ' 8' ' ' ILE . 49.3 m -58.51 -41.33 85.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.768 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.82 -37.64 88.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.362 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.738 HD13 ' CB ' ' A' ' 82' ' ' ALA . 43.2 mm -57.17 -45.28 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 118.534 -1.266 . . . . 0.0 111.847 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.4 mt -55.99 -50.05 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.354 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -51.13 67.24 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.048 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.03 -46.06 68.9 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.088 -171.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 17.8 t -50.61 -46.27 57.96 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.995 172.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER 107.62 67.43 0.0 OUTLIER 'General case' 0 C--N 1.351 0.633 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.231 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 p30 44.83 48.11 9.08 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.773 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 15' ' ' LEU . 51.8 t -92.75 -63.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.501 160.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.54 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.1 mm? -64.54 167.88 6.59 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.189 -1.823 . . . . 0.0 109.486 -167.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.586 ' C ' HD11 ' A' ' 8' ' ' ILE . 69.7 m-20 -95.08 -156.75 0.53 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.463 152.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 2.8 mp0 -55.03 -56.36 20.65 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.625 150.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' THR . 31.8 mttt -64.07 -49.36 72.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.845 -159.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -64.7 -33.29 75.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.194 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.7 -46.4 89.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.062 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LYS . 1.5 t -67.21 -37.86 84.33 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.029 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -68.27 -51.16 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.241 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.2 tp -51.63 -36.17 44.93 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.932 -1.486 . . . . 0.0 112.308 173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.2 -46.45 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.072 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -59.17 -48.71 80.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.364 -176.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.928 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -59.71 -50.11 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.676 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.847 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.76 -47.22 67.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.38 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -56.65 15.25 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.354 173.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -94.58 124.5 38.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 112.671 -2.059 . . . . 0.0 109.487 -161.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.505 ' HA ' HG22 ' A' ' 70' ' ' ILE . 71.5 m-20 -93.5 111.67 23.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.834 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 93.7 m-85 57.85 59.27 3.24 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.954 -162.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 33' ' ' THR . 4.9 tt -53.18 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.422 134.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 9.6 p -143.69 -177.44 5.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.747 140.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.02 63.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.475 160.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -54.33 -50.02 68.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.853 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.7 tt0 -62.0 -41.61 98.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 118.154 -1.418 . . . . 0.0 112.108 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' THR . 71.1 t -59.73 -40.96 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 117.718 -1.593 . . . . 0.0 111.868 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -53.36 -44.16 68.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.566 166.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.99 -41.25 71.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.141 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 40' ' ' VAL . 8.1 p -84.06 -11.8 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.529 -170.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -67.44 124.61 89.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 C-N-CA 117.429 -1.709 . . . . 0.0 109.79 159.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -62.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.085 1.857 . . . . 0.0 111.825 130.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -129.49 43.55 3.12 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.951 -152.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -95.05 -69.25 0.76 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.334 156.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 135.58 138.03 3.8 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.561 174.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.33 72.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 117.512 -1.675 . . . . 0.0 112.143 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.14 75.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.855 -1.521 . . . . 0.0 111.69 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.69 -43.21 96.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 C-N-CA 116.927 -1.909 . . . . 0.0 111.289 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 22' ' ' ILE . 55.1 t -58.89 -42.0 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 124.531 1.144 . . . . 0.0 112.128 -172.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -53.71 -47.19 70.78 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.945 171.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -43.26 99.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.483 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 56' ' ' LEU . 85.8 m-20 -68.29 -38.87 82.09 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.62 HG21 ' CD1' ' A' ' 69' ' ' LEU . 30.5 mt -68.04 -49.09 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.219 174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.91 96.37 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 119.0 -1.571 . . . . 0.0 113.62 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 p -68.14 -35.88 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.534 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.87 -47.49 74.18 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.247 162.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.94 -42.28 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 117.993 -1.483 . . . . 0.0 112.167 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -24.67 62.42 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.513 -172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -73.91 -50.18 21.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.981 167.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.58 99.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.221 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -121.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -159.76 97.66 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.627 -1.786 . . . . 0.0 106.945 68.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.928 HG21 HG21 ' A' ' 26' ' ' ILE . 14.4 p -147.88 150.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 126.523 1.929 . . . . 0.0 107.393 107.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' CD ' HG22 ' A' ' 72' ' ' THR . 22.1 mt-10 -105.08 122.02 45.0 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.831 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.96 114.83 20.11 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.837 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -113.01 106.61 14.9 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.374 -2.193 . . . . 0.0 109.019 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.13 96.63 2.23 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 117.985 -2.055 . . . . 0.0 110.648 -135.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -97.68 -44.06 6.93 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.206 -1.497 . . . . 0.0 111.998 66.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.43 161.93 12.56 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -147.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.9 mt -95.23 136.44 35.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.736 -1.732 . . . . 0.0 107.199 -165.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.7 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 12.5 pt -154.17 149.33 12.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 C-N-CA 117.102 -1.839 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.847 HD13 ' CB ' ' A' ' 27' ' ' ALA . 35.8 pt -96.1 150.76 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.197 -1.82 . . . . 0.0 110.302 -150.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' CD ' ' A' ' 63' ' ' GLU . 1.3 p -79.66 164.44 23.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.653 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -25.76 24.93 Favored Glycine 0 CA--C 1.545 1.944 0 C-N-CA 117.992 -2.051 . . . . 0.0 113.824 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -51.4 69.36 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.264 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.604 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.08 80.12 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.326 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -54.42 -35.86 63.38 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.905 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.18 -43.59 81.81 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.487 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -62.69 -47.08 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.954 -177.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.0 mm -67.95 -46.36 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.744 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -61.27 -47.14 87.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 117.595 -1.642 . . . . 0.0 111.779 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.43 -45.17 88.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 117.687 -1.605 . . . . 0.0 111.495 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.738 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.1 -47.51 73.96 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.629 -171.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.8 68.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 118.051 -1.459 . . . . 0.0 112.209 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 54.3 m -61.69 -40.24 94.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 117.794 -1.562 . . . . 0.0 112.008 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' ALA . 82.2 mt -60.94 -41.33 96.04 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 118.806 -1.157 . . . . 0.0 112.907 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -39.94 59.88 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.69 162.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -55.81 -46.1 78.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 116.809 -1.956 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.12 -43.07 99.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 116.537 -2.065 . . . . 0.0 112.369 -161.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 95' ' ' LEU . 3.9 mm-40 -69.76 -73.53 0.16 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 117.954 -1.498 . . . . 0.0 109.098 160.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -68.81 -74.37 0.13 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.298 -158.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' A' ' 94' ' ' LEU . . . 15.15 54.33 0.06 OUTLIER Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 113.144 -1.844 . . . . 0.0 113.996 -158.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.22 164.12 2.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.587 2.191 . . . . 0.0 111.496 -143.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 96' ' ' LYS . 22.0 mt-10 -56.04 75.33 0.0 OUTLIER 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.92 -67.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.755 ' CB ' ' HB3' ' A' ' 91' ' ' ALA . 1.1 tm? -69.18 -43.88 73.34 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 112.065 -2.334 . . . . 0.0 112.199 146.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.33 58.64 3.68 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.858 149.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.35 0.609 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.6 109.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.687 0.756 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -177.31 158.97 1.52 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.655 -142.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -64.09 -25.69 68.21 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.067 -1.878 . . . . 0.0 113.696 -154.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 34.2 m -58.76 -38.96 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.59 -156.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.888 ' HA ' HD12 ' A' ' 8' ' ' ILE . 1.3 t -58.93 -38.57 79.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 116.807 -1.957 . . . . 0.0 112.892 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -60.69 -37.76 82.7 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.389 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.858 HD13 ' CB ' ' A' ' 82' ' ' ALA . 45.6 mm -58.84 -44.34 90.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.955 175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.888 HD12 ' HA ' ' A' ' 5' ' ' THR . 35.3 mt -55.95 -50.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.086 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -51.2 67.07 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.942 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -68.05 -46.12 72.02 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.912 -1.494 . . . . 0.0 111.08 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' HD23 ' A' ' 15' ' ' LEU . 26.4 t -47.8 -54.67 11.67 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.294 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.67 -25.6 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.079 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 t70 63.23 68.22 0.63 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.08 -117.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 15' ' ' LEU . 54.4 t -105.03 -67.02 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.343 142.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 19' ' ' THR . 2.7 mm? -60.62 173.98 0.65 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.798 -154.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.4 t30 -102.33 -158.38 0.67 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.692 153.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.38 -55.91 28.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.007 161.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 21' ' ' THR . 25.4 mttt -64.28 -49.39 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.863 -163.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.496 ' CB ' HD12 ' A' ' 15' ' ' LEU . 51.4 p -64.12 -34.43 78.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 118.163 -1.415 . . . . 0.0 113.004 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . . . -61.68 -46.28 90.38 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.256 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.99 -37.82 84.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 118.334 -1.347 . . . . 0.0 112.597 178.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.845 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -69.39 -51.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.332 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' HD21 ' A' ' 56' ' ' LEU . 13.0 tp -51.6 -36.06 44.11 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.242 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.69 -46.68 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.043 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.534 HG21 ' CG1' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.89 -49.08 79.13 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.113 -1.435 . . . . 0.0 111.691 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.934 HG21 HG21 ' A' ' 62' ' ' VAL . 5.1 mt -58.71 -50.16 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 118.483 -1.287 . . . . 0.0 111.8 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.824 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.75 -46.98 67.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.332 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -54.22 42.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.36 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.48 127.63 42.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.366 -164.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -93.93 115.41 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.86 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.743 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 92.2 m-85 55.72 58.75 4.26 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.171 -1.831 . . . . 0.0 110.318 -161.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.0 tt -54.04 -169.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.08 134.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -137.66 -175.85 4.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.606 -1.634 . . . . 0.0 108.95 147.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.63 -41.88 64.12 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.32 -1.763 . . . . 0.0 112.719 158.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.57 -50.01 74.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.749 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.724 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 tt0 -61.95 -39.79 93.33 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.359 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.9 t -59.65 -44.01 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 117.019 -1.872 . . . . 0.0 111.56 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -54.72 -46.44 74.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.989 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -71.05 -41.24 71.02 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.402 -171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 36' ' ' GLU . 14.7 p -84.66 -12.79 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.266 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.84 108.74 1.72 Allowed Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 132.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.73 -59.85 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.525 2.15 . . . . 0.0 112.944 133.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.13 52.05 1.08 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.771 -163.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 21' ' ' THR . 7.0 mp -78.1 -64.81 1.07 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.273 145.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 141.45 137.36 3.39 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.8 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -61.67 -50.04 74.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 116.56 -2.056 . . . . 0.0 112.108 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.13 90.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 111.822 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.21 -44.99 87.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 116.88 -1.928 . . . . 0.0 111.037 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.845 HG22 HD11 ' A' ' 22' ' ' ILE . 33.0 t -58.84 -43.74 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 124.41 1.069 . . . . 0.0 111.641 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -53.7 -46.97 70.91 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.838 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.86 -43.16 99.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.474 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.0 m-20 -68.16 -39.06 82.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.403 -169.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.623 HG21 ' CD1' ' A' ' 69' ' ' LEU . 62.6 mt -67.24 -49.06 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.298 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.44 96.62 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.551 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.04 -35.83 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.447 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.82 -47.48 74.04 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.362 162.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.64 -42.19 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 117.811 -1.556 . . . . 0.0 112.219 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -23.59 62.15 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.573 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -73.79 -49.76 23.77 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.83 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.62 99.48 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -122.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -160.42 97.76 1.23 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.115 69.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.934 HG21 HG21 ' A' ' 26' ' ' ILE . 12.1 p -147.81 150.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 126.917 2.087 . . . . 0.0 107.653 105.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -103.71 123.33 46.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.367 167.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.88 113.06 18.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.521 176.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -112.88 106.61 14.95 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.32 -2.218 . . . . 0.0 109.042 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.63 96.78 2.24 Favored Glycine 0 C--N 1.347 1.182 0 C-N-CA 117.728 -2.177 . . . . 0.0 110.576 -137.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -43.66 6.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.064 67.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -90.06 -179.84 44.18 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -152.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.8 mt -111.08 134.9 52.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.824 -1.688 . . . . 0.0 108.5 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 31.2 pt -154.02 149.5 12.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 117.611 -1.636 . . . . 0.0 109.674 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.824 HD13 ' CB ' ' A' ' 27' ' ' ALA . 32.3 pt -96.24 152.6 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.531 -157.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.89 172.9 12.76 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.922 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -26.44 38.71 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 112.803 -1.999 . . . . 0.0 113.739 171.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.55 -52.13 66.94 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 111.213 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.41 -48.05 80.14 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.484 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -54.37 -35.68 63.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.904 -172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.13 -45.03 78.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.411 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mm -62.78 -47.22 93.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.261 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 79' ' ' ILE . 3.0 mm -63.61 -46.34 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.853 -175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -59.04 -47.15 86.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 118.212 -1.395 . . . . 0.0 111.937 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -63.9 -45.15 90.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.65 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.858 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -66.05 -47.45 74.32 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.743 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.73 68.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 118.052 -1.459 . . . . 0.0 112.311 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 51.9 m -61.71 -37.67 85.03 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.512 171.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 86.6 mt -63.7 -40.2 96.19 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.039 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -41.47 61.2 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.576 159.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -64.69 -43.8 92.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.214 -173.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -56.13 -43.01 77.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 117.886 -1.525 . . . . 0.0 112.571 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -116.83 -55.47 2.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.225 -154.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.7 -60.97 2.5 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.625 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -28.29 121.83 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 O-C-N 125.489 1.743 . . . . 0.0 112.69 -155.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HA ' ' H ' ' A' ' 96' ' ' LYS . 2.9 Cg_endo -72.72 165.9 31.44 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.734 1.623 . . . . 0.0 112.48 156.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -78.69 53.73 1.39 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 113.257 -1.792 . . . . 0.0 111.508 -78.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 91' ' ' ALA . 1.6 tm? -38.27 -60.35 0.79 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.106 -1.861 . . . . 0.0 112.448 123.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 94' ' ' LEU . 2.5 tm? -121.53 -56.44 1.88 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.01 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 92' ' ' PRO . 2.4 tmtm? . . . . . 0 C--N 1.35 0.611 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.784 -135.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 121.869 0.843 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 -65.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.96 -157.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -37.92 89.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.204 -152.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 12.8 m -58.72 -38.97 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.432 -171.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.79 ' HA ' HD12 ' A' ' 8' ' ' ILE . 25.1 m -58.54 -41.31 85.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 118.739 -1.185 . . . . 0.0 111.902 174.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -63.4 -37.59 87.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.454 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 24' ' ' ILE . 14.9 mm -58.25 -46.64 88.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.632 174.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 5' ' ' THR . 37.6 mt -55.8 -42.69 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.56 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.33 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.672 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.11 -46.13 68.46 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.07 -169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 14.5 t -51.04 -47.29 61.76 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.74 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 11' ' ' SER . 9.3 t-20 109.05 65.67 0.0 OUTLIER 'General case' 0 C--N 1.352 0.702 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.898 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 50.21 48.64 21.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.795 -2.002 . . . . 0.0 112.221 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 15' ' ' LEU . 40.3 t -96.64 -64.66 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.554 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.214 159.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD22 ' HB ' ' A' ' 14' ' ' VAL . 2.3 mm? -65.86 169.7 6.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.491 -161.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.637 ' C ' HD11 ' A' ' 8' ' ' ILE . 17.3 m-80 -94.89 -158.8 0.67 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 112.865 -1.97 . . . . 0.0 108.589 153.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -52.76 -55.22 24.43 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.777 146.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -64.18 -49.2 72.97 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.76 -158.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' LEU . 46.1 p -67.04 -33.71 76.13 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.26 -1.336 . . . . 0.0 113.288 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.77 -46.32 90.1 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.186 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -67.29 -37.93 84.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.25 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.833 ' CD1' HD23 ' A' ' 44' ' ' LEU . 1.9 mm -65.64 -51.37 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.418 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 56' ' ' LEU . 16.4 tp -51.82 -39.1 58.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.587 -1.642 . . . . 0.0 112.206 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 7' ' ' ILE . 2.5 mm -61.97 -49.36 84.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.574 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.701 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.98 -45.18 91.22 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.508 -172.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.948 HG21 HG21 ' A' ' 62' ' ' VAL . 5.9 mt -61.4 -50.35 80.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.491 168.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.805 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.01 68.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.518 -1.674 . . . . 0.0 112.121 -167.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -56.77 11.27 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.182 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -97.96 121.18 39.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.636 -164.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.1 m-20 -92.17 113.52 25.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.737 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 82.8 m-85 59.25 59.88 2.55 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.658 -156.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 33' ' ' THR . 4.3 tt -53.06 -164.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.477 131.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.3 p -143.61 -176.35 4.93 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.843 141.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.91 -38.21 67.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.974 159.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -57.3 -50.12 73.94 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.574 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 tt0 -61.86 -42.4 99.0 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.969 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' THR . 66.3 t -59.7 -40.84 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.013 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -45.42 74.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.378 164.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 4.0 mm-40 -71.22 -41.09 70.64 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.453 -163.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 25' ' ' THR . 2.1 p -55.41 -55.81 15.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.899 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 6.5 p80 -56.41 122.98 53.44 Favored Pre-proline 0 N--CA 1.439 -1.001 0 O-C-N 124.782 1.301 . . . . 0.0 111.218 -147.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 41' ' ' HIS . 3.6 Cg_exo -62.3 -62.01 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.391 1.394 . . . . 0.0 112.213 144.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -137.91 51.66 1.88 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.135 -162.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.833 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.8 mp -94.86 -68.7 0.79 Allowed 'General case' 0 C--N 1.349 0.547 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.502 151.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 126.53 128.96 3.23 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.783 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -50.28 62.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.569 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.22 75.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.819 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.8 m -64.63 -38.08 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 116.571 -2.052 . . . . 0.0 111.657 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 45' ' ' GLY . 72.1 t -58.9 -43.26 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.078 -174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.77 -47.22 70.94 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.95 170.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -62.99 -43.22 99.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.5 m-20 -68.2 -39.06 82.55 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.529 -167.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 69' ' ' LEU . 40.6 mt -67.2 -49.03 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.297 174.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.94 -42.0 96.58 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.556 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.27 -35.86 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 118.742 -1.183 . . . . 0.0 112.569 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.95 -47.55 74.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.351 162.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.16 -42.31 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 118.105 -1.438 . . . . 0.0 112.246 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.36 62.31 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.49 -173.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' HG13 ' A' ' 14' ' ' VAL . 15.8 mttm -73.83 -51.33 16.66 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.874 164.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.577 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 75.08 99.52 0.11 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -122.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -158.66 97.77 1.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.773 -1.714 . . . . 0.0 106.944 68.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 26' ' ' ILE . 10.5 p -147.66 150.45 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 126.767 2.027 . . . . 0.0 107.613 104.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.05 125.46 50.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.172 170.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' CB ' HD22 ' A' ' 69' ' ' LEU . 1.2 tmtp? -80.8 119.08 22.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.843 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -114.07 106.74 14.75 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.056 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.14 96.79 2.2 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 118.163 -1.97 . . . . 0.0 110.603 -136.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.0 -43.52 7.4 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.176 -1.512 . . . . 0.0 112.153 67.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.09 160.19 13.31 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -148.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 53' ' ' ILE . 5.2 mt -96.84 134.01 40.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 112.566 -1.817 . . . . 0.0 107.599 -165.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.707 HG22 ' HA ' ' A' ' 30' ' ' ASP . 20.8 pt -148.2 149.4 15.26 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.028 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.805 HD13 ' CB ' ' A' ' 27' ' ' ALA . 34.0 pt -94.99 152.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.795 -156.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.84 170.2 17.0 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.836 -1.984 . . . . 0.0 108.957 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.93 -26.02 25.34 Favored Glycine 0 CA--C 1.547 2.051 0 CA-C-N 112.44 -2.164 . . . . 0.0 113.694 171.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -52.14 66.99 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 117.404 -1.718 . . . . 0.0 111.23 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.44 -48.11 80.03 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.316 175.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -54.28 -35.78 62.95 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.844 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.02 -45.17 78.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.404 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mm -62.71 -47.25 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.484 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.6 mm -64.88 -46.18 92.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.954 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 m -58.9 -46.96 86.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.858 -1.537 . . . . 0.0 111.868 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -68.41 -45.37 72.83 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 117.016 -1.874 . . . . 0.0 111.494 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . -66.34 -44.98 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 117.96 -1.496 . . . . 0.0 112.123 -171.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.62 -38.87 72.69 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 118.233 -1.387 . . . . 0.0 112.318 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.7 m -61.78 -39.55 92.08 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 118.326 -1.349 . . . . 0.0 112.358 172.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.06 -40.95 95.62 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.051 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -41.87 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.563 161.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -62.77 -45.98 90.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.585 -1.646 . . . . 0.0 112.108 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.738 ' O ' HD13 ' A' ' 95' ' ' LEU . 7.8 pt20 -56.0 -39.72 72.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 118.216 -1.394 . . . . 0.0 112.753 -174.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' HD22 ' A' ' 95' ' ' LEU . 3.6 mm-40 -117.69 -57.41 2.12 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.956 -151.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -62.64 -57.97 9.15 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.59 77.82 0.35 Allowed Pre-proline 0 C--N 1.348 0.516 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.728 144.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.68 -52.27 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 114.013 168.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -145.37 62.99 1.28 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.217 -162.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.95 -62.81 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.708 -2.042 . . . . 0.0 109.328 -135.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 88' ' ' GLN . 7.4 tp -130.53 -60.45 0.99 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-N 112.036 -2.347 . . . . 0.0 110.001 -170.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? . . . . . 0 C--N 1.348 0.521 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.597 123.24 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.519 0.676 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t 51.6 49.02 21.77 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.301 -109.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HD2' HG21 ' A' ' 24' ' ' ILE . 4.8 ttmt -74.13 -52.29 12.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.428 172.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 19.5 m -59.02 -38.78 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.719 -162.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 8' ' ' ILE . 47.3 m -58.43 -39.37 79.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.947 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -61.91 -37.89 86.33 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.897 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.762 HD13 ' HB1' ' A' ' 82' ' ' ALA . 26.5 mm -62.16 -47.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.656 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 16' ' ' ASN . 71.3 mt -55.9 -50.02 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.434 173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -51.05 67.4 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.756 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.05 -46.06 68.83 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.328 -172.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 28.6 t -53.55 -46.07 70.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 118.422 -1.311 . . . . 0.0 112.614 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' SER . 12.1 t-20 105.01 64.84 0.0 OUTLIER 'General case' 0 C--N 1.352 0.679 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.003 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 52.23 47.61 24.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.161 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 15' ' ' LEU . 79.5 t -96.2 -60.45 2.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.933 158.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -64.31 166.86 7.49 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.661 -170.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' C ' HD11 ' A' ' 8' ' ' ILE . 32.6 t30 -97.09 -152.48 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.628 154.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.17 -57.03 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.741 155.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 21' ' ' THR . 7.6 mttp -64.2 -49.51 71.73 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.68 -160.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -62.58 -33.89 75.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.94 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.69 -46.35 90.06 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.065 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 44' ' ' LEU . 1.2 t -67.24 -38.78 85.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.821 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 49' ' ' VAL . 1.5 mm -67.17 -51.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.156 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 56' ' ' LEU . 12.9 tp -51.68 -40.46 60.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.802 -1.545 . . . . 0.0 111.951 171.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 7' ' ' ILE . 3.1 mm -63.56 -48.79 85.27 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.664 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.724 HG21 HG11 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -58.86 -44.22 90.97 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.546 -173.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.963 HG21 HG21 ' A' ' 62' ' ' VAL . 6.3 mt -59.79 -50.28 80.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.778 167.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.754 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.83 -47.08 67.94 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.439 -1.71 . . . . 0.0 112.312 -167.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.21 -60.1 3.79 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.743 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 118.19 30.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 112.802 -1.999 . . . . 0.0 109.554 -164.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.5 m-20 -88.63 110.63 21.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.7 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.717 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 6.8 m-30 62.24 57.78 1.91 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.335 -1.757 . . . . 0.0 109.511 -159.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 tt -50.35 -163.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 112.988 -1.914 . . . . 0.0 110.764 132.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 35' ' ' ALA . 18.1 p -142.88 -175.57 4.55 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.853 140.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.1 -42.81 66.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.644 159.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -53.78 -50.01 67.03 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.83 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.84 -41.36 97.71 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 117.582 -1.647 . . . . 0.0 112.075 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 49' ' ' VAL . 97.0 t -59.79 -40.74 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.04 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -54.17 -44.92 71.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 118.697 -1.201 . . . . 0.0 112.64 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 3.3 mm-40 -71.07 -41.08 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.211 -1.358 . . . . 0.0 112.221 -164.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 25' ' ' THR . 2.2 p -56.89 -53.15 46.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.154 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -54.9 124.52 52.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 124.665 1.228 . . . . 0.0 111.328 -160.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.59 -65.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.554 1.503 . . . . 0.0 111.666 134.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.36 44.61 2.71 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 112.856 -1.974 . . . . 0.0 110.666 -153.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 21' ' ' THR . 7.7 mp -101.92 -72.67 0.68 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.847 159.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 133.82 137.51 3.85 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 119.361 -1.4 . . . . 0.0 111.052 175.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.29 -50.32 71.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 117.673 -1.611 . . . . 0.0 112.208 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.99 -46.16 75.43 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.686 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 m -65.28 -42.64 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 117.215 -1.794 . . . . 0.0 111.348 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HD11 ' A' ' 22' ' ' ILE . 54.6 t -58.93 -41.38 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.277 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -53.91 -47.14 71.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.077 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -43.11 99.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.589 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 49' ' ' VAL . 86.0 m-20 -68.26 -38.86 82.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 36.6 mt -67.21 -48.99 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.45 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.76 96.16 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.583 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HE2' ' A' ' 58' ' ' LYS . 5.9 p -68.04 -35.88 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.532 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.79 -47.68 73.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.347 162.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.2 94.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.222 -1.391 . . . . 0.0 112.227 -174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HE2' HG23 ' A' ' 55' ' ' VAL . 29.1 pttt -68.85 -26.97 65.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.374 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -73.53 -49.29 27.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.768 168.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 72.13 99.54 0.07 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -122.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -159.59 97.75 1.34 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.769 -1.715 . . . . 0.0 107.314 69.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.963 HG21 HG21 ' A' ' 26' ' ' ILE . 11.8 p -147.79 150.58 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.285 2.234 . . . . 0.0 107.699 105.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -103.93 127.58 51.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.028 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CB ' HD22 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -80.79 124.22 28.88 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.364 177.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -117.46 106.74 13.51 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.371 -2.195 . . . . 0.0 109.123 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.05 97.35 2.31 Favored Glycine 0 C--N 1.348 1.232 0 C-N-CA 118.224 -1.941 . . . . 0.0 110.58 -139.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -97.2 -42.58 7.75 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.176 68.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.64 12.68 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -149.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 53' ' ' ILE . 4.9 mt -97.16 137.28 36.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.721 -1.739 . . . . 0.0 107.782 -167.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 15.1 pt -152.17 149.5 13.68 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 C-N-CA 117.039 -1.864 . . . . 0.0 110.035 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.754 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.5 pt -93.21 157.5 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.182 -1.827 . . . . 0.0 110.031 -155.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.4 p -77.79 176.45 9.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 111.801 -2.454 . . . . 0.0 109.218 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.31 56.75 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.098 -1.864 . . . . 0.0 113.433 164.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.83 -48.65 77.53 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 118.265 -1.374 . . . . 0.0 111.806 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -57.52 -47.98 80.5 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.216 171.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -54.33 -35.89 63.18 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.773 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.11 -45.09 78.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 118.984 -1.087 . . . . 0.0 111.451 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -62.82 -47.23 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.586 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.8 mm -63.43 -44.54 98.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.477 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.234 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 m -58.78 -47.06 86.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 117.672 -1.611 . . . . 0.0 111.649 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.09 -45.46 66.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 117.109 -1.836 . . . . 0.0 111.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.762 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -66.42 -48.39 70.2 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.306 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.77 -38.52 67.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.322 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.0 m -61.79 -41.04 97.22 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.57 169.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 62.8 mt -61.1 -37.48 82.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 118.446 -1.302 . . . . 0.0 113.351 177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.271 0.0 OUTLIER -57.4 -49.99 74.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.903 160.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -53.96 -38.71 65.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.74 -172.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 4.9 pt20 -55.95 -37.48 69.07 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.06 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.75 -61.96 1.6 Allowed 'General case' 0 C--N 1.352 0.674 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.77 -164.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -73.32 -28.24 61.96 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.408 -1.723 . . . . 0.0 112.861 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 94' ' ' LEU . . . 64.68 90.5 0.09 OUTLIER Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.1 145.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HD2' HD12 ' A' ' 94' ' ' LEU . 9.3 Cg_endo -81.4 145.21 14.83 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.486 2.124 . . . . 0.0 110.359 163.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.58 109.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.634 -107.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.815 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -148.16 -53.64 0.19 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 112.186 -2.279 . . . . 0.0 109.611 -148.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.8 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -51.34 -27.31 9.35 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.224 -1.807 . . . . 0.0 113.146 164.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.353 0.756 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -101.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.733 0.777 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.24 -63.32 0.22 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.333 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -64.05 -52.4 59.59 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.977 -150.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.2 m -65.98 -38.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.489 -173.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.682 ' HA ' HD12 ' A' ' 8' ' ' ILE . 59.3 m -58.47 -38.93 78.61 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.76 174.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -64.44 -37.69 88.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.594 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 24' ' ' ILE . 13.6 mm -58.03 -47.13 87.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 118.154 -1.419 . . . . 0.0 111.865 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 5' ' ' THR . 48.4 mt -55.88 -43.85 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.4 174.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.18 -51.26 70.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.624 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . . . -69.07 -46.1 68.68 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.065 -169.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 19.3 t -52.23 -46.71 65.82 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.539 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 11' ' ' SER . 13.3 t-20 107.1 65.84 0.0 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.916 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.55 48.64 22.51 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 112.685 -2.052 . . . . 0.0 112.063 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 15' ' ' LEU . 60.4 t -98.41 -61.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.724 160.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' N ' HD22 ' A' ' 15' ' ' LEU . 2.2 mm? -65.6 174.03 2.46 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.624 -165.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' C ' HD11 ' A' ' 8' ' ' ILE . 33.6 m120 -99.84 -157.62 0.62 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.495 150.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HD11 ' A' ' 8' ' ' ILE . 19.5 mt-10 -53.38 -55.84 21.7 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.747 149.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -64.09 -49.28 72.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.633 -1.622 . . . . 0.0 112.02 -158.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.424 ' CB ' HD12 ' A' ' 15' ' ' LEU . 44.5 p -65.61 -32.66 74.37 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.439 174.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 7' ' ' ILE . . . -61.72 -46.33 90.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.12 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.2 t -67.15 -42.0 85.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 118.479 -1.288 . . . . 0.0 113.198 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 49' ' ' VAL . 1.7 mm -61.73 -51.3 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.316 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 56' ' ' LEU . 17.7 tp -51.86 -39.29 58.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.357 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.908 HD11 HD11 ' A' ' 7' ' ' ILE . 2.1 mm -63.99 -46.94 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.037 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.709 HG21 HG11 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -58.95 -47.14 86.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 117.896 -1.522 . . . . 0.0 111.727 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 62' ' ' VAL . 5.0 mt -60.6 -50.18 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.678 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.819 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -52.81 -47.09 67.87 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.361 -1.745 . . . . 0.0 112.344 -170.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.46 -57.31 12.85 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.006 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -92.05 122.9 34.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.434 -162.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' HG22 ' A' ' 70' ' ' ILE . 65.2 m-20 -90.89 107.72 19.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.946 -1.934 . . . . 0.0 109.907 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.714 ' H ' ' CG2' ' A' ' 70' ' ' ILE . 7.7 m-30 62.33 58.31 1.77 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.694 -163.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 33' ' ' THR . 4.7 tt -50.76 -159.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.812 136.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 37' ' ' VAL . 10.7 p -144.41 -177.56 5.54 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.866 139.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.44 63.54 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.645 159.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 33' ' ' THR . . . -55.25 -50.11 70.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.855 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -61.95 -41.39 97.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 118.115 -1.434 . . . . 0.0 112.329 177.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 33' ' ' THR . 76.0 t -59.66 -40.98 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 117.745 -1.582 . . . . 0.0 111.968 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -53.65 -43.95 69.2 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.506 166.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.07 -41.16 71.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.205 -168.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.709 HG11 HG21 ' A' ' 25' ' ' THR . 7.2 p -83.3 -12.26 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.33 -1.305 . . . . 0.0 113.531 -171.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -67.2 124.12 88.12 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.853 161.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.08 -63.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.916 1.744 . . . . 0.0 111.669 131.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -132.66 44.23 2.89 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.939 -152.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' A' ' 22' ' ' ILE . 6.2 mp -89.64 -66.3 0.94 Allowed 'General case' 0 C--N 1.35 0.622 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.586 155.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 128.75 125.49 2.76 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.256 177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -54.02 -49.79 68.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.39 -1.724 . . . . 0.0 112.824 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.19 89.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 117.976 -1.489 . . . . 0.0 111.822 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 45' ' ' GLY . 8.4 m -64.3 -38.28 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 116.542 -2.063 . . . . 0.0 111.784 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLY . 77.8 t -61.98 -42.37 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 124.395 1.059 . . . . 0.0 112.18 -172.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -53.79 -46.96 71.22 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.923 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 t -62.96 -43.14 99.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 117.731 -1.588 . . . . 0.0 112.311 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' O ' HD22 ' A' ' 56' ' ' LEU . 87.1 m-20 -68.18 -38.95 82.57 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.091 -0.958 . . . . 0.0 113.485 -167.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 51.3 mt -67.08 -49.15 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.282 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.29 96.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 119.116 -1.516 . . . . 0.0 113.453 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.02 -35.96 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.501 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -54.88 -47.5 74.18 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 119.169 -1.013 . . . . 0.0 111.241 162.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.27 -42.32 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.126 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -24.06 62.25 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.584 -173.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -73.74 -49.63 24.61 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.948 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 61' ' ' LEU . . . 71.34 99.47 0.06 OUTLIER Glycine 0 C--N 1.348 1.21 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -121.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -159.38 97.82 1.37 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.729 -1.736 . . . . 0.0 107.134 69.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 26' ' ' ILE . 14.7 p -147.83 150.51 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.379 1.871 . . . . 0.0 107.772 107.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.669 ' CD ' HG22 ' A' ' 72' ' ' THR . 15.9 mt-10 -104.9 121.87 44.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.092 173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CB ' HD22 ' A' ' 69' ' ' LEU . 12.9 ttpt -81.03 115.88 20.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.63 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -113.81 106.53 14.58 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.583 -2.098 . . . . 0.0 109.058 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.33 87.87 0.68 Allowed Glycine 0 C--N 1.347 1.154 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.79 -127.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -150.1 61.44 0.98 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.132 -1.534 . . . . 0.0 110.029 72.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -150.1 176.1 28.89 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.199 134.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD1' ' CG2' ' A' ' 53' ' ' ILE . 5.4 mt -99.48 141.15 32.64 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 112.928 -1.636 . . . . 0.0 107.963 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.714 ' CG2' ' H ' ' A' ' 31' ' ' PHE . 16.4 pt -154.22 149.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 117.266 -1.774 . . . . 0.0 109.873 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 27' ' ' ALA . 36.3 pt -91.88 160.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 117.378 -1.729 . . . . 0.0 110.056 -156.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 63' ' ' GLU . 16.9 p -77.83 176.38 9.11 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 111.732 -2.485 . . . . 0.0 108.974 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.2 -38.05 55.85 Favored Glycine 0 CA--C 1.544 1.904 0 C-N-CA 118.22 -1.943 . . . . 0.0 113.514 163.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -56.95 -49.57 75.28 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.75 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -57.45 -47.54 81.56 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.243 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -54.22 -35.84 62.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.893 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.09 -45.08 78.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.398 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.79 -47.15 94.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.4 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.5 mm -64.19 -46.15 94.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.04 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 m -58.97 -46.98 86.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.78 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -45.28 72.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 117.386 -1.726 . . . . 0.0 111.585 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . . . -66.2 -47.22 74.61 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.916 -173.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.65 67.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 118.398 -1.321 . . . . 0.0 112.291 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.7 m -61.7 -39.37 91.24 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.544 171.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -40.57 96.19 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.026 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -42.19 62.35 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.552 161.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -61.99 -45.05 95.31 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 118.066 -1.454 . . . . 0.0 111.954 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.44 -43.06 83.57 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 117.721 -1.592 . . . . 0.0 112.507 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.65 -59.24 1.75 Allowed 'General case' 0 C--N 1.349 0.557 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.13 -162.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -63.22 -57.12 11.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 96' ' ' LYS . . . 64.58 75.64 0.36 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.197 149.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.49 -57.93 1.69 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 O-C-N 124.185 1.623 . . . . 0.0 112.826 -147.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.53 -66.96 1.02 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.075 161.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.402 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER 38.15 -85.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 111.925 -2.398 . . . . 0.0 112.292 144.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.72 -58.98 1.47 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.8 -1.546 . . . . 0.0 109.767 -173.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' H ' ' HB3' ' A' ' 91' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.349 0.58 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.082 -172.171 . . . . . . . . 2 2 . 1 stop_ save_